date generated: 2022-10-13
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## x
## 0610009B22Rik -1.1049767
## 0610009E02Rik 0.6328195
## 0610009L18Rik -1.8903112
## 0610010K14Rik 0.5240337
## 0610012G03Rik -0.2555955
## 0610030E20Rik 0.7313254
Here are some metrics about the input data profile:
Profile metrics | |
---|---|
num_genesets | 1604 |
num_genes_in_profile | 17516 |
duplicated_genes_present | 0 |
num_profile_genes_in_sets | 8436 |
num_profile_genes_not_in_sets | 9080 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Gene sets metrics | |
---|---|
num_genesets | 1604 |
num_genesets_excluded | 423 |
num_genesets_included | 1181 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
INCRETIN SYNTHESIS SECRETION AND INACTIVATION | 13 | 2.96e-04 | -0.580 | 3.39e-03 |
SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 | 12 | 8.60e-04 | -0.556 | 8.54e-03 |
HSF1 ACTIVATION | 27 | 8.90e-07 | -0.546 | 3.09e-05 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 4.78e-03 | -0.515 | 3.25e-02 |
ATTENUATION PHASE | 25 | 8.44e-06 | -0.515 | 1.89e-04 |
EUKARYOTIC TRANSLATION ELONGATION | 87 | 2.50e-16 | -0.508 | 5.91e-14 |
NEUROTOXICITY OF CLOSTRIDIUM TOXINS | 10 | 5.76e-03 | 0.504 | 3.72e-02 |
COMPLEX I BIOGENESIS | 56 | 8.77e-11 | -0.501 | 5.76e-09 |
NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | 21 | 9.99e-05 | 0.490 | 1.39e-03 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 1.81e-05 | -0.486 | 3.50e-04 |
ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 5.28e-04 | 0.486 | 5.64e-03 |
CHOLESTEROL BIOSYNTHESIS | 24 | 3.84e-05 | -0.485 | 6.30e-04 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 95 | 4.52e-16 | -0.482 | 8.91e-14 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 106 | 1.90e-17 | -0.478 | 7.48e-15 |
CGMP EFFECTS | 15 | 1.77e-03 | 0.466 | 1.53e-02 |
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 7.40e-04 | -0.447 | 7.47e-03 |
REDUCTION OF CYTOSOLIC CA LEVELS | 11 | 1.04e-02 | 0.446 | 6.23e-02 |
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 59 | 3.28e-09 | -0.445 | 1.80e-07 |
ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES | 10 | 1.48e-02 | 0.445 | 8.09e-02 |
LONG TERM POTENTIATION | 23 | 2.45e-04 | 0.442 | 2.89e-03 |
TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | 17 | 1.66e-03 | 0.440 | 1.48e-02 |
SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | 11 | 1.17e-02 | -0.439 | 6.69e-02 |
UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION | 21 | 5.24e-04 | 0.437 | 5.64e-03 |
RESPIRATORY ELECTRON TRANSPORT | 102 | 2.50e-14 | -0.437 | 3.28e-12 |
COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING | 35 | 8.65e-06 | -0.434 | 1.89e-04 |
VOLTAGE GATED POTASSIUM CHANNELS | 39 | 4.31e-06 | 0.425 | 1.21e-04 |
GLYCOGEN STORAGE DISEASES | 12 | 1.08e-02 | -0.425 | 6.35e-02 |
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 29 | 7.53e-05 | -0.425 | 1.11e-03 |
EUKARYOTIC TRANSLATION INITIATION | 114 | 6.04e-15 | -0.423 | 8.91e-13 |
AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA | 53 | 1.10e-07 | -0.422 | 4.80e-06 |
RHOBTB2 GTPASE CYCLE | 23 | 4.91e-04 | -0.420 | 5.37e-03 |
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 10 | 2.23e-02 | -0.417 | 1.10e-01 |
EFFECTS OF PIP2 HYDROLYSIS | 27 | 1.77e-04 | 0.417 | 2.20e-03 |
REGULATION OF EXPRESSION OF SLITS AND ROBOS | 161 | 1.06e-19 | -0.415 | 6.27e-17 |
TRAFFICKING OF AMPA RECEPTORS | 31 | 7.78e-05 | 0.410 | 1.13e-03 |
SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 60 | 5.02e-08 | -0.407 | 2.47e-06 |
SELENOAMINO ACID METABOLISM | 110 | 3.40e-13 | -0.402 | 3.34e-11 |
STAT5 ACTIVATION DOWNSTREAM OF FLT3 ITD MUTANTS | 10 | 2.80e-02 | 0.401 | 1.32e-01 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 19 | 2.48e-03 | -0.401 | 1.96e-02 |
GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | 19 | 2.49e-03 | 0.401 | 1.96e-02 |
SIGNALING BY HIPPO | 20 | 2.00e-03 | -0.399 | 1.66e-02 |
G PROTEIN ACTIVATION | 22 | 1.25e-03 | -0.397 | 1.18e-02 |
HEDGEHOG LIGAND BIOGENESIS | 61 | 7.95e-08 | -0.397 | 3.76e-06 |
MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS | 13 | 1.33e-02 | -0.397 | 7.45e-02 |
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 2.33e-02 | 0.395 | 1.14e-01 |
PD 1 SIGNALING | 10 | 3.16e-02 | 0.393 | 1.45e-01 |
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY | 53 | 9.22e-07 | -0.390 | 3.11e-05 |
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 125 | 8.49e-14 | -0.386 | 1.00e-11 |
DEGRADATION OF DVL | 55 | 8.10e-07 | -0.385 | 2.97e-05 |
NONSENSE MEDIATED DECAY NMD | 109 | 5.77e-12 | -0.382 | 4.26e-10 |
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
INCRETIN SYNTHESIS SECRETION AND INACTIVATION | 13 | 2.96e-04 | -0.580000 | 3.39e-03 |
SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 | 12 | 8.60e-04 | -0.556000 | 8.54e-03 |
HSF1 ACTIVATION | 27 | 8.90e-07 | -0.546000 | 3.09e-05 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 4.78e-03 | -0.515000 | 3.25e-02 |
ATTENUATION PHASE | 25 | 8.44e-06 | -0.515000 | 1.89e-04 |
EUKARYOTIC TRANSLATION ELONGATION | 87 | 2.50e-16 | -0.508000 | 5.91e-14 |
NEUROTOXICITY OF CLOSTRIDIUM TOXINS | 10 | 5.76e-03 | 0.504000 | 3.72e-02 |
COMPLEX I BIOGENESIS | 56 | 8.77e-11 | -0.501000 | 5.76e-09 |
NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | 21 | 9.99e-05 | 0.490000 | 1.39e-03 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 1.81e-05 | -0.486000 | 3.50e-04 |
ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 5.28e-04 | 0.486000 | 5.64e-03 |
CHOLESTEROL BIOSYNTHESIS | 24 | 3.84e-05 | -0.485000 | 6.30e-04 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 95 | 4.52e-16 | -0.482000 | 8.91e-14 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 106 | 1.90e-17 | -0.478000 | 7.48e-15 |
CGMP EFFECTS | 15 | 1.77e-03 | 0.466000 | 1.53e-02 |
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 7.40e-04 | -0.447000 | 7.47e-03 |
REDUCTION OF CYTOSOLIC CA LEVELS | 11 | 1.04e-02 | 0.446000 | 6.23e-02 |
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 59 | 3.28e-09 | -0.445000 | 1.80e-07 |
ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES | 10 | 1.48e-02 | 0.445000 | 8.09e-02 |
LONG TERM POTENTIATION | 23 | 2.45e-04 | 0.442000 | 2.89e-03 |
TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | 17 | 1.66e-03 | 0.440000 | 1.48e-02 |
SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | 11 | 1.17e-02 | -0.439000 | 6.69e-02 |
UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION | 21 | 5.24e-04 | 0.437000 | 5.64e-03 |
RESPIRATORY ELECTRON TRANSPORT | 102 | 2.50e-14 | -0.437000 | 3.28e-12 |
COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING | 35 | 8.65e-06 | -0.434000 | 1.89e-04 |
VOLTAGE GATED POTASSIUM CHANNELS | 39 | 4.31e-06 | 0.425000 | 1.21e-04 |
GLYCOGEN STORAGE DISEASES | 12 | 1.08e-02 | -0.425000 | 6.35e-02 |
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 29 | 7.53e-05 | -0.425000 | 1.11e-03 |
EUKARYOTIC TRANSLATION INITIATION | 114 | 6.04e-15 | -0.423000 | 8.91e-13 |
AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA | 53 | 1.10e-07 | -0.422000 | 4.80e-06 |
RHOBTB2 GTPASE CYCLE | 23 | 4.91e-04 | -0.420000 | 5.37e-03 |
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 10 | 2.23e-02 | -0.417000 | 1.10e-01 |
EFFECTS OF PIP2 HYDROLYSIS | 27 | 1.77e-04 | 0.417000 | 2.20e-03 |
REGULATION OF EXPRESSION OF SLITS AND ROBOS | 161 | 1.06e-19 | -0.415000 | 6.27e-17 |
TRAFFICKING OF AMPA RECEPTORS | 31 | 7.78e-05 | 0.410000 | 1.13e-03 |
SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 60 | 5.02e-08 | -0.407000 | 2.47e-06 |
SELENOAMINO ACID METABOLISM | 110 | 3.40e-13 | -0.402000 | 3.34e-11 |
STAT5 ACTIVATION DOWNSTREAM OF FLT3 ITD MUTANTS | 10 | 2.80e-02 | 0.401000 | 1.32e-01 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 19 | 2.48e-03 | -0.401000 | 1.96e-02 |
GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | 19 | 2.49e-03 | 0.401000 | 1.96e-02 |
SIGNALING BY HIPPO | 20 | 2.00e-03 | -0.399000 | 1.66e-02 |
G PROTEIN ACTIVATION | 22 | 1.25e-03 | -0.397000 | 1.18e-02 |
HEDGEHOG LIGAND BIOGENESIS | 61 | 7.95e-08 | -0.397000 | 3.76e-06 |
MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS | 13 | 1.33e-02 | -0.397000 | 7.45e-02 |
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 2.33e-02 | 0.395000 | 1.14e-01 |
PD 1 SIGNALING | 10 | 3.16e-02 | 0.393000 | 1.45e-01 |
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY | 53 | 9.22e-07 | -0.390000 | 3.11e-05 |
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 125 | 8.49e-14 | -0.386000 | 1.00e-11 |
DEGRADATION OF DVL | 55 | 8.10e-07 | -0.385000 | 2.97e-05 |
NONSENSE MEDIATED DECAY NMD | 109 | 5.77e-12 | -0.382000 | 4.26e-10 |
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA | 13 | 1.72e-02 | -0.382000 | 8.90e-02 |
NEGATIVE REGULATION OF NOTCH4 SIGNALING | 54 | 1.38e-06 | -0.380000 | 4.53e-05 |
DEGRADATION OF AXIN | 53 | 1.82e-06 | -0.379000 | 5.80e-05 |
INTERLEUKIN 6 FAMILY SIGNALING | 19 | 4.40e-03 | 0.377000 | 3.06e-02 |
HDR THROUGH MMEJ ALT NHEJ | 10 | 4.17e-02 | 0.372000 | 1.78e-01 |
PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | 16 | 1.10e-02 | -0.367000 | 6.44e-02 |
INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | 29 | 6.36e-04 | -0.366000 | 6.59e-03 |
CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | 46 | 1.97e-05 | -0.364000 | 3.76e-04 |
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS | 84 | 8.81e-09 | -0.363000 | 4.52e-07 |
CALNEXIN CALRETICULIN CYCLE | 26 | 1.36e-03 | -0.363000 | 1.26e-02 |
NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING | 34 | 2.54e-04 | -0.363000 | 2.97e-03 |
DEGRADATION OF GLI1 BY THE PROTEASOME | 57 | 2.23e-06 | -0.362000 | 6.74e-05 |
STABILIZATION OF P53 | 54 | 5.19e-06 | -0.359000 | 1.30e-04 |
PLASMA LIPOPROTEIN REMODELING | 17 | 1.07e-02 | 0.358000 | 6.33e-02 |
DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS | 59 | 2.04e-06 | -0.358000 | 6.33e-05 |
THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT | 66 | 5.46e-07 | -0.357000 | 2.15e-05 |
INFLUENZA INFECTION | 145 | 1.43e-13 | -0.356000 | 1.54e-11 |
NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION | 21 | 5.22e-03 | 0.352000 | 3.47e-02 |
BBSOME MEDIATED CARGO TARGETING TO CILIUM | 23 | 3.57e-03 | -0.351000 | 2.53e-02 |
ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | 25 | 2.43e-03 | -0.350000 | 1.95e-02 |
CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 5.58e-02 | 0.349000 | 2.28e-01 |
SEROTONIN NEUROTRANSMITTER RELEASE CYCLE | 18 | 1.06e-02 | 0.348000 | 6.31e-02 |
ELASTIC FIBRE FORMATION | 38 | 2.28e-04 | 0.346000 | 2.75e-03 |
THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | 22 | 5.06e-03 | -0.345000 | 3.37e-02 |
CD28 DEPENDENT VAV1 PATHWAY | 11 | 4.93e-02 | -0.342000 | 2.07e-01 |
LGI ADAM INTERACTIONS | 14 | 2.67e-02 | 0.342000 | 1.27e-01 |
APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | 70 | 8.31e-07 | -0.341000 | 2.97e-05 |
ER QUALITY CONTROL COMPARTMENT ERQC | 21 | 7.15e-03 | -0.339000 | 4.49e-02 |
SIGNAL AMPLIFICATION | 30 | 1.42e-03 | -0.337000 | 1.30e-02 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1 | 23 | 5.26e-03 | -0.336000 | 3.47e-02 |
SIGNALING BY LEPTIN | 10 | 6.57e-02 | 0.336000 | 2.51e-01 |
TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | 10 | 6.61e-02 | -0.336000 | 2.52e-01 |
SIGNALING BY ROBO RECEPTORS | 206 | 1.04e-16 | -0.336000 | 3.06e-14 |
CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY | 85 | 1.09e-07 | -0.333000 | 4.80e-06 |
TRANSLATION | 286 | 4.41e-22 | -0.332000 | 5.21e-19 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONES | 12 | 4.64e-02 | -0.332000 | 1.97e-01 |
TERMINATION OF O GLYCAN BIOSYNTHESIS | 10 | 7.13e-02 | 0.329000 | 2.61e-01 |
SYNAPTIC ADHESION LIKE MOLECULES | 21 | 9.16e-03 | 0.329000 | 5.63e-02 |
ASYMMETRIC LOCALIZATION OF PCP PROTEINS | 62 | 1.13e-05 | -0.322000 | 2.38e-04 |
DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING | 58 | 2.19e-05 | -0.322000 | 3.99e-04 |
G1 S DNA DAMAGE CHECKPOINTS | 65 | 7.46e-06 | -0.321000 | 1.78e-04 |
DETOXIFICATION OF REACTIVE OXYGEN SPECIES | 32 | 1.68e-03 | -0.321000 | 1.48e-02 |
G BETA GAMMA SIGNALLING THROUGH CDC42 | 18 | 1.89e-02 | -0.320000 | 9.64e-02 |
PREGNENOLONE BIOSYNTHESIS | 12 | 5.61e-02 | -0.319000 | 2.28e-01 |
INTERACTION BETWEEN L1 AND ANKYRINS | 28 | 3.57e-03 | 0.318000 | 2.53e-02 |
NEPHRIN FAMILY INTERACTIONS | 22 | 9.92e-03 | 0.318000 | 6.01e-02 |
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 6.90e-02 | -0.317000 | 2.57e-01 |
RHOBTB GTPASE CYCLE | 35 | 1.21e-03 | -0.316000 | 1.15e-02 |
PYROPTOSIS | 21 | 1.23e-02 | -0.316000 | 6.91e-02 |
MITOCHONDRIAL TRANSLATION | 93 | 1.53e-07 | -0.315000 | 6.45e-06 |
METABOLISM OF POLYAMINES | 57 | 4.14e-05 | -0.314000 | 6.69e-04 |
DAP12 INTERACTIONS | 31 | 2.48e-03 | -0.314000 | 1.96e-02 |
RORA ACTIVATES GENE EXPRESSION | 18 | 2.16e-02 | 0.313000 | 1.08e-01 |
MOLECULES ASSOCIATED WITH ELASTIC FIBRES | 32 | 2.21e-03 | 0.313000 | 1.82e-02 |
RHOBTB3 ATPASE CYCLE | 10 | 8.71e-02 | -0.312000 | 2.87e-01 |
NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | 12 | 6.15e-02 | -0.312000 | 2.38e-01 |
HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR | 48 | 1.90e-04 | -0.311000 | 2.34e-03 |
TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | 16 | 3.13e-02 | -0.311000 | 1.44e-01 |
FGFR1 LIGAND BINDING AND ACTIVATION | 10 | 8.90e-02 | 0.311000 | 2.91e-01 |
N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | 35 | 1.47e-03 | -0.311000 | 1.34e-02 |
REGULATION OF PTEN STABILITY AND ACTIVITY | 66 | 1.30e-05 | -0.310000 | 2.70e-04 |
REGULATION OF HMOX1 EXPRESSION AND ACTIVITY | 63 | 2.18e-05 | -0.309000 | 3.99e-04 |
MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS | 18 | 2.33e-02 | 0.309000 | 1.14e-01 |
REGULATION OF RAS BY GAPS | 66 | 1.46e-05 | -0.309000 | 2.97e-04 |
ANTIGEN PROCESSING CROSS PRESENTATION | 94 | 2.48e-07 | -0.308000 | 1.01e-05 |
GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 6.54e-02 | -0.307000 | 2.51e-01 |
INTERLEUKIN 7 SIGNALING | 18 | 2.46e-02 | 0.306000 | 1.19e-01 |
CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 | 11 | 7.90e-02 | -0.306000 | 2.71e-01 |
DSCAM INTERACTIONS | 10 | 9.52e-02 | 0.305000 | 3.03e-01 |
STIMULI SENSING CHANNELS | 79 | 2.85e-06 | 0.305000 | 8.40e-05 |
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 18 | 2.54e-02 | -0.304000 | 1.22e-01 |
GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION | 31 | 3.37e-03 | -0.304000 | 2.44e-02 |
CELLULAR RESPONSE TO HYPOXIA | 72 | 8.16e-06 | -0.304000 | 1.89e-04 |
RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE | 23 | 1.18e-02 | -0.303000 | 6.75e-02 |
ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 9.81e-02 | 0.302000 | 3.10e-01 |
CELLULAR RESPONSE TO STARVATION | 146 | 3.10e-10 | -0.302000 | 1.93e-08 |
ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR ANDROGEN RECEPTOR REGULATED GENES KLK2 AND KLK3 | 22 | 1.43e-02 | -0.302000 | 7.87e-02 |
TRP CHANNELS | 21 | 1.69e-02 | 0.301000 | 8.81e-02 |
METABOLISM OF STEROID HORMONES | 22 | 1.49e-02 | -0.300000 | 8.11e-02 |
NEUREXINS AND NEUROLIGINS | 54 | 1.39e-04 | 0.300000 | 1.83e-03 |
ROLE OF SECOND MESSENGERS IN NETRIN 1 SIGNALING | 10 | 1.01e-01 | 0.299000 | 3.15e-01 |
ORC1 REMOVAL FROM CHROMATIN | 68 | 2.05e-05 | -0.299000 | 3.84e-04 |
CHONDROITIN SULFATE BIOSYNTHESIS | 18 | 2.83e-02 | 0.299000 | 1.33e-01 |
TICAM1 DEPENDENT ACTIVATION OF IRF3 IRF7 | 12 | 7.51e-02 | -0.297000 | 2.65e-01 |
ZINC TRANSPORTERS | 15 | 4.69e-02 | 0.296000 | 1.99e-01 |
NEUROTRANSMITTER RELEASE CYCLE | 49 | 3.43e-04 | 0.296000 | 3.90e-03 |
REGULATION OF TLR BY ENDOGENOUS LIGAND | 10 | 1.06e-01 | -0.296000 | 3.20e-01 |
ION HOMEOSTASIS | 48 | 4.05e-04 | 0.295000 | 4.52e-03 |
KERATAN SULFATE DEGRADATION | 12 | 7.72e-02 | 0.295000 | 2.68e-01 |
INTERLEUKIN 6 SIGNALING | 10 | 1.07e-01 | 0.294000 | 3.22e-01 |
REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | 84 | 3.21e-06 | -0.294000 | 9.26e-05 |
DAG AND IP3 SIGNALING | 40 | 1.35e-03 | 0.293000 | 1.26e-02 |
HEDGEHOG ON STATE | 82 | 5.02e-06 | -0.292000 | 1.30e-04 |
DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX | 82 | 5.06e-06 | -0.291000 | 1.30e-04 |
APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS | 82 | 5.14e-06 | -0.291000 | 1.30e-04 |
INITIAL TRIGGERING OF COMPLEMENT | 11 | 9.46e-02 | 0.291000 | 3.03e-01 |
DAP12 SIGNALING | 24 | 1.37e-02 | -0.291000 | 7.63e-02 |
GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | 23 | 1.59e-02 | 0.290000 | 8.55e-02 |
CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND | 10 | 1.14e-01 | 0.289000 | 3.35e-01 |
RRNA PROCESSING | 194 | 5.36e-12 | -0.287000 | 4.22e-10 |
IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | 10 | 1.18e-01 | 0.285000 | 3.43e-01 |
SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE | 87 | 4.74e-06 | -0.284000 | 1.30e-04 |
DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | 23 | 2.01e-02 | 0.280000 | 1.02e-01 |
PHASE 0 RAPID DEPOLARISATION | 29 | 9.31e-03 | 0.279000 | 5.68e-02 |
PERK REGULATES GENE EXPRESSION | 28 | 1.07e-02 | -0.279000 | 6.33e-02 |
PROTEIN UBIQUITINATION | 70 | 5.63e-05 | -0.278000 | 8.86e-04 |
FREE FATTY ACIDS REGULATE INSULIN SECRETION | 10 | 1.28e-01 | -0.278000 | 3.62e-01 |
HSF1 DEPENDENT TRANSACTIVATION | 35 | 4.45e-03 | -0.278000 | 3.07e-02 |
MRNA SPLICING MINOR PATHWAY | 52 | 5.30e-04 | -0.278000 | 5.64e-03 |
TRIGLYCERIDE CATABOLISM | 14 | 7.39e-02 | -0.276000 | 2.65e-01 |
REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | 15 | 6.44e-02 | 0.276000 | 2.48e-01 |
GP1B IX V ACTIVATION SIGNALLING | 10 | 1.32e-01 | 0.275000 | 3.68e-01 |
ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | 65 | 1.37e-04 | -0.274000 | 1.82e-03 |
INTERLEUKIN 12 SIGNALING | 36 | 4.52e-03 | -0.273000 | 3.11e-02 |
MAPK6 MAPK4 SIGNALING | 83 | 1.76e-05 | -0.273000 | 3.47e-04 |
THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | 29 | 1.11e-02 | -0.273000 | 6.44e-02 |
CRISTAE FORMATION | 31 | 8.66e-03 | -0.272000 | 5.38e-02 |
P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 1.03e-01 | -0.272000 | 3.17e-01 |
HEME SIGNALING | 44 | 1.89e-03 | 0.271000 | 1.59e-02 |
IRAK4 DEFICIENCY TLR2 4 | 11 | 1.23e-01 | -0.268000 | 3.51e-01 |
RNA POLYMERASE I PROMOTER ESCAPE | 48 | 1.32e-03 | -0.268000 | 1.23e-02 |
SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER | 15 | 7.48e-02 | -0.266000 | 2.65e-01 |
REGULATION OF RUNX2 EXPRESSION AND ACTIVITY | 68 | 1.56e-04 | -0.265000 | 2.00e-03 |
SIGNALING BY ERBB2 ECD MUTANTS | 16 | 6.81e-02 | -0.263000 | 2.56e-01 |
PLATELET CALCIUM HOMEOSTASIS | 26 | 2.04e-02 | 0.263000 | 1.03e-01 |
THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | 172 | 2.80e-09 | -0.263000 | 1.65e-07 |
CONSTITUTIVE SIGNALING BY LIGAND RESPONSIVE EGFR CANCER VARIANTS | 19 | 4.86e-02 | -0.261000 | 2.05e-01 |
CONDENSATION OF PROPHASE CHROMOSOMES | 28 | 1.69e-02 | -0.261000 | 8.81e-02 |
ENDOSOMAL VACUOLAR PATHWAY | 11 | 1.37e-01 | -0.259000 | 3.76e-01 |
CELLULAR HEXOSE TRANSPORT | 11 | 1.38e-01 | 0.259000 | 3.76e-01 |
PURINE SALVAGE | 12 | 1.22e-01 | -0.258000 | 3.48e-01 |
SODIUM CALCIUM EXCHANGERS | 10 | 1.59e-01 | 0.257000 | 4.06e-01 |
APOPTOTIC FACTOR MEDIATED RESPONSE | 18 | 5.94e-02 | -0.257000 | 2.35e-01 |
ABC TRANSPORTER DISORDERS | 69 | 2.36e-04 | -0.256000 | 2.81e-03 |
TNFR2 NON CANONICAL NF KB PATHWAY | 82 | 6.63e-05 | -0.255000 | 1.00e-03 |
RNA POLYMERASE II TRANSCRIPTION TERMINATION | 65 | 3.95e-04 | -0.254000 | 4.45e-03 |
RESPONSE OF EIF2AK1 HRI TO HEME DEFICIENCY | 15 | 9.04e-02 | -0.253000 | 2.94e-01 |
CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER | 26 | 2.70e-02 | 0.251000 | 1.28e-01 |
GLYCOGEN SYNTHESIS | 14 | 1.05e-01 | -0.250000 | 3.19e-01 |
SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | 52 | 1.80e-03 | 0.250000 | 1.54e-02 |
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | 15 | 9.53e-02 | 0.249000 | 3.03e-01 |
DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER S DISEASE MODELS | 19 | 6.12e-02 | 0.248000 | 2.38e-01 |
MET ACTIVATES RAP1 AND RAC1 | 10 | 1.77e-01 | -0.247000 | 4.35e-01 |
E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS | 51 | 2.37e-03 | -0.246000 | 1.92e-02 |
NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 7.91e-02 | 0.246000 | 2.71e-01 |
IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS | 13 | 1.27e-01 | 0.244000 | 3.61e-01 |
MISCELLANEOUS TRANSPORT AND BINDING EVENTS | 21 | 5.36e-02 | 0.243000 | 2.20e-01 |
SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX | 12 | 1.46e-01 | 0.242000 | 3.86e-01 |
RHO GTPASES ACTIVATE NADPH OXIDASES | 20 | 6.16e-02 | 0.241000 | 2.38e-01 |
SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION | 25 | 3.81e-02 | -0.240000 | 1.66e-01 |
REGULATED NECROSIS | 46 | 5.05e-03 | -0.239000 | 3.37e-02 |
SIGNALING BY NOTCH4 | 83 | 1.73e-04 | -0.239000 | 2.19e-03 |
SCAVENGING OF HEME FROM PLASMA | 10 | 1.92e-01 | 0.238000 | 4.54e-01 |
MITOCHONDRIAL PROTEIN IMPORT | 63 | 1.13e-03 | -0.237000 | 1.09e-02 |
MUCOPOLYSACCHARIDOSES | 11 | 1.74e-01 | 0.237000 | 4.31e-01 |
ABERRANT REGULATION OF MITOTIC EXIT IN CANCER DUE TO RB1 DEFECTS | 19 | 7.41e-02 | -0.237000 | 2.65e-01 |
CA DEPENDENT EVENTS | 36 | 1.41e-02 | 0.236000 | 7.83e-02 |
CLASS B 2 SECRETIN FAMILY RECEPTORS | 71 | 6.09e-04 | -0.235000 | 6.42e-03 |
AMINE LIGAND BINDING RECEPTORS | 31 | 2.35e-02 | 0.235000 | 1.15e-01 |
INACTIVATION OF CSF3 G CSF SIGNALING | 24 | 4.64e-02 | -0.235000 | 1.97e-01 |
HEDGEHOG OFF STATE | 106 | 3.09e-05 | -0.234000 | 5.21e-04 |
PCP CE PATHWAY | 89 | 1.33e-04 | -0.234000 | 1.79e-03 |
TRANSCRIPTIONAL REGULATION BY MECP2 | 59 | 1.89e-03 | 0.234000 | 1.59e-02 |
SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL | 13 | 1.45e-01 | 0.234000 | 3.86e-01 |
METALLOPROTEASE DUBS | 26 | 3.93e-02 | -0.234000 | 1.71e-01 |
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 2.02e-01 | 0.233000 | 4.64e-01 |
INHIBITION OF DNA RECOMBINATION AT TELOMERE | 36 | 1.59e-02 | -0.232000 | 8.55e-02 |
APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | 21 | 6.63e-02 | -0.231000 | 2.52e-01 |
MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | 15 | 1.22e-01 | -0.231000 | 3.48e-01 |
MEIOTIC RECOMBINATION | 40 | 1.16e-02 | -0.231000 | 6.69e-02 |
DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | 79 | 4.16e-04 | -0.230000 | 4.59e-03 |
ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS | 17 | 1.02e-01 | -0.229000 | 3.16e-01 |
MATURATION OF NUCLEOPROTEIN | 10 | 2.10e-01 | -0.229000 | 4.75e-01 |
UCH PROTEINASES | 89 | 1.97e-04 | -0.228000 | 2.39e-03 |
DNA METHYLATION | 21 | 7.08e-02 | -0.228000 | 2.60e-01 |
PROTEIN PROTEIN INTERACTIONS AT SYNAPSES | 85 | 2.91e-04 | 0.227000 | 3.36e-03 |
METABOLISM OF AMINO ACIDS AND DERIVATIVES | 318 | 3.85e-12 | -0.227000 | 3.25e-10 |
SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | 14 | 1.43e-01 | -0.226000 | 3.83e-01 |
RAS ACTIVATION UPON CA2 INFLUX THROUGH NMDA RECEPTOR | 20 | 8.08e-02 | 0.226000 | 2.74e-01 |
RETROGRADE NEUROTROPHIN SIGNALLING | 14 | 1.48e-01 | 0.223000 | 3.86e-01 |
DISEASES OF DNA REPAIR | 11 | 2.00e-01 | -0.223000 | 4.62e-01 |
CROSSLINKING OF COLLAGEN FIBRILS | 17 | 1.14e-01 | 0.221000 | 3.36e-01 |
PHOSPHORYLATION OF THE APC C | 17 | 1.16e-01 | -0.220000 | 3.37e-01 |
ERK MAPK TARGETS | 22 | 7.38e-02 | 0.220000 | 2.65e-01 |
HYALURONAN METABOLISM | 16 | 1.27e-01 | 0.220000 | 3.61e-01 |
NRAGE SIGNALS DEATH THROUGH JNK | 55 | 4.84e-03 | 0.220000 | 3.27e-02 |
DNA REPLICATION PRE INITIATION | 81 | 6.36e-04 | -0.220000 | 6.59e-03 |
SIGNALING BY EGFR IN CANCER | 22 | 7.46e-02 | -0.220000 | 2.65e-01 |
CYCLIN D ASSOCIATED EVENTS IN G1 | 46 | 1.01e-02 | -0.219000 | 6.10e-02 |
SIGNALING BY HEDGEHOG | 141 | 7.52e-06 | -0.219000 | 1.78e-04 |
SMOOTH MUSCLE CONTRACTION | 32 | 3.28e-02 | 0.218000 | 1.48e-01 |
DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA | 64 | 2.59e-03 | -0.218000 | 2.03e-02 |
GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER | 25 | 5.96e-02 | -0.218000 | 2.35e-01 |
TCF DEPENDENT SIGNALING IN RESPONSE TO WNT | 178 | 5.72e-07 | -0.217000 | 2.18e-05 |
POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 1.21e-01 | -0.217000 | 3.48e-01 |
CONSTITUTIVE SIGNALING BY EGFRVIII | 15 | 1.46e-01 | -0.217000 | 3.86e-01 |
REGULATION OF MECP2 EXPRESSION AND ACTIVITY | 30 | 4.00e-02 | 0.217000 | 1.73e-01 |
ION CHANNEL TRANSPORT | 144 | 8.59e-06 | 0.215000 | 1.89e-04 |
PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS | 19 | 1.06e-01 | -0.214000 | 3.21e-01 |
VLDLR INTERNALISATION AND DEGRADATION | 12 | 2.00e-01 | 0.213000 | 4.62e-01 |
SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP | 64 | 3.16e-03 | -0.213000 | 2.34e-02 |
METAL ION SLC TRANSPORTERS | 24 | 7.14e-02 | 0.213000 | 2.61e-01 |
RAS PROCESSING | 24 | 7.20e-02 | -0.212000 | 2.62e-01 |
SIGNALING BY FGFR3 FUSIONS IN CANCER | 10 | 2.46e-01 | -0.212000 | 5.25e-01 |
CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | 33 | 3.54e-02 | 0.212000 | 1.57e-01 |
PINK1 PRKN MEDIATED MITOPHAGY | 22 | 8.61e-02 | -0.211000 | 2.85e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX2 | 109 | 1.43e-04 | -0.211000 | 1.86e-03 |
ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 23 | 8.01e-02 | -0.211000 | 2.73e-01 |
ASSEMBLY OF THE HIV VIRION | 16 | 1.45e-01 | -0.210000 | 3.86e-01 |
G2 M CHECKPOINTS | 134 | 2.81e-05 | -0.210000 | 4.87e-04 |
RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 59 | 5.45e-03 | -0.209000 | 3.56e-02 |
TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | 13 | 1.92e-01 | -0.209000 | 4.54e-01 |
KERATINIZATION | 33 | 3.82e-02 | 0.209000 | 1.66e-01 |
HIV TRANSCRIPTION INITIATION | 45 | 1.56e-02 | -0.208000 | 8.46e-02 |
ABC TRANSPORTERS IN LIPID HOMEOSTASIS | 13 | 1.96e-01 | 0.207000 | 4.57e-01 |
CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR MEDIATED ACTIVATION OF RAS SIGNALING | 28 | 5.81e-02 | 0.207000 | 2.34e-01 |
RHOBTB1 GTPASE CYCLE | 23 | 8.61e-02 | -0.207000 | 2.85e-01 |
FGFR2 ALTERNATIVE SPLICING | 25 | 7.48e-02 | -0.206000 | 2.65e-01 |
DNA REPLICATION | 123 | 8.13e-05 | -0.206000 | 1.17e-03 |
MISMATCH REPAIR | 14 | 1.83e-01 | -0.206000 | 4.40e-01 |
SIGNALING BY FGFR4 IN DISEASE | 10 | 2.61e-01 | -0.205000 | 5.45e-01 |
JOSEPHIN DOMAIN DUBS | 11 | 2.39e-01 | -0.205000 | 5.16e-01 |
PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION | 23 | 9.10e-02 | -0.204000 | 2.94e-01 |
AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | 14 | 1.88e-01 | 0.203000 | 4.48e-01 |
NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 13 | 2.06e-01 | -0.203000 | 4.69e-01 |
TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | 87 | 1.13e-03 | 0.202000 | 1.09e-02 |
FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF | 14 | 1.93e-01 | 0.201000 | 4.55e-01 |
PROTEIN FOLDING | 89 | 1.09e-03 | -0.200000 | 1.06e-02 |
S PHASE | 156 | 1.64e-05 | -0.200000 | 3.29e-04 |
NICOTINAMIDE SALVAGING | 16 | 1.69e-01 | -0.199000 | 4.25e-01 |
INTERLEUKIN 20 FAMILY SIGNALING | 13 | 2.18e-01 | 0.197000 | 4.89e-01 |
CELLULAR RESPONSE TO CHEMICAL STRESS | 151 | 2.95e-05 | -0.197000 | 5.06e-04 |
RHOU GTPASE CYCLE | 33 | 5.15e-02 | 0.196000 | 2.14e-01 |
DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX | 41 | 3.01e-02 | -0.196000 | 1.40e-01 |
PI 3K CASCADE FGFR1 | 16 | 1.76e-01 | 0.196000 | 4.34e-01 |
APC CDC20 MEDIATED DEGRADATION OF NEK2A | 25 | 9.06e-02 | -0.196000 | 2.94e-01 |
SUMOYLATION OF TRANSCRIPTION FACTORS | 17 | 1.63e-01 | -0.195000 | 4.15e-01 |
HYALURONAN UPTAKE AND DEGRADATION | 12 | 2.43e-01 | 0.195000 | 5.21e-01 |
DEPOLYMERISATION OF THE NUCLEAR LAMINA | 13 | 2.24e-01 | 0.195000 | 4.97e-01 |
WNT5A DEPENDENT INTERNALIZATION OF FZD4 | 15 | 1.93e-01 | 0.194000 | 4.55e-01 |
HOST INTERACTIONS OF HIV FACTORS | 126 | 1.74e-04 | -0.194000 | 2.19e-03 |
SURFACTANT METABOLISM | 16 | 1.81e-01 | -0.193000 | 4.39e-01 |
DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | 26 | 8.94e-02 | -0.192000 | 2.92e-01 |
FORMATION OF THE CORNIFIED ENVELOPE | 32 | 5.97e-02 | 0.192000 | 2.35e-01 |
AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | 28 | 7.87e-02 | 0.192000 | 2.71e-01 |
BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS | 11 | 2.71e-01 | 0.192000 | 5.54e-01 |
HS GAG DEGRADATION | 21 | 1.29e-01 | 0.192000 | 3.62e-01 |
ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS | 23 | 1.12e-01 | 0.191000 | 3.34e-01 |
MRNA SPLICING | 188 | 6.37e-06 | -0.191000 | 1.57e-04 |
AMYLOID FIBER FORMATION | 58 | 1.20e-02 | -0.191000 | 6.78e-02 |
INTERLEUKIN 12 FAMILY SIGNALING | 42 | 3.25e-02 | -0.191000 | 1.48e-01 |
VXPX CARGO TARGETING TO CILIUM | 20 | 1.41e-01 | 0.190000 | 3.81e-01 |
FORMATION OF FIBRIN CLOT CLOTTING CASCADE | 21 | 1.32e-01 | 0.190000 | 3.67e-01 |
SIGNALING BY CSF3 G CSF | 29 | 7.65e-02 | -0.190000 | 2.67e-01 |
CYTOCHROME C MEDIATED APOPTOTIC RESPONSE | 12 | 2.55e-01 | -0.190000 | 5.37e-01 |
PI METABOLISM | 80 | 3.41e-03 | 0.189000 | 2.45e-02 |
HDMS DEMETHYLATE HISTONES | 28 | 8.40e-02 | 0.189000 | 2.83e-01 |
METABOLISM OF NUCLEOTIDES | 93 | 1.77e-03 | -0.188000 | 1.53e-02 |
MRNA CAPPING | 29 | 8.09e-02 | -0.187000 | 2.74e-01 |
MITOTIC G1 PHASE AND G1 S TRANSITION | 144 | 1.07e-04 | -0.187000 | 1.45e-03 |
FCERI MEDIATED NF KB ACTIVATION | 77 | 4.55e-03 | -0.187000 | 3.11e-02 |
ANTIMICROBIAL PEPTIDES | 17 | 1.82e-01 | 0.187000 | 4.40e-01 |
BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION | 26 | 1.00e-01 | 0.186000 | 3.13e-01 |
SEPARATION OF SISTER CHROMATIDS | 168 | 3.28e-05 | -0.186000 | 5.46e-04 |
REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION | 30 | 7.83e-02 | 0.186000 | 2.70e-01 |
INWARDLY RECTIFYING K CHANNELS | 31 | 7.45e-02 | -0.185000 | 2.65e-01 |
METABOLISM OF RNA | 645 | 1.61e-15 | -0.184000 | 2.71e-13 |
PRC2 METHYLATES HISTONES AND DNA | 30 | 8.07e-02 | -0.184000 | 2.74e-01 |
DISEASES OF MITOTIC CELL CYCLE | 37 | 5.26e-02 | -0.184000 | 2.18e-01 |
DCC MEDIATED ATTRACTIVE SIGNALING | 14 | 2.33e-01 | -0.184000 | 5.10e-01 |
SHC1 EVENTS IN EGFR SIGNALING | 11 | 2.90e-01 | -0.184000 | 5.72e-01 |
GLYCOGEN METABOLISM | 25 | 1.11e-01 | -0.184000 | 3.33e-01 |
TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS | 45 | 3.28e-02 | -0.184000 | 1.48e-01 |
EXTRA NUCLEAR ESTROGEN SIGNALING | 67 | 9.33e-03 | -0.184000 | 5.68e-02 |
ADHERENS JUNCTIONS INTERACTIONS | 31 | 7.69e-02 | -0.184000 | 2.68e-01 |
ECM PROTEOGLYCANS | 68 | 9.01e-03 | 0.183000 | 5.57e-02 |
TRANSCRIPTIONAL REGULATION BY RUNX3 | 93 | 2.33e-03 | -0.183000 | 1.91e-02 |
RETINOID CYCLE DISEASE EVENTS | 11 | 2.95e-01 | 0.183000 | 5.74e-01 |
REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE | 77 | 5.67e-03 | -0.182000 | 3.68e-02 |
NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX | 32 | 7.49e-02 | 0.182000 | 2.65e-01 |
NEGATIVE REGULATION OF FGFR1 SIGNALING | 27 | 1.02e-01 | 0.182000 | 3.16e-01 |
MUSCLE CONTRACTION | 157 | 9.64e-05 | 0.180000 | 1.36e-03 |
FANCONI ANEMIA PATHWAY | 36 | 6.10e-02 | 0.180000 | 2.38e-01 |
SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL | 10 | 3.24e-01 | -0.180000 | 5.98e-01 |
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | 16 | 2.13e-01 | 0.180000 | 4.79e-01 |
NEURONAL SYSTEM | 369 | 3.36e-09 | 0.180000 | 1.80e-07 |
REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | 91 | 3.18e-03 | 0.179000 | 2.34e-02 |
ENOS ACTIVATION | 11 | 3.04e-01 | -0.179000 | 5.85e-01 |
SIGNALING BY THE B CELL RECEPTOR BCR | 104 | 1.63e-03 | -0.179000 | 1.46e-02 |
GLUCAGON TYPE LIGAND RECEPTORS | 26 | 1.15e-01 | -0.178000 | 3.37e-01 |
REGULATION OF GENE EXPRESSION BY HYPOXIA INDUCIBLE FACTOR | 10 | 3.30e-01 | 0.178000 | 6.00e-01 |
BUDDING AND MATURATION OF HIV VIRION | 27 | 1.10e-01 | -0.178000 | 3.29e-01 |
SIGNALING BY NODAL | 16 | 2.20e-01 | 0.177000 | 4.92e-01 |
NETRIN 1 SIGNALING | 49 | 3.22e-02 | 0.177000 | 1.47e-01 |
CLEC7A DECTIN 1 SIGNALING | 94 | 3.07e-03 | -0.177000 | 2.31e-02 |
ABC FAMILY PROTEINS MEDIATED TRANSPORT | 93 | 3.27e-03 | -0.177000 | 2.38e-02 |
TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES | 11 | 3.13e-01 | 0.176000 | 5.93e-01 |
NR1H2 AND NR1H3 MEDIATED SIGNALING | 38 | 6.15e-02 | 0.175000 | 2.38e-01 |
TERMINATION OF TRANSLESION DNA SYNTHESIS | 32 | 8.62e-02 | -0.175000 | 2.85e-01 |
TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS | 54 | 2.59e-02 | 0.175000 | 1.24e-01 |
NUCLEAR PORE COMPLEX NPC DISASSEMBLY | 32 | 8.65e-02 | 0.175000 | 2.85e-01 |
TRAF6 MEDIATED IRF7 ACTIVATION | 15 | 2.42e-01 | -0.175000 | 5.21e-01 |
RIPK1 MEDIATED REGULATED NECROSIS | 25 | 1.32e-01 | -0.174000 | 3.68e-01 |
NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | 14 | 2.62e-01 | 0.173000 | 5.45e-01 |
NUCLEOBASE BIOSYNTHESIS | 15 | 2.46e-01 | -0.173000 | 5.24e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST | 13 | 2.81e-01 | -0.173000 | 5.65e-01 |
UPTAKE AND FUNCTION OF ANTHRAX TOXINS | 11 | 3.22e-01 | 0.173000 | 5.97e-01 |
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 RBL1 AND P130 RBL2 IN COMPLEX WITH HDAC1 | 15 | 2.48e-01 | -0.172000 | 5.26e-01 |
TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | 68 | 1.43e-02 | 0.172000 | 7.87e-02 |
NUCLEOTIDE SALVAGE | 21 | 1.74e-01 | -0.172000 | 4.31e-01 |
CELLULAR RESPONSES TO EXTERNAL STIMULI | 604 | 7.66e-13 | -0.171000 | 6.96e-11 |
B WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION | 48 | 4.08e-02 | -0.171000 | 1.76e-01 |
SLC MEDIATED TRANSMEMBRANE TRANSPORT | 193 | 4.48e-05 | 0.171000 | 7.15e-04 |
ESTROGEN DEPENDENT GENE EXPRESSION | 105 | 2.62e-03 | -0.170000 | 2.04e-02 |
NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 66 | 1.73e-02 | -0.170000 | 8.90e-02 |
TP53 REGULATES METABOLIC GENES | 85 | 7.11e-03 | -0.169000 | 4.49e-02 |
FERTILIZATION | 12 | 3.12e-01 | -0.168000 | 5.93e-01 |
BASE EXCISION REPAIR AP SITE FORMATION | 30 | 1.11e-01 | -0.168000 | 3.32e-01 |
INTERLEUKIN 17 SIGNALING | 66 | 1.83e-02 | 0.168000 | 9.33e-02 |
DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | 13 | 2.94e-01 | -0.168000 | 5.74e-01 |
ACTIVATION OF RAC1 | 13 | 2.95e-01 | -0.168000 | 5.74e-01 |
PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | 237 | 9.12e-06 | -0.168000 | 1.96e-04 |
RESOLUTION OF D LOOP STRUCTURES | 30 | 1.13e-01 | 0.167000 | 3.34e-01 |
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS | 13 | 2.97e-01 | 0.167000 | 5.74e-01 |
NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 26 | 1.42e-01 | -0.167000 | 3.82e-01 |
CYTOPROTECTION BY HMOX1 | 120 | 1.64e-03 | -0.167000 | 1.46e-02 |
SULFUR AMINO ACID METABOLISM | 24 | 1.58e-01 | -0.166000 | 4.05e-01 |
GLUCAGON SIGNALING IN METABOLIC REGULATION | 29 | 1.21e-01 | -0.166000 | 3.48e-01 |
CARDIAC CONDUCTION | 107 | 2.95e-03 | 0.166000 | 2.24e-02 |
CS DS DEGRADATION | 14 | 2.83e-01 | 0.166000 | 5.66e-01 |
PROCESSING OF DNA DOUBLE STRAND BREAK ENDS | 71 | 1.61e-02 | -0.165000 | 8.61e-02 |
ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | 32 | 1.06e-01 | -0.165000 | 3.20e-01 |
SIGNALING BY NOTCH | 189 | 9.39e-05 | -0.165000 | 1.34e-03 |
GABA B RECEPTOR ACTIVATION | 39 | 7.83e-02 | -0.163000 | 2.70e-01 |
TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53 DEPENDENT APOPTOSIS REMAIN UNCERTAIN | 12 | 3.29e-01 | 0.163000 | 5.99e-01 |
MITOTIC METAPHASE AND ANAPHASE | 209 | 5.73e-05 | -0.162000 | 8.90e-04 |
NUCLEAR ENVELOPE BREAKDOWN | 49 | 5.05e-02 | 0.162000 | 2.11e-01 |
ION TRANSPORT BY P TYPE ATPASES | 48 | 5.32e-02 | 0.161000 | 2.20e-01 |
SUPPRESSION OF PHAGOSOMAL MATURATION | 13 | 3.14e-01 | -0.161000 | 5.94e-01 |
AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS | 10 | 3.81e-01 | 0.160000 | 6.60e-01 |
SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS | 15 | 2.85e-01 | -0.160000 | 5.68e-01 |
SHC MEDIATED CASCADE FGFR4 | 13 | 3.19e-01 | -0.160000 | 5.96e-01 |
TRIGLYCERIDE METABOLISM | 24 | 1.78e-01 | -0.159000 | 4.35e-01 |
SYNTHESIS OF PC | 26 | 1.61e-01 | 0.159000 | 4.10e-01 |
SLC TRANSPORTER DISORDERS | 77 | 1.64e-02 | 0.158000 | 8.66e-02 |
TRANSLATION OF SARS COV 2 STRUCTURAL PROTEINS | 44 | 6.97e-02 | -0.158000 | 2.58e-01 |
RHO GTPASES ACTIVATE PKNS | 48 | 5.96e-02 | -0.157000 | 2.35e-01 |
MITOPHAGY | 29 | 1.44e-01 | -0.157000 | 3.84e-01 |
METABOLISM OF COFACTORS | 19 | 2.36e-01 | -0.157000 | 5.14e-01 |
G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | 23 | 1.94e-01 | -0.156000 | 4.56e-01 |
THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION | 15 | 2.95e-01 | 0.156000 | 5.74e-01 |
NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 20 | 2.27e-01 | 0.156000 | 5.03e-01 |
CELL CYCLE CHECKPOINTS | 245 | 2.70e-05 | -0.156000 | 4.77e-04 |
ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | 30 | 1.40e-01 | -0.156000 | 3.81e-01 |
REPRESSION OF WNT TARGET GENES | 14 | 3.13e-01 | -0.156000 | 5.93e-01 |
HIV INFECTION | 222 | 6.48e-05 | -0.156000 | 9.94e-04 |
G2 M DNA DAMAGE CHECKPOINT | 66 | 2.88e-02 | -0.156000 | 1.35e-01 |
ERCC6 CSB AND EHMT2 G9A POSITIVELY REGULATE RRNA EXPRESSION | 33 | 1.22e-01 | -0.156000 | 3.48e-01 |
CHEMOKINE RECEPTORS BIND CHEMOKINES | 13 | 3.33e-01 | -0.155000 | 6.03e-01 |
SCAVENGING BY CLASS A RECEPTORS | 14 | 3.16e-01 | 0.155000 | 5.94e-01 |
SENSORY PROCESSING OF SOUND | 62 | 3.51e-02 | 0.155000 | 1.56e-01 |
SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL | 26 | 1.72e-01 | 0.155000 | 4.31e-01 |
TICAM1 RIP1 MEDIATED IKK COMPLEX RECRUITMENT | 18 | 2.57e-01 | -0.154000 | 5.41e-01 |
PROCESSING OF CAPPED INTRONLESS PRE MRNA | 28 | 1.58e-01 | -0.154000 | 4.05e-01 |
BETA CATENIN INDEPENDENT WNT SIGNALING | 137 | 1.90e-03 | -0.154000 | 1.59e-02 |
ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | 11 | 3.77e-01 | -0.154000 | 6.56e-01 |
SIGNALING BY ERBB2 IN CANCER | 25 | 1.84e-01 | -0.154000 | 4.40e-01 |
STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES | 14 | 3.21e-01 | -0.153000 | 5.96e-01 |
A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | 26 | 1.76e-01 | 0.153000 | 4.35e-01 |
CD28 DEPENDENT PI3K AKT SIGNALING | 21 | 2.24e-01 | 0.153000 | 4.97e-01 |
ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT | 23 | 2.05e-01 | -0.153000 | 4.69e-01 |
FORMATION OF THE EARLY ELONGATION COMPLEX | 33 | 1.29e-01 | -0.153000 | 3.64e-01 |
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K | 11 | 3.83e-01 | 0.152000 | 6.60e-01 |
BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA | 16 | 2.93e-01 | -0.152000 | 5.74e-01 |
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX | 18 | 2.65e-01 | -0.152000 | 5.46e-01 |
TNFR1 INDUCED PROAPOPTOTIC SIGNALING | 12 | 3.64e-01 | 0.151000 | 6.40e-01 |
METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS | 11 | 3.85e-01 | 0.151000 | 6.60e-01 |
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | 11 | 3.86e-01 | 0.151000 | 6.60e-01 |
ESR MEDIATED SIGNALING | 168 | 7.49e-04 | -0.151000 | 7.50e-03 |
SIGNALING BY WNT | 268 | 2.40e-05 | -0.150000 | 4.29e-04 |
RAP1 SIGNALLING | 15 | 3.17e-01 | 0.149000 | 5.94e-01 |
G0 AND EARLY G1 | 25 | 1.97e-01 | -0.149000 | 4.57e-01 |
NOTCH HLH TRANSCRIPTION PATHWAY | 28 | 1.73e-01 | 0.149000 | 4.31e-01 |
PHASE 2 PLATEAU PHASE | 11 | 3.94e-01 | 0.148000 | 6.60e-01 |
C TYPE LECTIN RECEPTORS CLRS | 113 | 6.55e-03 | -0.148000 | 4.20e-02 |
TRANSCRIPTION OF THE HIV GENOME | 67 | 3.70e-02 | -0.147000 | 1.63e-01 |
INFECTIOUS DISEASE | 738 | 1.23e-11 | -0.147000 | 8.56e-10 |
PIWI INTERACTING RNA PIRNA BIOGENESIS | 21 | 2.46e-01 | -0.146000 | 5.24e-01 |
NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | 17 | 2.96e-01 | -0.146000 | 5.74e-01 |
SEROTONIN RECEPTORS | 10 | 4.24e-01 | 0.146000 | 6.79e-01 |
RNA POLYMERASE I TRANSCRIPTION | 68 | 3.80e-02 | -0.146000 | 1.66e-01 |
TRANSMISSION ACROSS CHEMICAL SYNAPSES | 241 | 1.01e-04 | 0.146000 | 1.39e-03 |
FCERI MEDIATED MAPK ACTIVATION | 28 | 1.84e-01 | -0.145000 | 4.40e-01 |
SIGNALING BY TGF BETA RECEPTOR COMPLEX | 72 | 3.39e-02 | -0.145000 | 1.52e-01 |
GENERATION OF SECOND MESSENGER MOLECULES | 20 | 2.64e-01 | 0.144000 | 5.46e-01 |
INTERFERON ALPHA BETA SIGNALING | 58 | 5.89e-02 | -0.143000 | 2.35e-01 |
IRF3 MEDIATED INDUCTION OF TYPE I IFN | 11 | 4.11e-01 | -0.143000 | 6.75e-01 |
FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES | 16 | 3.23e-01 | 0.143000 | 5.97e-01 |
NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 23 | 2.36e-01 | -0.143000 | 5.14e-01 |
CELLULAR RESPONSE TO HEAT STRESS | 96 | 1.62e-02 | -0.142000 | 8.62e-02 |
TRANSCRIPTIONAL REGULATION BY RUNX1 | 179 | 1.08e-03 | -0.142000 | 1.06e-02 |
PI3K AKT SIGNALING IN CANCER | 89 | 2.09e-02 | 0.142000 | 1.05e-01 |
GABA RECEPTOR ACTIVATION | 53 | 7.43e-02 | -0.142000 | 2.65e-01 |
O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS | 35 | 1.47e-01 | 0.142000 | 3.86e-01 |
MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | 31 | 1.73e-01 | 0.141000 | 4.31e-01 |
SIGNALING BY TGFB FAMILY MEMBERS | 97 | 1.63e-02 | -0.141000 | 8.62e-02 |
FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX | 47 | 9.44e-02 | -0.141000 | 3.03e-01 |
CARNITINE METABOLISM | 14 | 3.62e-01 | 0.141000 | 6.39e-01 |
PLATELET SENSITIZATION BY LDL | 15 | 3.45e-01 | -0.141000 | 6.17e-01 |
ASPARTATE AND ASPARAGINE METABOLISM | 11 | 4.21e-01 | 0.140000 | 6.78e-01 |
COMPLEMENT CASCADE | 27 | 2.07e-01 | 0.140000 | 4.70e-01 |
CDC42 GTPASE CYCLE | 154 | 2.69e-03 | 0.140000 | 2.08e-02 |
PROTEIN LOCALIZATION | 158 | 2.37e-03 | -0.140000 | 1.92e-02 |
CTLA4 INHIBITORY SIGNALING | 20 | 2.78e-01 | -0.140000 | 5.62e-01 |
SIGNALING BY ERBB4 | 57 | 6.75e-02 | -0.140000 | 2.55e-01 |
CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | 19 | 2.91e-01 | -0.140000 | 5.72e-01 |
SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | 31 | 1.78e-01 | -0.140000 | 4.35e-01 |
ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS | 36 | 1.46e-01 | 0.140000 | 3.86e-01 |
NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 11 | 4.22e-01 | 0.140000 | 6.78e-01 |
NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | 21 | 2.67e-01 | -0.140000 | 5.50e-01 |
E2F MEDIATED REGULATION OF DNA REPLICATION | 20 | 2.79e-01 | -0.140000 | 5.63e-01 |
POTASSIUM CHANNELS | 90 | 2.21e-02 | 0.140000 | 1.09e-01 |
CYTOSOLIC TRNA AMINOACYLATION | 24 | 2.38e-01 | -0.139000 | 5.15e-01 |
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 3.85e-01 | -0.139000 | 6.60e-01 |
FC EPSILON RECEPTOR FCERI SIGNALING | 124 | 7.51e-03 | -0.139000 | 4.69e-02 |
RHO GTPASES ACTIVATE KTN1 | 11 | 4.25e-01 | -0.139000 | 6.80e-01 |
FRS MEDIATED FGFR1 SIGNALING | 18 | 3.09e-01 | 0.138000 | 5.92e-01 |
TELOMERE C STRAND SYNTHESIS INITIATION | 13 | 3.88e-01 | 0.138000 | 6.60e-01 |
SEMA3A PAK DEPENDENT AXON REPULSION | 16 | 3.40e-01 | -0.138000 | 6.10e-01 |
CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | 48 | 9.85e-02 | 0.138000 | 3.10e-01 |
G PROTEIN MEDIATED EVENTS | 52 | 8.59e-02 | 0.138000 | 2.85e-01 |
P75NTR RECRUITS SIGNALLING COMPLEXES | 13 | 3.91e-01 | -0.137000 | 6.60e-01 |
TOLL LIKE RECEPTOR 9 TLR9 CASCADE | 90 | 2.50e-02 | 0.137000 | 1.21e-01 |
COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 44 | 1.17e-01 | -0.137000 | 3.41e-01 |
DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | 39 | 1.41e-01 | -0.136000 | 3.81e-01 |
DUAL INCISION IN TC NER | 65 | 5.82e-02 | -0.136000 | 2.34e-01 |
NEGATIVE REGULATION OF FGFR3 SIGNALING | 25 | 2.40e-01 | 0.136000 | 5.17e-01 |
PTEN REGULATION | 134 | 6.75e-03 | -0.136000 | 4.30e-02 |
JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | 22 | 2.71e-01 | 0.136000 | 5.54e-01 |
LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS | 20 | 2.95e-01 | -0.135000 | 5.74e-01 |
BASIGIN INTERACTIONS | 22 | 2.73e-01 | -0.135000 | 5.56e-01 |
RHOB GTPASE CYCLE | 67 | 5.63e-02 | 0.135000 | 2.29e-01 |
CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION | 22 | 2.76e-01 | -0.134000 | 5.61e-01 |
DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS | 18 | 3.25e-01 | 0.134000 | 5.98e-01 |
VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS | 36 | 1.64e-01 | -0.134000 | 4.17e-01 |
TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA | 16 | 3.54e-01 | -0.134000 | 6.27e-01 |
ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3 | 10 | 4.64e-01 | -0.134000 | 7.04e-01 |
CELL CELL JUNCTION ORGANIZATION | 50 | 1.02e-01 | -0.134000 | 3.16e-01 |
RHO GTPASES ACTIVATE PAKS | 21 | 2.90e-01 | 0.133000 | 5.72e-01 |
EARLY PHASE OF HIV LIFE CYCLE | 14 | 3.88e-01 | -0.133000 | 6.60e-01 |
PEPTIDE HORMONE METABOLISM | 62 | 7.02e-02 | -0.133000 | 2.59e-01 |
SYNDECAN INTERACTIONS | 27 | 2.34e-01 | 0.132000 | 5.11e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST | 15 | 3.76e-01 | -0.132000 | 6.54e-01 |
NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | 58 | 8.21e-02 | 0.132000 | 2.77e-01 |
BLOOD GROUP SYSTEMS BIOSYNTHESIS | 13 | 4.10e-01 | -0.132000 | 6.75e-01 |
NOD1 2 SIGNALING PATHWAY | 34 | 1.83e-01 | 0.132000 | 4.40e-01 |
WNT LIGAND BIOGENESIS AND TRAFFICKING | 21 | 2.97e-01 | -0.132000 | 5.74e-01 |
DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM | 40 | 1.51e-01 | 0.131000 | 3.91e-01 |
REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | 29 | 2.23e-01 | 0.131000 | 4.97e-01 |
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES | 62 | 7.60e-02 | -0.130000 | 2.67e-01 |
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 4.54e-01 | -0.130000 | 7.01e-01 |
OTHER INTERLEUKIN SIGNALING | 21 | 3.02e-01 | 0.130000 | 5.82e-01 |
TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | 32 | 2.02e-01 | -0.130000 | 4.64e-01 |
NONHOMOLOGOUS END JOINING NHEJ | 44 | 1.37e-01 | -0.130000 | 3.76e-01 |
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | 12 | 4.39e-01 | -0.129000 | 6.92e-01 |
RUNX3 REGULATES NOTCH SIGNALING | 13 | 4.22e-01 | 0.129000 | 6.78e-01 |
G PROTEIN BETA GAMMA SIGNALLING | 30 | 2.23e-01 | -0.129000 | 4.97e-01 |
MET ACTIVATES PTK2 SIGNALING | 29 | 2.32e-01 | 0.128000 | 5.09e-01 |
INTRAFLAGELLAR TRANSPORT | 51 | 1.13e-01 | -0.128000 | 3.34e-01 |
N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | 24 | 2.77e-01 | -0.128000 | 5.62e-01 |
ELEVATION OF CYTOSOLIC CA2 LEVELS | 15 | 3.91e-01 | 0.128000 | 6.60e-01 |
MITOTIC G2 G2 M PHASES | 184 | 2.89e-03 | -0.127000 | 2.21e-02 |
NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS | 11 | 4.64e-01 | -0.127000 | 7.04e-01 |
SIGNALING BY FGFR2 IN DISEASE | 37 | 1.81e-01 | -0.127000 | 4.39e-01 |
APOPTOSIS | 163 | 5.37e-03 | -0.126000 | 3.53e-02 |
TRANSCRIPTIONAL REGULATION BY E2F6 | 34 | 2.02e-01 | -0.126000 | 4.64e-01 |
PHOSPHOLIPID METABOLISM | 187 | 2.91e-03 | 0.126000 | 2.21e-02 |
PROGRAMMED CELL DEATH | 185 | 3.14e-03 | -0.126000 | 2.34e-02 |
FORMATION OF TC NER PRE INCISION COMPLEX | 53 | 1.13e-01 | -0.126000 | 3.34e-01 |
GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | 30 | 2.34e-01 | 0.126000 | 5.11e-01 |
ENDOGENOUS STEROLS | 21 | 3.19e-01 | 0.126000 | 5.96e-01 |
PYRIMIDINE SALVAGE | 10 | 4.92e-01 | -0.126000 | 7.21e-01 |
INTERLEUKIN 1 SIGNALING | 96 | 3.37e-02 | -0.125000 | 1.52e-01 |
REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS | 12 | 4.55e-01 | 0.124000 | 7.01e-01 |
TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY | 12 | 4.56e-01 | -0.124000 | 7.01e-01 |
THE NLRP3 INFLAMMASOME | 15 | 4.05e-01 | -0.124000 | 6.72e-01 |
OVARIAN TUMOR DOMAIN PROTEASES | 36 | 1.97e-01 | -0.124000 | 4.57e-01 |
TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER | 78 | 5.88e-02 | -0.124000 | 2.35e-01 |
MITOCHONDRIAL TRNA AMINOACYLATION | 21 | 3.26e-01 | -0.124000 | 5.98e-01 |
THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS | 28 | 2.57e-01 | -0.124000 | 5.41e-01 |
INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | 20 | 3.39e-01 | -0.124000 | 6.10e-01 |
TRNA AMINOACYLATION | 42 | 1.68e-01 | -0.123000 | 4.24e-01 |
DOWNREGULATION OF ERBB2 SIGNALING | 28 | 2.62e-01 | -0.122000 | 5.45e-01 |
ANCHORING FIBRIL FORMATION | 15 | 4.12e-01 | 0.122000 | 6.75e-01 |
SIGNALING BY ACTIVIN | 12 | 4.64e-01 | 0.122000 | 7.04e-01 |
FGFR2 LIGAND BINDING AND ACTIVATION | 12 | 4.64e-01 | 0.122000 | 7.04e-01 |
TRANSLESION SYNTHESIS BY POLK | 17 | 3.84e-01 | -0.122000 | 6.60e-01 |
PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES | 14 | 4.30e-01 | -0.122000 | 6.85e-01 |
PHOSPHOLIPASE C MEDIATED CASCADE FGFR2 | 12 | 4.66e-01 | 0.122000 | 7.05e-01 |
TCR SIGNALING | 102 | 3.40e-02 | -0.122000 | 1.52e-01 |
RHO GTPASES ACTIVATE CIT | 18 | 3.73e-01 | 0.121000 | 6.52e-01 |
UB SPECIFIC PROCESSING PROTEASES | 168 | 6.78e-03 | -0.121000 | 4.30e-02 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS | 22 | 3.27e-01 | 0.121000 | 5.98e-01 |
BILE ACID AND BILE SALT METABOLISM | 25 | 2.96e-01 | 0.121000 | 5.74e-01 |
PHASE II CONJUGATION OF COMPOUNDS | 62 | 1.00e-01 | -0.121000 | 3.13e-01 |
SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS | 11 | 4.88e-01 | 0.121000 | 7.21e-01 |
GLYCOSAMINOGLYCAN METABOLISM | 117 | 2.46e-02 | 0.120000 | 1.19e-01 |
SENSORY PROCESSING OF SOUND BY OUTER HAIR CELLS OF THE COCHLEA | 42 | 1.78e-01 | 0.120000 | 4.35e-01 |
RUNX2 REGULATES BONE DEVELOPMENT | 29 | 2.63e-01 | -0.120000 | 5.46e-01 |
MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | 15 | 4.22e-01 | 0.120000 | 6.78e-01 |
INLB MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL | 15 | 4.23e-01 | -0.120000 | 6.78e-01 |
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 17 | 3.93e-01 | 0.120000 | 6.60e-01 |
PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR | 21 | 3.46e-01 | -0.119000 | 6.17e-01 |
CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE | 50 | 1.46e-01 | -0.119000 | 3.86e-01 |
OLFACTORY SIGNALING PATHWAY | 30 | 2.61e-01 | 0.119000 | 5.45e-01 |
GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 14 | 4.43e-01 | -0.119000 | 6.96e-01 |
ACYL CHAIN REMODELLING OF PC | 16 | 4.12e-01 | -0.118000 | 6.75e-01 |
SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III | 23 | 3.28e-01 | -0.118000 | 5.98e-01 |
NUCLEAR IMPORT OF REV PROTEIN | 32 | 2.49e-01 | 0.118000 | 5.27e-01 |
FOXO MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS METABOLIC AND NEURONAL GENES | 24 | 3.21e-01 | 0.117000 | 5.96e-01 |
BETA CATENIN PHOSPHORYLATION CASCADE | 16 | 4.18e-01 | -0.117000 | 6.78e-01 |
ERYTHROPOIETIN ACTIVATES RAS | 13 | 4.69e-01 | -0.116000 | 7.07e-01 |
PLATELET HOMEOSTASIS | 78 | 7.64e-02 | 0.116000 | 2.67e-01 |
PI 3K CASCADE FGFR3 | 14 | 4.53e-01 | 0.116000 | 7.01e-01 |
STRIATED MUSCLE CONTRACTION | 24 | 3.27e-01 | 0.116000 | 5.98e-01 |
POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | 61 | 1.19e-01 | 0.116000 | 3.44e-01 |
TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES | 45 | 1.80e-01 | -0.115000 | 4.39e-01 |
ACETYLCHOLINE REGULATES INSULIN SECRETION | 10 | 5.27e-01 | -0.115000 | 7.38e-01 |
FORMATION OF APOPTOSOME | 10 | 5.28e-01 | -0.115000 | 7.38e-01 |
ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | 23 | 3.38e-01 | 0.115000 | 6.10e-01 |
LYSOSPHINGOLIPID AND LPA RECEPTORS | 13 | 4.72e-01 | -0.115000 | 7.10e-01 |
ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS | 84 | 6.84e-02 | 0.115000 | 2.56e-01 |
SIGNALING BY FLT3 ITD AND TKD MUTANTS | 16 | 4.27e-01 | 0.115000 | 6.81e-01 |
UNWINDING OF DNA | 12 | 4.92e-01 | 0.115000 | 7.21e-01 |
PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE | 19 | 3.88e-01 | -0.114000 | 6.60e-01 |
DISEASES ASSOCIATED WITH O GLYCOSYLATION OF PROTEINS | 51 | 1.58e-01 | 0.114000 | 4.05e-01 |
PROCESSING AND ACTIVATION OF SUMO | 10 | 5.32e-01 | -0.114000 | 7.41e-01 |
GLUTATHIONE CONJUGATION | 29 | 2.88e-01 | -0.114000 | 5.71e-01 |
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION | 12 | 4.96e-01 | 0.113000 | 7.21e-01 |
REGULATION OF GENE EXPRESSION IN BETA CELLS | 12 | 4.97e-01 | -0.113000 | 7.21e-01 |
REPRODUCTION | 78 | 8.55e-02 | -0.113000 | 2.85e-01 |
RHOJ GTPASE CYCLE | 54 | 1.53e-01 | 0.112000 | 3.95e-01 |
RAF INDEPENDENT MAPK1 3 ACTIVATION | 21 | 3.75e-01 | 0.112000 | 6.54e-01 |
BIOTIN TRANSPORT AND METABOLISM | 11 | 5.21e-01 | 0.112000 | 7.38e-01 |
METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION | 15 | 4.54e-01 | -0.112000 | 7.01e-01 |
SIGNALING BY WNT IN CANCER | 31 | 2.82e-01 | -0.112000 | 5.66e-01 |
ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA | 15 | 4.57e-01 | -0.111000 | 7.01e-01 |
PROLONGED ERK ACTIVATION EVENTS | 14 | 4.72e-01 | 0.111000 | 7.10e-01 |
MYOGENESIS | 24 | 3.47e-01 | 0.111000 | 6.18e-01 |
HEME BIOSYNTHESIS | 13 | 4.90e-01 | 0.111000 | 7.21e-01 |
PECAM1 INTERACTIONS | 12 | 5.09e-01 | 0.110000 | 7.29e-01 |
SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | 18 | 4.20e-01 | 0.110000 | 6.78e-01 |
HEPARAN SULFATE HEPARIN HS GAG METABOLISM | 53 | 1.68e-01 | 0.110000 | 4.23e-01 |
TRANSLATION OF SARS COV 1 STRUCTURAL PROTEINS | 28 | 3.16e-01 | -0.109000 | 5.94e-01 |
CELL JUNCTION ORGANIZATION | 74 | 1.04e-01 | -0.109000 | 3.18e-01 |
ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | 15 | 4.63e-01 | -0.109000 | 7.04e-01 |
CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER | 62 | 1.37e-01 | 0.109000 | 3.76e-01 |
TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 43 | 2.16e-01 | 0.109000 | 4.85e-01 |
RNA POLYMERASE I TRANSCRIPTION TERMINATION | 31 | 2.94e-01 | -0.109000 | 5.74e-01 |
POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 63 | 1.35e-01 | -0.109000 | 3.75e-01 |
RA BIOSYNTHESIS PATHWAY | 13 | 4.99e-01 | -0.108000 | 7.22e-01 |
METHYLATION | 12 | 5.16e-01 | -0.108000 | 7.35e-01 |
NICOTINATE METABOLISM | 26 | 3.40e-01 | -0.108000 | 6.10e-01 |
PROLACTIN RECEPTOR SIGNALING | 12 | 5.17e-01 | -0.108000 | 7.35e-01 |
SIGNALING BY NOTCH3 | 48 | 1.97e-01 | -0.108000 | 4.57e-01 |
INTERLEUKIN RECEPTOR SHC SIGNALING | 20 | 4.06e-01 | -0.107000 | 6.72e-01 |
HIV TRANSCRIPTION ELONGATION | 42 | 2.29e-01 | -0.107000 | 5.06e-01 |
CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION | 11 | 5.38e-01 | 0.107000 | 7.46e-01 |
RHO GTPASES ACTIVATE ROCKS | 19 | 4.21e-01 | 0.107000 | 6.78e-01 |
DEGRADATION OF CYSTEINE AND HOMOCYSTEINE | 14 | 4.93e-01 | -0.106000 | 7.21e-01 |
ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | 10 | 5.63e-01 | 0.106000 | 7.59e-01 |
HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | 10 | 5.63e-01 | 0.106000 | 7.59e-01 |
LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME | 13 | 5.11e-01 | 0.105000 | 7.29e-01 |
EPHB MEDIATED FORWARD SIGNALING | 42 | 2.38e-01 | -0.105000 | 5.15e-01 |
RESPONSE OF MTB TO PHAGOCYTOSIS | 22 | 3.94e-01 | -0.105000 | 6.60e-01 |
INITIATION OF NUCLEAR ENVELOPE NE REFORMATION | 17 | 4.54e-01 | -0.105000 | 7.01e-01 |
INSULIN RECEPTOR SIGNALLING CASCADE | 45 | 2.24e-01 | 0.105000 | 4.97e-01 |
DISEASES OF IMMUNE SYSTEM | 22 | 3.95e-01 | -0.105000 | 6.60e-01 |
GAP JUNCTION ASSEMBLY | 21 | 4.07e-01 | -0.105000 | 6.72e-01 |
ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION | 14 | 4.98e-01 | -0.105000 | 7.22e-01 |
MITOTIC SPINDLE CHECKPOINT | 99 | 7.33e-02 | -0.104000 | 2.65e-01 |
CELL EXTRACELLULAR MATRIX INTERACTIONS | 18 | 4.44e-01 | -0.104000 | 6.96e-01 |
PENTOSE PHOSPHATE PATHWAY | 13 | 5.17e-01 | -0.104000 | 7.35e-01 |
APOPTOSIS INDUCED DNA FRAGMENTATION | 10 | 5.72e-01 | 0.103000 | 7.66e-01 |
DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE | 45 | 2.32e-01 | -0.103000 | 5.09e-01 |
MAP2K AND MAPK ACTIVATION | 36 | 2.87e-01 | -0.103000 | 5.70e-01 |
MEIOSIS | 66 | 1.51e-01 | -0.102000 | 3.91e-01 |
UNFOLDED PROTEIN RESPONSE UPR | 86 | 1.01e-01 | -0.102000 | 3.15e-01 |
CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | 12 | 5.40e-01 | 0.102000 | 7.48e-01 |
INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | 34 | 3.04e-01 | 0.102000 | 5.85e-01 |
METABOLISM OF STEROIDS | 116 | 5.86e-02 | -0.102000 | 2.35e-01 |
RIP MEDIATED NFKB ACTIVATION VIA ZBP1 | 15 | 4.96e-01 | 0.102000 | 7.21e-01 |
TELOMERE MAINTENANCE | 79 | 1.20e-01 | -0.101000 | 3.47e-01 |
REGULATION OF IFNG SIGNALING | 13 | 5.28e-01 | 0.101000 | 7.38e-01 |
PLASMA LIPOPROTEIN CLEARANCE | 27 | 3.64e-01 | -0.101000 | 6.40e-01 |
SIGNALING BY NTRKS | 128 | 4.91e-02 | 0.101000 | 2.06e-01 |
SENSORY PERCEPTION | 154 | 3.12e-02 | 0.101000 | 1.44e-01 |
ACTIVATION OF GENE EXPRESSION BY SREBF SREBP | 43 | 2.53e-01 | -0.101000 | 5.36e-01 |
RAC1 GTPASE CYCLE | 177 | 2.15e-02 | 0.100000 | 1.08e-01 |
NEUTROPHIL DEGRANULATION | 390 | 7.05e-04 | -0.100000 | 7.24e-03 |
RAB GERANYLGERANYLATION | 58 | 1.88e-01 | -0.100000 | 4.48e-01 |
SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R | 46 | 2.47e-01 | 0.098800 | 5.25e-01 |
CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | 344 | 1.69e-03 | -0.098700 | 1.48e-02 |
O LINKED GLYCOSYLATION | 86 | 1.15e-01 | 0.098300 | 3.37e-01 |
BRANCHED CHAIN AMINO ACID CATABOLISM | 21 | 4.36e-01 | -0.098200 | 6.90e-01 |
NON INTEGRIN MEMBRANE ECM INTERACTIONS | 58 | 1.96e-01 | 0.098200 | 4.57e-01 |
ACYL CHAIN REMODELLING OF PG | 10 | 5.91e-01 | -0.098200 | 7.73e-01 |
FGFR2 MUTANT RECEPTOR ACTIVATION | 27 | 3.78e-01 | -0.098000 | 6.57e-01 |
CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | 10 | 5.92e-01 | -0.098000 | 7.73e-01 |
SIGNALING BY FGFR2 IIIA TM | 19 | 4.60e-01 | -0.098000 | 7.04e-01 |
NEGATIVE REGULATION OF THE PI3K AKT NETWORK | 95 | 9.92e-02 | 0.097900 | 3.11e-01 |
TRANS GOLGI NETWORK VESICLE BUDDING | 69 | 1.61e-01 | -0.097600 | 4.10e-01 |
SIALIC ACID METABOLISM | 32 | 3.40e-01 | 0.097500 | 6.10e-01 |
INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | 13 | 5.43e-01 | -0.097500 | 7.49e-01 |
SARS COV 2 INFECTION | 65 | 1.74e-01 | -0.097500 | 4.32e-01 |
P38MAPK EVENTS | 12 | 5.60e-01 | -0.097200 | 7.58e-01 |
DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE | 20 | 4.53e-01 | 0.096900 | 7.01e-01 |
INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING | 79 | 1.37e-01 | -0.096800 | 3.76e-01 |
ADENYLATE CYCLASE INHIBITORY PATHWAY | 13 | 5.46e-01 | 0.096700 | 7.49e-01 |
LYSOSOME VESICLE BIOGENESIS | 32 | 3.46e-01 | -0.096300 | 6.17e-01 |
DISEASES OF GLYCOSYLATION | 125 | 6.35e-02 | 0.096200 | 2.45e-01 |
TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | 79 | 1.40e-01 | -0.096100 | 3.81e-01 |
TRANSPORT OF SMALL MOLECULES | 587 | 7.47e-05 | 0.096000 | 1.11e-03 |
L1CAM INTERACTIONS | 109 | 8.43e-02 | 0.095800 | 2.83e-01 |
OXIDATIVE STRESS INDUCED SENESCENCE | 79 | 1.42e-01 | -0.095600 | 3.82e-01 |
RMTS METHYLATE HISTONE ARGININES | 44 | 2.73e-01 | -0.095600 | 5.56e-01 |
REGULATION OF TP53 ACTIVITY THROUGH METHYLATION | 18 | 4.84e-01 | -0.095400 | 7.18e-01 |
PHASE 4 RESTING MEMBRANE POTENTIAL | 14 | 5.38e-01 | -0.095000 | 7.46e-01 |
MITOCHONDRIAL FATTY ACID BETA OXIDATION | 35 | 3.32e-01 | -0.094800 | 6.03e-01 |
SIGNALING BY EGFR | 47 | 2.64e-01 | -0.094300 | 5.46e-01 |
EXTRACELLULAR MATRIX ORGANIZATION | 245 | 1.15e-02 | 0.093900 | 6.65e-02 |
SIGNALING BY BMP | 25 | 4.17e-01 | -0.093900 | 6.78e-01 |
INFECTION WITH MYCOBACTERIUM TUBERCULOSIS | 25 | 4.17e-01 | -0.093800 | 6.78e-01 |
ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION | 26 | 4.10e-01 | -0.093400 | 6.75e-01 |
DEGRADATION OF THE EXTRACELLULAR MATRIX | 108 | 9.44e-02 | 0.093200 | 3.03e-01 |
NGF STIMULATED TRANSCRIPTION | 36 | 3.34e-01 | 0.093000 | 6.04e-01 |
M PHASE | 343 | 3.19e-03 | -0.092800 | 2.34e-02 |
SIGNALING BY NUCLEAR RECEPTORS | 225 | 1.77e-02 | -0.091900 | 9.07e-02 |
SIGNALING BY ERBB2 | 49 | 2.68e-01 | -0.091500 | 5.50e-01 |
DOWNSTREAM SIGNAL TRANSDUCTION | 29 | 3.95e-01 | 0.091300 | 6.60e-01 |
COPII MEDIATED VESICLE TRANSPORT | 65 | 2.04e-01 | 0.091200 | 4.66e-01 |
CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | 73 | 1.78e-01 | 0.091100 | 4.35e-01 |
BASE EXCISION REPAIR | 58 | 2.31e-01 | -0.091000 | 5.08e-01 |
SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX | 13 | 5.71e-01 | -0.090800 | 7.66e-01 |
NEGATIVE REGULATION OF FGFR2 SIGNALING | 28 | 4.06e-01 | 0.090700 | 6.72e-01 |
TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE | 39 | 3.28e-01 | -0.090600 | 5.98e-01 |
CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND | 12 | 5.89e-01 | -0.090200 | 7.73e-01 |
SARS COV INFECTIONS | 140 | 6.65e-02 | -0.089900 | 2.52e-01 |
FORMATION OF INCISION COMPLEX IN GG NER | 43 | 3.08e-01 | -0.089800 | 5.91e-01 |
TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS | 41 | 3.20e-01 | 0.089700 | 5.96e-01 |
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER | 28 | 4.13e-01 | 0.089400 | 6.75e-01 |
ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING | 21 | 4.81e-01 | -0.088900 | 7.16e-01 |
RHOD GTPASE CYCLE | 50 | 2.82e-01 | 0.088000 | 5.66e-01 |
TELOMERE EXTENSION BY TELOMERASE | 22 | 4.77e-01 | -0.087600 | 7.14e-01 |
NEGATIVE REGULATION OF FLT3 | 14 | 5.72e-01 | 0.087300 | 7.66e-01 |
MYD88 INDEPENDENT TLR4 CASCADE | 92 | 1.48e-01 | 0.087300 | 3.86e-01 |
INTERLEUKIN 37 SIGNALING | 18 | 5.22e-01 | 0.087100 | 7.38e-01 |
VEGFR2 MEDIATED VASCULAR PERMEABILITY | 27 | 4.34e-01 | -0.086900 | 6.89e-01 |
CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT | 20 | 5.03e-01 | -0.086600 | 7.25e-01 |
RECYCLING PATHWAY OF L1 | 40 | 3.43e-01 | 0.086600 | 6.15e-01 |
INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION | 13 | 5.89e-01 | 0.086500 | 7.73e-01 |
SIGNALING BY RETINOIC ACID | 33 | 3.91e-01 | 0.086300 | 6.60e-01 |
SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS | 58 | 2.58e-01 | 0.085800 | 5.42e-01 |
SIGNALING BY PTK6 | 52 | 2.85e-01 | -0.085700 | 5.68e-01 |
ERBB2 REGULATES CELL MOTILITY | 14 | 5.80e-01 | -0.085500 | 7.69e-01 |
INTERLEUKIN 1 FAMILY SIGNALING | 122 | 1.03e-01 | -0.085400 | 3.17e-01 |
EPHA MEDIATED GROWTH CONE COLLAPSE | 28 | 4.34e-01 | 0.085400 | 6.89e-01 |
IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | 20 | 5.11e-01 | -0.085000 | 7.29e-01 |
DNA DOUBLE STRAND BREAK RESPONSE | 53 | 2.85e-01 | -0.084900 | 5.68e-01 |
INTERFERON GAMMA SIGNALING | 80 | 1.90e-01 | -0.084900 | 4.51e-01 |
SYNTHESIS OF PE | 13 | 5.96e-01 | 0.084900 | 7.76e-01 |
COLLAGEN FORMATION | 79 | 1.93e-01 | -0.084800 | 4.55e-01 |
NERVOUS SYSTEM DEVELOPMENT | 550 | 7.20e-04 | -0.084600 | 7.33e-03 |
CD209 DC SIGN SIGNALING | 18 | 5.35e-01 | -0.084400 | 7.44e-01 |
REGULATION OF SIGNALING BY CBL | 22 | 4.94e-01 | -0.084300 | 7.21e-01 |
CLATHRIN MEDIATED ENDOCYTOSIS | 134 | 9.23e-02 | 0.084300 | 2.98e-01 |
AQUAPORIN MEDIATED TRANSPORT | 39 | 3.64e-01 | -0.084000 | 6.40e-01 |
METABOLISM OF PORPHYRINS | 19 | 5.28e-01 | 0.083700 | 7.38e-01 |
PEROXISOMAL LIPID METABOLISM | 26 | 4.61e-01 | 0.083600 | 7.04e-01 |
PKMTS METHYLATE HISTONE LYSINES | 49 | 3.13e-01 | 0.083400 | 5.93e-01 |
TIGHT JUNCTION INTERACTIONS | 17 | 5.54e-01 | -0.082900 | 7.52e-01 |
PRE NOTCH PROCESSING IN GOLGI | 17 | 5.54e-01 | 0.082900 | 7.52e-01 |
DEFECTIVE EXT2 CAUSES EXOSTOSES 2 | 14 | 5.93e-01 | 0.082600 | 7.74e-01 |
MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION | 16 | 5.68e-01 | 0.082500 | 7.64e-01 |
YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | 12 | 6.21e-01 | 0.082500 | 7.97e-01 |
SPRY REGULATION OF FGF SIGNALING | 16 | 5.68e-01 | 0.082400 | 7.64e-01 |
NUCLEOTIDE EXCISION REPAIR | 110 | 1.37e-01 | -0.082100 | 3.76e-01 |
TNFR1 INDUCED NFKAPPAB SIGNALING PATHWAY | 29 | 4.44e-01 | 0.082100 | 6.96e-01 |
CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY | 22 | 5.05e-01 | 0.082100 | 7.27e-01 |
RHO GTPASES ACTIVATE IQGAPS | 24 | 4.87e-01 | -0.082000 | 7.21e-01 |
DEUBIQUITINATION | 242 | 2.84e-02 | -0.081900 | 1.33e-01 |
HDACS DEACETYLATE HISTONES | 47 | 3.33e-01 | -0.081600 | 6.03e-01 |
INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING | 41 | 3.67e-01 | -0.081400 | 6.43e-01 |
TICAM1 TRAF6 DEPENDENT INDUCTION OF TAK1 COMPLEX | 11 | 6.40e-01 | -0.081400 | 8.09e-01 |
FORMATION OF RNA POL II ELONGATION COMPLEX | 57 | 2.89e-01 | -0.081300 | 5.71e-01 |
PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE | 52 | 3.11e-01 | 0.081300 | 5.93e-01 |
RESOLUTION OF SISTER CHROMATID COHESION | 104 | 1.53e-01 | -0.081200 | 3.95e-01 |
HIV LIFE CYCLE | 143 | 9.53e-02 | -0.080900 | 3.03e-01 |
RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES | 20 | 5.32e-01 | 0.080800 | 7.41e-01 |
INSULIN PROCESSING | 24 | 4.94e-01 | 0.080700 | 7.21e-01 |
TOLL LIKE RECEPTOR TLR1 TLR2 CASCADE | 91 | 1.84e-01 | 0.080700 | 4.40e-01 |
NF KB IS ACTIVATED AND SIGNALS SURVIVAL | 13 | 6.15e-01 | -0.080700 | 7.92e-01 |
RHOA GTPASE CYCLE | 143 | 9.65e-02 | 0.080600 | 3.06e-01 |
TRANSCRIPTIONAL REGULATION BY VENTX | 35 | 4.12e-01 | -0.080200 | 6.75e-01 |
KSRP KHSRP BINDS AND DESTABILIZES MRNA | 16 | 5.80e-01 | -0.079900 | 7.69e-01 |
SUMOYLATION OF UBIQUITINYLATION PROTEINS | 37 | 4.02e-01 | 0.079700 | 6.68e-01 |
SHC MEDIATED CASCADE FGFR1 | 16 | 5.82e-01 | 0.079500 | 7.69e-01 |
KETONE BODY METABOLISM | 10 | 6.64e-01 | -0.079300 | 8.26e-01 |
DISEASES OF CARBOHYDRATE METABOLISM | 29 | 4.61e-01 | -0.079100 | 7.04e-01 |
FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS | 83 | 2.14e-01 | 0.079000 | 4.80e-01 |
PI3K EVENTS IN ERBB2 SIGNALING | 15 | 5.97e-01 | -0.078900 | 7.76e-01 |
INTRA GOLGI TRAFFIC | 43 | 3.71e-01 | 0.078900 | 6.49e-01 |
RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX | 30 | 4.55e-01 | -0.078900 | 7.01e-01 |
IRON UPTAKE AND TRANSPORT | 52 | 3.26e-01 | -0.078800 | 5.98e-01 |
NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION | 180 | 6.87e-02 | 0.078700 | 2.57e-01 |
HIV ELONGATION ARREST AND RECOVERY | 32 | 4.41e-01 | -0.078700 | 6.95e-01 |
CHROMOSOME MAINTENANCE | 103 | 1.70e-01 | -0.078400 | 4.25e-01 |
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 20 | 5.44e-01 | -0.078300 | 7.49e-01 |
MEIOTIC SYNAPSIS | 41 | 3.88e-01 | -0.077900 | 6.60e-01 |
NUCLEOBASE CATABOLISM | 32 | 4.48e-01 | -0.077500 | 7.00e-01 |
SIGNALING BY FGFR | 74 | 2.51e-01 | -0.077200 | 5.31e-01 |
CELL CYCLE MITOTIC | 480 | 3.87e-03 | -0.077200 | 2.70e-02 |
REGULATION OF FZD BY UBIQUITINATION | 20 | 5.51e-01 | -0.077100 | 7.50e-01 |
P75 NTR RECEPTOR MEDIATED SIGNALLING | 94 | 1.97e-01 | 0.077000 | 4.57e-01 |
RHOF GTPASE CYCLE | 40 | 4.00e-01 | 0.076900 | 6.66e-01 |
SYNTHESIS OF PA | 30 | 4.67e-01 | -0.076800 | 7.05e-01 |
RHOQ GTPASE CYCLE | 58 | 3.12e-01 | 0.076700 | 5.93e-01 |
DISEASES ASSOCIATED WITH N GLYCOSYLATION OF PROTEINS | 17 | 5.84e-01 | -0.076600 | 7.70e-01 |
RAF ACTIVATION | 34 | 4.39e-01 | -0.076600 | 6.93e-01 |
GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION | 26 | 5.00e-01 | -0.076500 | 7.22e-01 |
LDL CLEARANCE | 16 | 5.99e-01 | -0.075900 | 7.79e-01 |
GAP JUNCTION TRAFFICKING AND REGULATION | 33 | 4.54e-01 | -0.075400 | 7.01e-01 |
CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS | 94 | 2.07e-01 | 0.075300 | 4.70e-01 |
REGULATION OF GLYCOLYSIS BY FRUCTOSE 2 6 BISPHOSPHATE METABOLISM | 11 | 6.66e-01 | -0.075100 | 8.28e-01 |
SIGNALING BY NOTCH1 | 75 | 2.62e-01 | -0.075000 | 5.45e-01 |
RHO GTPASES ACTIVATE FORMINS | 121 | 1.55e-01 | -0.074800 | 4.01e-01 |
GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER | 84 | 2.38e-01 | -0.074500 | 5.16e-01 |
SIGNALING BY NOTCH2 | 33 | 4.62e-01 | -0.074000 | 7.04e-01 |
METABOLISM OF FOLATE AND PTERINES | 15 | 6.20e-01 | -0.073900 | 7.97e-01 |
DEATH RECEPTOR SIGNALLING | 133 | 1.42e-01 | 0.073800 | 3.82e-01 |
SIGNALING BY FGFR2 | 63 | 3.15e-01 | -0.073200 | 5.94e-01 |
ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | 286 | 3.40e-02 | -0.073000 | 1.52e-01 |
GLYCEROPHOSPHOLIPID BIOSYNTHESIS | 108 | 1.97e-01 | 0.071900 | 4.57e-01 |
CILIUM ASSEMBLY | 192 | 8.76e-02 | -0.071600 | 2.87e-01 |
NUCLEAR SIGNALING BY ERBB4 | 31 | 4.91e-01 | -0.071400 | 7.21e-01 |
GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | 17 | 6.10e-01 | -0.071400 | 7.88e-01 |
NEDDYLATION | 219 | 6.95e-02 | -0.071300 | 2.58e-01 |
PEPTIDE LIGAND BINDING RECEPTORS | 118 | 1.82e-01 | -0.071100 | 4.40e-01 |
TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES | 37 | 4.55e-01 | 0.070900 | 7.01e-01 |
NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 | 11 | 6.84e-01 | 0.070900 | 8.35e-01 |
P75NTR SIGNALS VIA NF KB | 16 | 6.24e-01 | -0.070900 | 7.98e-01 |
G ALPHA S SIGNALLING EVENTS | 107 | 2.07e-01 | 0.070600 | 4.70e-01 |
IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | 51 | 3.84e-01 | -0.070400 | 6.60e-01 |
TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS | 31 | 5.00e-01 | -0.070000 | 7.22e-01 |
RET SIGNALING | 38 | 4.57e-01 | 0.069800 | 7.01e-01 |
HOMOLOGY DIRECTED REPAIR | 108 | 2.11e-01 | -0.069700 | 4.77e-01 |
TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA | 34 | 4.82e-01 | 0.069600 | 7.18e-01 |
CELL CYCLE | 598 | 3.79e-03 | -0.069500 | 2.67e-02 |
MATURATION OF SARS COV 2 SPIKE PROTEIN | 29 | 5.17e-01 | -0.069500 | 7.35e-01 |
PYRIMIDINE CATABOLISM | 11 | 6.90e-01 | -0.069400 | 8.38e-01 |
SARS COV 1 INFECTION | 48 | 4.07e-01 | -0.069200 | 6.72e-01 |
ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | 28 | 5.26e-01 | -0.069200 | 7.38e-01 |
INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS | 35 | 4.80e-01 | 0.069000 | 7.16e-01 |
UPTAKE AND ACTIONS OF BACTERIAL TOXINS | 29 | 5.20e-01 | 0.069000 | 7.38e-01 |
RNA POLYMERASE II TRANSCRIBES SNRNA GENES | 74 | 3.05e-01 | -0.068900 | 5.86e-01 |
TRANSCRIPTIONAL REGULATION BY SMALL RNAS | 62 | 3.50e-01 | -0.068700 | 6.21e-01 |
ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY | 11 | 6.94e-01 | 0.068500 | 8.39e-01 |
COMMON PATHWAY OF FIBRIN CLOT FORMATION | 11 | 6.94e-01 | 0.068500 | 8.39e-01 |
RAC3 GTPASE CYCLE | 89 | 2.65e-01 | 0.068400 | 5.46e-01 |
SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER | 59 | 3.66e-01 | -0.068100 | 6.42e-01 |
SUMOYLATION OF INTRACELLULAR RECEPTORS | 27 | 5.43e-01 | -0.067600 | 7.49e-01 |
TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | 43 | 4.44e-01 | -0.067500 | 6.96e-01 |
REGULATION OF BETA CELL DEVELOPMENT | 30 | 5.22e-01 | -0.067500 | 7.38e-01 |
REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION | 87 | 2.78e-01 | -0.067400 | 5.62e-01 |
TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | 32 | 5.10e-01 | 0.067300 | 7.29e-01 |
SPHINGOLIPID DE NOVO BIOSYNTHESIS | 42 | 4.52e-01 | -0.067100 | 7.01e-01 |
REGULATION OF IFNA SIGNALING | 12 | 6.88e-01 | 0.067000 | 8.36e-01 |
TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS | 20 | 6.07e-01 | -0.066500 | 7.85e-01 |
GPCR LIGAND BINDING | 286 | 5.34e-02 | -0.066500 | 2.20e-01 |
ACTIVATION OF MATRIX METALLOPROTEINASES | 14 | 6.67e-01 | -0.066400 | 8.28e-01 |
HCMV LATE EVENTS | 66 | 3.51e-01 | -0.066300 | 6.23e-01 |
EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS | 31 | 5.27e-01 | 0.065700 | 7.38e-01 |
RHO GTPASES ACTIVATE WASPS AND WAVES | 36 | 4.96e-01 | 0.065600 | 7.21e-01 |
SNRNP ASSEMBLY | 51 | 4.18e-01 | -0.065500 | 6.78e-01 |
MITOTIC TELOPHASE CYTOKINESIS | 13 | 6.84e-01 | 0.065100 | 8.35e-01 |
NEGATIVE REGULATION OF FGFR4 SIGNALING | 24 | 5.83e-01 | 0.064800 | 7.69e-01 |
INTERFERON SIGNALING | 168 | 1.48e-01 | -0.064800 | 3.86e-01 |
IRAK1 RECRUITS IKK COMPLEX | 14 | 6.77e-01 | -0.064400 | 8.30e-01 |
GLUCONEOGENESIS | 27 | 5.63e-01 | -0.064300 | 7.59e-01 |
RND1 GTPASE CYCLE | 38 | 4.93e-01 | 0.064300 | 7.21e-01 |
MICRORNA MIRNA BIOGENESIS | 24 | 5.87e-01 | -0.064100 | 7.71e-01 |
SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | 62 | 3.85e-01 | 0.063900 | 6.60e-01 |
CIRCADIAN CLOCK | 68 | 3.63e-01 | 0.063800 | 6.40e-01 |
SUMOYLATION OF IMMUNE RESPONSE PROTEINS | 11 | 7.16e-01 | -0.063300 | 8.46e-01 |
SIGNALING BY BRAF AND RAF FUSIONS | 60 | 3.97e-01 | 0.063200 | 6.63e-01 |
PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | 15 | 6.72e-01 | -0.063100 | 8.28e-01 |
TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES | 61 | 3.94e-01 | -0.063100 | 6.60e-01 |
G ALPHA 12 13 SIGNALLING EVENTS | 74 | 3.49e-01 | 0.063000 | 6.20e-01 |
GRB2 EVENTS IN ERBB2 SIGNALING | 15 | 6.73e-01 | -0.063000 | 8.28e-01 |
HCMV INFECTION | 104 | 2.68e-01 | -0.062900 | 5.50e-01 |
RAC2 GTPASE CYCLE | 86 | 3.16e-01 | 0.062600 | 5.94e-01 |
SIGNALING BY FGFR IN DISEASE | 56 | 4.18e-01 | -0.062500 | 6.78e-01 |
CARGO CONCENTRATION IN THE ER | 30 | 5.55e-01 | 0.062300 | 7.52e-01 |
GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION | 38 | 5.09e-01 | -0.061900 | 7.29e-01 |
SIGNALING BY NTRK2 TRKB | 23 | 6.09e-01 | 0.061700 | 7.87e-01 |
NUCLEAR ENVELOPE NE REASSEMBLY | 64 | 3.95e-01 | -0.061500 | 6.60e-01 |
FGFR1 MUTANT RECEPTOR ACTIVATION | 27 | 5.80e-01 | 0.061500 | 7.69e-01 |
FRS MEDIATED FGFR3 SIGNALING | 16 | 6.71e-01 | 0.061400 | 8.28e-01 |
ACTIVATION OF SMO | 16 | 6.73e-01 | -0.061000 | 8.28e-01 |
TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN | 20 | 6.37e-01 | -0.060900 | 8.08e-01 |
INFLAMMASOMES | 19 | 6.46e-01 | -0.060900 | 8.14e-01 |
MHC CLASS II ANTIGEN PRESENTATION | 103 | 2.86e-01 | 0.060900 | 5.68e-01 |
COSTIMULATION BY THE CD28 FAMILY | 52 | 4.48e-01 | 0.060900 | 7.00e-01 |
TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | 13 | 7.04e-01 | -0.060800 | 8.40e-01 |
ACYL CHAIN REMODELLING OF PS | 14 | 6.94e-01 | 0.060700 | 8.39e-01 |
GAB1 SIGNALOSOME | 14 | 6.94e-01 | -0.060700 | 8.39e-01 |
TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX | 14 | 6.95e-01 | 0.060500 | 8.39e-01 |
INTERLEUKIN 15 SIGNALING | 13 | 7.06e-01 | 0.060400 | 8.40e-01 |
KERATAN SULFATE BIOSYNTHESIS | 26 | 5.95e-01 | 0.060300 | 7.75e-01 |
ORGANIC CATION ANION ZWITTERION TRANSPORT | 11 | 7.30e-01 | 0.060200 | 8.57e-01 |
CHROMATIN MODIFYING ENZYMES | 219 | 1.30e-01 | 0.059400 | 3.65e-01 |
G ALPHA Z SIGNALLING EVENTS | 45 | 4.92e-01 | -0.059200 | 7.21e-01 |
GPVI MEDIATED ACTIVATION CASCADE | 31 | 5.68e-01 | -0.059200 | 7.64e-01 |
VITAMIN B5 PANTOTHENATE METABOLISM | 14 | 7.02e-01 | 0.059000 | 8.40e-01 |
PEROXISOMAL PROTEIN IMPORT | 59 | 4.35e-01 | -0.058800 | 6.89e-01 |
ARACHIDONIC ACID METABOLISM | 38 | 5.34e-01 | 0.058300 | 7.44e-01 |
INOSITOL PHOSPHATE METABOLISM | 47 | 4.91e-01 | 0.058100 | 7.21e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR4 | 20 | 6.53e-01 | -0.058100 | 8.19e-01 |
THE PHOTOTRANSDUCTION CASCADE | 22 | 6.38e-01 | 0.058000 | 8.08e-01 |
POTENTIAL THERAPEUTICS FOR SARS | 77 | 3.81e-01 | -0.057800 | 6.60e-01 |
FRS MEDIATED FGFR4 SIGNALING | 15 | 7.03e-01 | -0.056900 | 8.40e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR1 | 26 | 6.16e-01 | 0.056800 | 7.93e-01 |
RND3 GTPASE CYCLE | 38 | 5.48e-01 | -0.056400 | 7.49e-01 |
RHOV GTPASE CYCLE | 32 | 5.82e-01 | 0.056300 | 7.69e-01 |
REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION | 10 | 7.59e-01 | 0.056000 | 8.75e-01 |
SUMOYLATION OF SUMOYLATION PROTEINS | 33 | 5.79e-01 | 0.055800 | 7.69e-01 |
CRMPS IN SEMA3A SIGNALING | 16 | 6.99e-01 | 0.055800 | 8.40e-01 |
DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | 23 | 6.44e-01 | 0.055700 | 8.12e-01 |
MAPK FAMILY SIGNALING CASCADES | 289 | 1.04e-01 | -0.055700 | 3.18e-01 |
DEADENYLATION OF MRNA | 25 | 6.31e-01 | 0.055600 | 8.04e-01 |
NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | 52 | 4.97e-01 | 0.054500 | 7.21e-01 |
SIGNALING BY PDGFRA TRANSMEMBRANE JUXTAMEMBRANE AND KINASE DOMAIN MUTANTS | 12 | 7.44e-01 | 0.054500 | 8.66e-01 |
AGGREPHAGY | 35 | 5.78e-01 | -0.054400 | 7.69e-01 |
RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | 25 | 6.39e-01 | -0.054100 | 8.09e-01 |
KILLING MECHANISMS | 11 | 7.57e-01 | 0.053800 | 8.75e-01 |
IRE1ALPHA ACTIVATES CHAPERONES | 50 | 5.10e-01 | -0.053800 | 7.29e-01 |
LYSINE CATABOLISM | 11 | 7.58e-01 | 0.053700 | 8.75e-01 |
NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 23 | 6.56e-01 | -0.053700 | 8.21e-01 |
RNA POLYMERASE I TRANSCRIPTION INITIATION | 47 | 5.25e-01 | -0.053600 | 7.38e-01 |
SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | 20 | 6.79e-01 | 0.053500 | 8.32e-01 |
APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | 34 | 5.91e-01 | -0.053300 | 7.73e-01 |
IRS MEDIATED SIGNALLING | 40 | 5.61e-01 | 0.053100 | 7.59e-01 |
REGULATION OF KIT SIGNALING | 16 | 7.14e-01 | -0.052800 | 8.45e-01 |
RNA POLYMERASE II TRANSCRIPTION | 1092 | 3.43e-03 | -0.052800 | 2.45e-02 |
RND2 GTPASE CYCLE | 38 | 5.76e-01 | 0.052500 | 7.69e-01 |
TRAF6 MEDIATED NF KB ACTIVATION | 22 | 6.71e-01 | -0.052400 | 8.28e-01 |
ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS | 18 | 7.01e-01 | -0.052300 | 8.40e-01 |
GAP JUNCTION DEGRADATION | 11 | 7.64e-01 | -0.052200 | 8.78e-01 |
HCMV EARLY EVENTS | 81 | 4.18e-01 | -0.052100 | 6.78e-01 |
DEVELOPMENTAL BIOLOGY | 827 | 1.19e-02 | -0.051700 | 6.75e-02 |
LAMININ INTERACTIONS | 30 | 6.26e-01 | 0.051400 | 8.00e-01 |
COHESIN LOADING ONTO CHROMATIN | 10 | 7.80e-01 | 0.051000 | 8.91e-01 |
CYTOKINE SIGNALING IN IMMUNE SYSTEM | 549 | 4.17e-02 | -0.051000 | 1.78e-01 |
NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 48 | 5.42e-01 | -0.050900 | 7.49e-01 |
ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS | 10 | 7.80e-01 | 0.050900 | 8.91e-01 |
INNATE IMMUNE SYSTEM | 786 | 1.66e-02 | -0.050500 | 8.69e-02 |
ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE | 96 | 3.95e-01 | -0.050300 | 6.60e-01 |
TRANSCRIPTIONAL REGULATION BY TP53 | 342 | 1.12e-01 | -0.050100 | 3.34e-01 |
ACTIVATION OF AMPK DOWNSTREAM OF NMDARS | 20 | 7.02e-01 | -0.049400 | 8.40e-01 |
DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE | 26 | 6.64e-01 | -0.049200 | 8.26e-01 |
RESOLUTION OF D LOOP STRUCTURES THROUGH SYNTHESIS DEPENDENT STRAND ANNEALING SDSA | 24 | 6.77e-01 | 0.049200 | 8.30e-01 |
BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS | 12 | 7.69e-01 | 0.049000 | 8.81e-01 |
PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | 51 | 5.49e-01 | 0.048600 | 7.49e-01 |
TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | 74 | 4.70e-01 | 0.048500 | 7.09e-01 |
POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE | 25 | 6.75e-01 | 0.048400 | 8.30e-01 |
CELLULAR SENESCENCE | 143 | 3.20e-01 | -0.048200 | 5.96e-01 |
GLUTAMATE AND GLUTAMINE METABOLISM | 13 | 7.65e-01 | -0.048000 | 8.78e-01 |
SEMA4D IN SEMAPHORIN SIGNALING | 24 | 6.85e-01 | 0.047800 | 8.35e-01 |
REGULATION OF LIPID METABOLISM BY PPARALPHA | 108 | 3.91e-01 | 0.047800 | 6.60e-01 |
TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX | 12 | 7.77e-01 | 0.047300 | 8.89e-01 |
PARASITE INFECTION | 56 | 5.47e-01 | 0.046500 | 7.49e-01 |
CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN | 36 | 6.30e-01 | -0.046400 | 8.04e-01 |
OTHER SEMAPHORIN INTERACTIONS | 19 | 7.27e-01 | 0.046400 | 8.55e-01 |
ACTIVATION OF THE PRE REPLICATIVE COMPLEX | 31 | 6.55e-01 | 0.046300 | 8.21e-01 |
RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION | 23 | 7.01e-01 | -0.046300 | 8.40e-01 |
SIGNALING BY PDGF | 57 | 5.46e-01 | 0.046300 | 7.49e-01 |
ONCOGENIC MAPK SIGNALING | 77 | 4.86e-01 | 0.046000 | 7.21e-01 |
LATE ENDOSOMAL MICROAUTOPHAGY | 32 | 6.54e-01 | -0.045800 | 8.19e-01 |
SIGNALING BY INSULIN RECEPTOR | 64 | 5.26e-01 | 0.045800 | 7.38e-01 |
SIGNALING BY ERYTHROPOIETIN | 24 | 7.00e-01 | 0.045500 | 8.40e-01 |
SELECTIVE AUTOPHAGY | 72 | 5.06e-01 | -0.045300 | 7.28e-01 |
PI 3K CASCADE FGFR2 | 17 | 7.47e-01 | 0.045100 | 8.70e-01 |
BIOLOGICAL OXIDATIONS | 127 | 3.82e-01 | -0.044900 | 6.60e-01 |
N GLYCAN ANTENNAE ELONGATION | 15 | 7.64e-01 | -0.044800 | 8.78e-01 |
EGFR DOWNREGULATION | 28 | 6.82e-01 | -0.044800 | 8.34e-01 |
INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE | 22 | 7.18e-01 | -0.044500 | 8.46e-01 |
DISEASES OF METABOLISM | 200 | 2.79e-01 | 0.044500 | 5.63e-01 |
DISEASES OF SIGNAL TRANSDUCTION BY GROWTH FACTOR RECEPTORS AND SECOND MESSENGERS | 367 | 1.45e-01 | -0.044400 | 3.86e-01 |
DUAL INCISION IN GG NER | 41 | 6.24e-01 | -0.044300 | 7.98e-01 |
REGULATION OF TP53 EXPRESSION AND DEGRADATION | 35 | 6.53e-01 | 0.043900 | 8.19e-01 |
VEGFR2 MEDIATED CELL PROLIFERATION | 19 | 7.41e-01 | 0.043800 | 8.64e-01 |
RECEPTOR MEDIATED MITOPHAGY | 11 | 8.02e-01 | -0.043700 | 8.98e-01 |
INSULIN RECEPTOR RECYCLING | 20 | 7.36e-01 | -0.043600 | 8.60e-01 |
TOLL LIKE RECEPTOR CASCADES | 135 | 3.87e-01 | 0.043100 | 6.60e-01 |
PYRUVATE METABOLISM | 27 | 6.99e-01 | 0.043000 | 8.40e-01 |
GOLGI ASSOCIATED VESICLE BIOGENESIS | 54 | 5.86e-01 | -0.042900 | 7.71e-01 |
DERMATAN SULFATE BIOSYNTHESIS | 11 | 8.06e-01 | 0.042900 | 8.99e-01 |
TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | 30 | 6.86e-01 | 0.042600 | 8.36e-01 |
INTEGRIN SIGNALING | 24 | 7.18e-01 | -0.042600 | 8.46e-01 |
NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | 45 | 6.24e-01 | -0.042200 | 7.98e-01 |
CHAPERONE MEDIATED AUTOPHAGY | 21 | 7.40e-01 | -0.041900 | 8.64e-01 |
GLYCOLYSIS | 67 | 5.55e-01 | 0.041800 | 7.52e-01 |
NCAM1 INTERACTIONS | 42 | 6.41e-01 | -0.041600 | 8.09e-01 |
FCERI MEDIATED CA 2 MOBILIZATION | 26 | 7.14e-01 | -0.041600 | 8.45e-01 |
EPIGENETIC REGULATION OF GENE EXPRESSION | 104 | 4.66e-01 | -0.041400 | 7.05e-01 |
TELOMERE C STRAND LAGGING STRAND SYNTHESIS | 33 | 6.83e-01 | 0.041100 | 8.35e-01 |
RHO GTPASE CYCLE | 427 | 1.47e-01 | 0.041000 | 3.86e-01 |
RHOC GTPASE CYCLE | 73 | 5.46e-01 | 0.040900 | 7.49e-01 |
ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | 38 | 6.64e-01 | -0.040800 | 8.26e-01 |
PURINE CATABOLISM | 16 | 7.78e-01 | -0.040700 | 8.90e-01 |
ROS AND RNS PRODUCTION IN PHAGOCYTES | 29 | 7.05e-01 | -0.040700 | 8.40e-01 |
ORGANELLE BIOGENESIS AND MAINTENANCE | 284 | 2.44e-01 | -0.040200 | 5.24e-01 |
INTEGRATION OF ENERGY METABOLISM | 99 | 4.90e-01 | 0.040200 | 7.21e-01 |
TRANSLOCATION OF SLC2A4 GLUT4 TO THE PLASMA MEMBRANE | 63 | 5.83e-01 | -0.040000 | 7.69e-01 |
COLLAGEN CHAIN TRIMERIZATION | 40 | 6.62e-01 | -0.039900 | 8.26e-01 |
BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | 76 | 5.50e-01 | 0.039700 | 7.50e-01 |
SPHINGOLIPID METABOLISM | 80 | 5.43e-01 | -0.039300 | 7.49e-01 |
SHC1 EVENTS IN ERBB4 SIGNALING | 13 | 8.06e-01 | -0.039300 | 8.99e-01 |
SUMOYLATION OF RNA BINDING PROTEINS | 45 | 6.49e-01 | 0.039300 | 8.17e-01 |
METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES | 21 | 7.58e-01 | 0.038900 | 8.75e-01 |
NEGATIVE REGULATION OF MAPK PATHWAY | 42 | 6.64e-01 | -0.038700 | 8.26e-01 |
ACYL CHAIN REMODELLING OF PE | 16 | 7.89e-01 | -0.038600 | 8.94e-01 |
G1 S SPECIFIC TRANSCRIPTION | 27 | 7.29e-01 | -0.038500 | 8.57e-01 |
HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE | 40 | 6.75e-01 | -0.038300 | 8.30e-01 |
DISORDERS OF TRANSMEMBRANE TRANSPORTERS | 146 | 4.31e-01 | -0.037800 | 6.86e-01 |
INTRINSIC PATHWAY FOR APOPTOSIS | 52 | 6.38e-01 | -0.037700 | 8.08e-01 |
PROTEIN METHYLATION | 17 | 7.88e-01 | -0.037700 | 8.93e-01 |
ANTI INFLAMMATORY RESPONSE FAVOURING LEISHMANIA PARASITE INFECTION | 120 | 4.80e-01 | -0.037400 | 7.16e-01 |
GROWTH HORMONE RECEPTOR SIGNALING | 21 | 7.68e-01 | 0.037200 | 8.81e-01 |
ADORA2B MEDIATED ANTI INFLAMMATORY CYTOKINES PRODUCTION | 94 | 5.35e-01 | -0.037100 | 7.44e-01 |
REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS | 15 | 8.06e-01 | 0.036600 | 8.99e-01 |
AMINO ACIDS REGULATE MTORC1 | 51 | 6.53e-01 | 0.036400 | 8.19e-01 |
ADAPTIVE IMMUNE SYSTEM | 606 | 1.30e-01 | -0.036100 | 3.65e-01 |
SIGNALING BY GPCR | 503 | 1.68e-01 | 0.036000 | 4.23e-01 |
METABOLISM OF CARBOHYDRATES | 262 | 3.17e-01 | 0.036000 | 5.94e-01 |
ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | 75 | 5.91e-01 | -0.035900 | 7.73e-01 |
DNA DOUBLE STRAND BREAK REPAIR | 137 | 4.79e-01 | -0.035100 | 7.16e-01 |
DNA DAMAGE RECOGNITION IN GG NER | 38 | 7.09e-01 | 0.035000 | 8.42e-01 |
RHOG GTPASE CYCLE | 73 | 6.07e-01 | 0.034900 | 7.85e-01 |
MET PROMOTES CELL MOTILITY | 39 | 7.07e-01 | 0.034800 | 8.40e-01 |
ER TO GOLGI ANTEROGRADE TRANSPORT | 141 | 4.76e-01 | 0.034800 | 7.14e-01 |
INTERLEUKIN 10 SIGNALING | 20 | 7.88e-01 | -0.034800 | 8.93e-01 |
MITOTIC PROMETAPHASE | 179 | 4.25e-01 | -0.034600 | 6.80e-01 |
PRE NOTCH EXPRESSION AND PROCESSING | 64 | 6.33e-01 | -0.034500 | 8.06e-01 |
PEXOPHAGY | 11 | 8.43e-01 | 0.034400 | 9.25e-01 |
GOLGI TO ER RETROGRADE TRANSPORT | 120 | 5.20e-01 | -0.034000 | 7.38e-01 |
DNA DAMAGE BYPASS | 48 | 6.97e-01 | -0.032500 | 8.40e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR3 | 21 | 7.99e-01 | 0.032200 | 8.97e-01 |
VIRAL MESSENGER RNA SYNTHESIS | 42 | 7.21e-01 | 0.031800 | 8.49e-01 |
METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS | 103 | 5.82e-01 | 0.031400 | 7.69e-01 |
ONCOGENE INDUCED SENESCENCE | 32 | 7.59e-01 | -0.031400 | 8.75e-01 |
APOPTOTIC EXECUTION PHASE | 45 | 7.16e-01 | -0.031300 | 8.46e-01 |
SIGNALING BY INTERLEUKINS | 346 | 3.22e-01 | -0.031000 | 5.97e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE | 19 | 8.15e-01 | 0.031000 | 9.05e-01 |
CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | 12 | 8.53e-01 | 0.030900 | 9.30e-01 |
VISUAL PHOTOTRANSDUCTION | 64 | 6.70e-01 | 0.030800 | 8.28e-01 |
RAB GEFS EXCHANGE GTP FOR GDP ON RABS | 88 | 6.19e-01 | -0.030700 | 7.96e-01 |
ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS | 26 | 7.87e-01 | -0.030600 | 8.93e-01 |
MTOR SIGNALLING | 40 | 7.40e-01 | 0.030300 | 8.64e-01 |
REGULATION OF TP53 ACTIVITY | 151 | 5.27e-01 | 0.029900 | 7.38e-01 |
NS1 MEDIATED EFFECTS ON HOST PATHWAYS | 37 | 7.54e-01 | 0.029700 | 8.74e-01 |
PKA MEDIATED PHOSPHORYLATION OF CREB | 19 | 8.23e-01 | -0.029700 | 9.09e-01 |
METABOLISM OF FAT SOLUBLE VITAMINS | 35 | 7.64e-01 | 0.029400 | 8.78e-01 |
TRNA PROCESSING | 105 | 6.04e-01 | 0.029300 | 7.83e-01 |
REGULATED PROTEOLYSIS OF P75NTR | 12 | 8.60e-01 | -0.029300 | 9.34e-01 |
POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION | 26 | 7.96e-01 | 0.029300 | 8.95e-01 |
NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 12 | 8.61e-01 | -0.029300 | 9.34e-01 |
FLT3 SIGNALING IN DISEASE | 28 | 7.93e-01 | 0.028700 | 8.95e-01 |
CITRIC ACID CYCLE TCA CYCLE | 22 | 8.16e-01 | 0.028700 | 9.05e-01 |
O LINKED GLYCOSYLATION OF MUCINS | 42 | 7.48e-01 | 0.028600 | 8.70e-01 |
EICOSANOID LIGAND BINDING RECEPTORS | 10 | 8.76e-01 | -0.028400 | 9.45e-01 |
IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX | 10 | 8.77e-01 | 0.028200 | 9.45e-01 |
SUMOYLATION OF TRANSCRIPTION COFACTORS | 42 | 7.52e-01 | -0.028200 | 8.73e-01 |
PLASMA LIPOPROTEIN ASSEMBLY | 13 | 8.61e-01 | 0.028100 | 9.34e-01 |
DNA STRAND ELONGATION | 32 | 7.83e-01 | 0.028100 | 8.93e-01 |
DARPP 32 EVENTS | 23 | 8.17e-01 | -0.027800 | 9.06e-01 |
OPIOID SIGNALLING | 86 | 6.60e-01 | 0.027500 | 8.25e-01 |
KERATAN SULFATE KERATIN METABOLISM | 32 | 7.88e-01 | 0.027500 | 8.93e-01 |
REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP SREBF | 56 | 7.32e-01 | -0.026500 | 8.58e-01 |
SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | 14 | 8.65e-01 | 0.026300 | 9.38e-01 |
FCGR3A MEDIATED IL10 SYNTHESIS | 33 | 7.95e-01 | -0.026200 | 8.95e-01 |
TFAP2 AP 2 FAMILY REGULATES TRANSCRIPTION OF GROWTH FACTORS AND THEIR RECEPTORS | 10 | 8.87e-01 | -0.025900 | 9.49e-01 |
MITOCHONDRIAL BIOGENESIS | 92 | 6.69e-01 | 0.025800 | 8.28e-01 |
FGFRL1 MODULATION OF FGFR1 SIGNALING | 10 | 8.88e-01 | 0.025800 | 9.49e-01 |
RNA POLYMERASE III CHAIN ELONGATION | 18 | 8.50e-01 | 0.025800 | 9.28e-01 |
INTRACELLULAR SIGNALING BY SECOND MESSENGERS | 283 | 4.60e-01 | 0.025600 | 7.04e-01 |
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 8.80e-01 | -0.025300 | 9.45e-01 |
PHASE I FUNCTIONALIZATION OF COMPOUNDS | 62 | 7.32e-01 | 0.025200 | 8.58e-01 |
SIGNALING BY MET | 75 | 7.07e-01 | -0.025100 | 8.40e-01 |
RRNA PROCESSING IN THE MITOCHONDRION | 10 | 8.91e-01 | 0.025100 | 9.50e-01 |
ASPARAGINE N LINKED GLYCOSYLATION | 284 | 4.77e-01 | -0.024600 | 7.14e-01 |
ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES | 53 | 7.58e-01 | 0.024500 | 8.75e-01 |
FLT3 SIGNALING | 36 | 8.00e-01 | 0.024400 | 8.97e-01 |
GLUCOSE METABOLISM | 81 | 7.04e-01 | 0.024400 | 8.40e-01 |
PKA ACTIVATION IN GLUCAGON SIGNALLING | 16 | 8.68e-01 | -0.024000 | 9.40e-01 |
LAGGING STRAND SYNTHESIS | 20 | 8.54e-01 | -0.023800 | 9.30e-01 |
REGULATION OF TNFR1 SIGNALING | 34 | 8.14e-01 | 0.023400 | 9.04e-01 |
RNA POLYMERASE III TRANSCRIPTION | 41 | 8.06e-01 | 0.022200 | 8.99e-01 |
PLATELET ACTIVATION SIGNALING AND AGGREGATION | 223 | 5.75e-01 | -0.021800 | 7.69e-01 |
HEMOSTASIS | 476 | 4.22e-01 | 0.021500 | 6.78e-01 |
EPH EPHRIN MEDIATED REPULSION OF CELLS | 50 | 7.93e-01 | -0.021500 | 8.95e-01 |
LEISHMANIA INFECTION | 201 | 6.00e-01 | -0.021500 | 7.79e-01 |
HS GAG BIOSYNTHESIS | 30 | 8.39e-01 | -0.021400 | 9.24e-01 |
G ALPHA Q SIGNALLING EVENTS | 171 | 6.33e-01 | -0.021200 | 8.06e-01 |
SUMOYLATION OF DNA REPLICATION PROTEINS | 43 | 8.14e-01 | -0.020800 | 9.04e-01 |
SHC1 EVENTS IN ERBB2 SIGNALING | 21 | 8.70e-01 | 0.020600 | 9.41e-01 |
REGULATION OF BACH1 ACTIVITY | 11 | 9.06e-01 | -0.020600 | 9.58e-01 |
BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS | 34 | 8.36e-01 | 0.020500 | 9.21e-01 |
TRANSLESION SYNTHESIS BY POLH | 19 | 8.78e-01 | -0.020300 | 9.45e-01 |
INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC | 186 | 6.34e-01 | -0.020200 | 8.06e-01 |
MITOTIC PROPHASE | 95 | 7.35e-01 | 0.020100 | 8.60e-01 |
TBC RABGAPS | 42 | 8.23e-01 | 0.020000 | 9.09e-01 |
PROCESSING OF INTRONLESS PRE MRNAS | 19 | 8.82e-01 | 0.019600 | 9.46e-01 |
HDR THROUGH HOMOLOGOUS RECOMBINATION HRR | 63 | 7.88e-01 | -0.019600 | 8.93e-01 |
MTORC1 MEDIATED SIGNALLING | 24 | 8.68e-01 | 0.019500 | 9.40e-01 |
SUMOYLATION OF DNA METHYLATION PROTEINS | 16 | 8.94e-01 | -0.019300 | 9.52e-01 |
CA2 PATHWAY | 56 | 8.03e-01 | 0.019300 | 8.99e-01 |
ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | 34 | 8.47e-01 | -0.019100 | 9.28e-01 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | 12 | 9.09e-01 | 0.019100 | 9.60e-01 |
TRANSFERRIN ENDOCYTOSIS AND RECYCLING | 26 | 8.71e-01 | 0.018400 | 9.41e-01 |
SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3 | 633 | 4.37e-01 | 0.018200 | 6.90e-01 |
TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS | 15 | 9.03e-01 | 0.018100 | 9.56e-01 |
PROCESSING OF SMDT1 | 16 | 9.00e-01 | -0.018100 | 9.55e-01 |
SIGNALING BY FGFR4 | 34 | 8.57e-01 | -0.017800 | 9.33e-01 |
TNF SIGNALING | 43 | 8.40e-01 | 0.017800 | 9.24e-01 |
SHC MEDIATED CASCADE FGFR3 | 14 | 9.13e-01 | -0.016900 | 9.61e-01 |
PI 3K CASCADE FGFR4 | 13 | 9.17e-01 | -0.016700 | 9.62e-01 |
CLASS A 1 RHODOPSIN LIKE RECEPTORS | 203 | 6.87e-01 | -0.016400 | 8.36e-01 |
REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION | 85 | 7.95e-01 | -0.016300 | 8.95e-01 |
CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA | 59 | 8.28e-01 | -0.016300 | 9.14e-01 |
SIGNALING BY PDGFR IN DISEASE | 20 | 9.03e-01 | 0.015700 | 9.56e-01 |
HATS ACETYLATE HISTONES | 93 | 7.98e-01 | 0.015400 | 8.97e-01 |
COLLAGEN DEGRADATION | 52 | 8.48e-01 | -0.015300 | 9.28e-01 |
GLUTATHIONE SYNTHESIS AND RECYCLING | 11 | 9.31e-01 | -0.015100 | 9.71e-01 |
ERBB2 ACTIVATES PTK6 SIGNALING | 12 | 9.29e-01 | 0.014800 | 9.70e-01 |
CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | 90 | 8.09e-01 | 0.014700 | 9.02e-01 |
SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS | 41 | 8.72e-01 | 0.014500 | 9.42e-01 |
SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS | 18 | 9.16e-01 | -0.014400 | 9.62e-01 |
VESICLE MEDIATED TRANSPORT | 612 | 5.47e-01 | 0.014300 | 7.49e-01 |
TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | 170 | 7.49e-01 | 0.014200 | 8.70e-01 |
CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY | 13 | 9.29e-01 | 0.014200 | 9.70e-01 |
REGULATION OF INSULIN SECRETION | 71 | 8.41e-01 | 0.013700 | 9.24e-01 |
DEFECTS IN COBALAMIN B12 METABOLISM | 13 | 9.32e-01 | -0.013600 | 9.71e-01 |
MEMBRANE TRAFFICKING | 580 | 5.78e-01 | 0.013600 | 7.69e-01 |
RHO GTPASE EFFECTORS | 253 | 7.11e-01 | -0.013500 | 8.43e-01 |
AUTOPHAGY | 139 | 7.86e-01 | -0.013300 | 8.93e-01 |
RHOH GTPASE CYCLE | 37 | 8.89e-01 | 0.013300 | 9.49e-01 |
RAB REGULATION OF TRAFFICKING | 118 | 8.10e-01 | -0.012800 | 9.02e-01 |
SIGNAL TRANSDUCTION BY L1 | 21 | 9.21e-01 | 0.012600 | 9.65e-01 |
FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES | 15 | 9.34e-01 | 0.012300 | 9.71e-01 |
RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK | 48 | 8.83e-01 | 0.012300 | 9.46e-01 |
SIGNALLING TO RAS | 19 | 9.27e-01 | 0.012100 | 9.69e-01 |
RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN | 37 | 8.99e-01 | -0.012100 | 9.55e-01 |
COPI MEDIATED ANTEROGRADE TRANSPORT | 91 | 8.42e-01 | 0.012100 | 9.24e-01 |
GENE SILENCING BY RNA | 86 | 8.51e-01 | -0.011800 | 9.28e-01 |
CD28 CO STIMULATION | 31 | 9.10e-01 | 0.011700 | 9.60e-01 |
EPH EPHRIN SIGNALING | 91 | 8.50e-01 | -0.011500 | 9.28e-01 |
INTERLEUKIN 2 FAMILY SIGNALING | 33 | 9.11e-01 | 0.011200 | 9.60e-01 |
FATTY ACID METABOLISM | 146 | 8.19e-01 | 0.011000 | 9.07e-01 |
ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS | 66 | 8.80e-01 | -0.010700 | 9.45e-01 |
SIGNALING BY NTRK3 TRKC | 16 | 9.41e-01 | 0.010600 | 9.73e-01 |
FATTY ACYL COA BIOSYNTHESIS | 32 | 9.17e-01 | -0.010600 | 9.62e-01 |
SIGNALING BY RECEPTOR TYROSINE KINASES | 465 | 7.00e-01 | 0.010500 | 8.40e-01 |
NEGATIVE REGULATION OF MET ACTIVITY | 20 | 9.36e-01 | 0.010400 | 9.71e-01 |
PLATELET ADHESION TO EXPOSED COLLAGEN | 12 | 9.51e-01 | 0.010300 | 9.77e-01 |
EPHRIN SIGNALING | 19 | 9.40e-01 | -0.009980 | 9.73e-01 |
METABOLISM OF VITAMINS AND COFACTORS | 156 | 8.30e-01 | 0.009950 | 9.16e-01 |
RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | 78 | 8.84e-01 | -0.009530 | 9.47e-01 |
KINESINS | 48 | 9.10e-01 | 0.009480 | 9.60e-01 |
SIGNALING BY KIT IN DISEASE | 20 | 9.42e-01 | 0.009470 | 9.73e-01 |
AURKA ACTIVATION BY TPX2 | 71 | 8.91e-01 | -0.009430 | 9.50e-01 |
EGR2 AND SOX10 MEDIATED INITIATION OF SCHWANN CELL MYELINATION | 26 | 9.34e-01 | 0.009320 | 9.71e-01 |
SIGNALING BY FGFR3 | 36 | 9.24e-01 | 0.009210 | 9.67e-01 |
GLYCOSPHINGOLIPID METABOLISM | 38 | 9.28e-01 | -0.008520 | 9.69e-01 |
FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | 120 | 8.77e-01 | 0.008180 | 9.45e-01 |
REGULATION OF PTEN GENE TRANSCRIPTION | 59 | 9.16e-01 | -0.007970 | 9.62e-01 |
RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | 85 | 9.00e-01 | -0.007920 | 9.55e-01 |
ACTIVATION OF BH3 ONLY PROTEINS | 30 | 9.41e-01 | -0.007770 | 9.73e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR2 | 24 | 9.50e-01 | -0.007450 | 9.77e-01 |
ERKS ARE INACTIVATED | 13 | 9.63e-01 | 0.007380 | 9.81e-01 |
COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM | 14 | 9.64e-01 | 0.006950 | 9.81e-01 |
CELL CELL COMMUNICATION | 106 | 9.02e-01 | 0.006930 | 9.56e-01 |
ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | 28 | 9.50e-01 | 0.006890 | 9.77e-01 |
FRS MEDIATED FGFR2 SIGNALING | 19 | 9.59e-01 | 0.006810 | 9.81e-01 |
CYTOSOLIC SULFONATION OF SMALL MOLECULES | 15 | 9.65e-01 | 0.006530 | 9.81e-01 |
DEFECTS IN VITAMIN AND COFACTOR METABOLISM | 21 | 9.59e-01 | 0.006440 | 9.81e-01 |
METABOLISM OF LIPIDS | 619 | 7.91e-01 | 0.006260 | 8.95e-01 |
MITOCHONDRIAL CALCIUM ION TRANSPORT | 23 | 9.61e-01 | 0.005860 | 9.81e-01 |
P75NTR REGULATES AXONOGENESIS | 10 | 9.76e-01 | 0.005530 | 9.87e-01 |
TRNA PROCESSING IN THE NUCLEUS | 56 | 9.44e-01 | -0.005390 | 9.75e-01 |
RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION | 51 | 9.48e-01 | -0.005330 | 9.77e-01 |
SIGNALING BY SCF KIT | 41 | 9.54e-01 | 0.005260 | 9.79e-01 |
DEADENYLATION DEPENDENT MRNA DECAY | 55 | 9.48e-01 | -0.005050 | 9.77e-01 |
RESOLUTION OF ABASIC SITES AP SITES | 38 | 9.59e-01 | 0.004840 | 9.81e-01 |
TRIGLYCERIDE BIOSYNTHESIS | 10 | 9.79e-01 | 0.004800 | 9.88e-01 |
POLO LIKE KINASE MEDIATED EVENTS | 14 | 9.76e-01 | 0.004620 | 9.87e-01 |
RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | 105 | 9.35e-01 | -0.004590 | 9.71e-01 |
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | 28 | 9.67e-01 | 0.004510 | 9.82e-01 |
DNA REPAIR | 293 | 8.96e-01 | -0.004430 | 9.54e-01 |
POST TRANSLATIONAL PROTEIN MODIFICATION | 1225 | 7.96e-01 | -0.004430 | 8.95e-01 |
SIGNALING BY VEGF | 102 | 9.39e-01 | -0.004360 | 9.73e-01 |
PLATELET AGGREGATION PLUG FORMATION | 32 | 9.70e-01 | -0.003890 | 9.84e-01 |
INTEGRIN CELL SURFACE INTERACTIONS | 74 | 9.57e-01 | -0.003640 | 9.81e-01 |
FOXO MEDIATED TRANSCRIPTION | 58 | 9.64e-01 | 0.003440 | 9.81e-01 |
DISEASES OF PROGRAMMED CELL DEATH | 55 | 9.65e-01 | 0.003440 | 9.81e-01 |
NCAM SIGNALING FOR NEURITE OUT GROWTH | 62 | 9.65e-01 | 0.003260 | 9.81e-01 |
COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 87 | 9.65e-01 | 0.002730 | 9.81e-01 |
SIGNALING BY FGFR1 | 44 | 9.76e-01 | 0.002590 | 9.87e-01 |
SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS | 73 | 9.71e-01 | 0.002480 | 9.84e-01 |
SIGNALING BY FGFR1 IN DISEASE | 34 | 9.80e-01 | -0.002420 | 9.88e-01 |
HDR THROUGH SINGLE STRAND ANNEALING SSA | 36 | 9.80e-01 | -0.002410 | 9.88e-01 |
SIGNALLING TO ERKS | 33 | 9.84e-01 | 0.001980 | 9.90e-01 |
SEMAPHORIN INTERACTIONS | 64 | 9.79e-01 | -0.001950 | 9.88e-01 |
EXTENSION OF TELOMERES | 49 | 9.81e-01 | -0.001920 | 9.88e-01 |
TIE2 SIGNALING | 17 | 9.89e-01 | 0.001900 | 9.93e-01 |
POLYMERASE SWITCHING | 14 | 9.92e-01 | -0.001610 | 9.94e-01 |
WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 | 13 | 9.96e-01 | 0.000752 | 9.98e-01 |
SUMOYLATION | 165 | 9.87e-01 | -0.000746 | 9.92e-01 |
SIGNALING BY FLT3 FUSION PROTEINS | 19 | 9.97e-01 | -0.000532 | 9.98e-01 |
G ALPHA I SIGNALLING EVENTS | 207 | 9.90e-01 | 0.000485 | 9.94e-01 |
RNA POLYMERASE III TRANSCRIPTION TERMINATION | 23 | 9.98e-01 | -0.000321 | 9.98e-01 |
INCRETIN SYNTHESIS SECRETION AND INACTIVATION
443 | |
---|---|
set | INCRETIN SYNTHESIS SECRETION AND INACTIVATION |
setSize | 13 |
pANOVA | 0.000296 |
s.dist | -0.58 |
p.adjustANOVA | 0.00339 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Isl1 | -7810 |
Sec11a | -7800 |
Gng13 | -7337 |
Sec11c | -7082 |
Grp | -6663 |
Spcs2 | -6336 |
Spcs3 | -6189 |
Tcf7l2 | -5682 |
Spcs1 | -4766 |
Pax6 | -4664 |
Dpp4 | -3478 |
Ctnnb1 | -3040 |
Pcsk1 | 2114 |
GeneID | Gene Rank |
---|---|
Isl1 | -7810 |
Sec11a | -7800 |
Gng13 | -7337 |
Sec11c | -7082 |
Grp | -6663 |
Spcs2 | -6336 |
Spcs3 | -6189 |
Tcf7l2 | -5682 |
Spcs1 | -4766 |
Pax6 | -4664 |
Dpp4 | -3478 |
Ctnnb1 | -3040 |
Pcsk1 | 2114 |
SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1
1057 | |
---|---|
set | SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 |
setSize | 12 |
pANOVA | 0.00086 |
s.dist | -0.556 |
p.adjustANOVA | 0.00854 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Sec11a | -7800 |
Gng13 | -7337 |
Sec11c | -7082 |
Grp | -6663 |
Spcs2 | -6336 |
Spcs3 | -6189 |
Tcf7l2 | -5682 |
Spcs1 | -4766 |
Pax6 | -4664 |
Dpp4 | -3478 |
Ctnnb1 | -3040 |
Pcsk1 | 2114 |
GeneID | Gene Rank |
---|---|
Sec11a | -7800 |
Gng13 | -7337 |
Sec11c | -7082 |
Grp | -6663 |
Spcs2 | -6336 |
Spcs3 | -6189 |
Tcf7l2 | -5682 |
Spcs1 | -4766 |
Pax6 | -4664 |
Dpp4 | -3478 |
Ctnnb1 | -3040 |
Pcsk1 | 2114 |
HSF1 ACTIVATION
434 | |
---|---|
set | HSF1 ACTIVATION |
setSize | 27 |
pANOVA | 8.9e-07 |
s.dist | -0.546 |
p.adjustANOVA | 3.09e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Serpinh1 | -8963 |
Hspa1b | -8925 |
Dnajb1 | -8909 |
Hsph1 | -8886 |
Hspa1a | -8857 |
Fkbp4 | -8855 |
Hspb1 | -8786 |
Hsp90aa1 | -8747 |
Ptges3 | -8484 |
Hsp90ab1 | -8390 |
Rpa1 | -7213 |
Dedd2 | -7114 |
Mrpl18 | -6432 |
Hsbp1 | -6298 |
Cryba4 | -5971 |
Dnajb6 | -5640 |
Hsf1 | -5595 |
Rpa2 | -5048 |
Eef1a1 | -4814 |
Ubb | -4777 |
GeneID | Gene Rank |
---|---|
Serpinh1 | -8963 |
Hspa1b | -8925 |
Dnajb1 | -8909 |
Hsph1 | -8886 |
Hspa1a | -8857 |
Fkbp4 | -8855 |
Hspb1 | -8786 |
Hsp90aa1 | -8747 |
Ptges3 | -8484 |
Hsp90ab1 | -8390 |
Rpa1 | -7213 |
Dedd2 | -7114 |
Mrpl18 | -6432 |
Hsbp1 | -6298 |
Cryba4 | -5971 |
Dnajb6 | -5640 |
Hsf1 | -5595 |
Rpa2 | -5048 |
Eef1a1 | -4814 |
Ubb | -4777 |
Ywhae | -4529 |
Vcp | -1938 |
Tnfrsf21 | -484 |
Rpa3 | 945 |
Rln1 | 4395 |
Hdac6 | 5084 |
Col4a6 | 8449 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES
82 | |
---|---|
set | ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES |
setSize | 10 |
pANOVA | 0.00478 |
s.dist | -0.515 |
p.adjustANOVA | 0.0325 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Hspa5 | -8934 |
Ddit3 | -8873 |
Xbp1 | -8778 |
Hsp90b1 | -8470 |
Calr | -8053 |
Nfyb | -7194 |
Atf4 | -5578 |
Nfya | -1797 |
Nfyc | 2139 |
Atf6 | 8296 |
GeneID | Gene Rank |
---|---|
Hspa5 | -8934 |
Ddit3 | -8873 |
Xbp1 | -8778 |
Hsp90b1 | -8470 |
Calr | -8053 |
Nfyb | -7194 |
Atf4 | -5578 |
Nfya | -1797 |
Nfyc | 2139 |
Atf6 | 8296 |
ATTENUATION PHASE
84 | |
---|---|
set | ATTENUATION PHASE |
setSize | 25 |
pANOVA | 8.44e-06 |
s.dist | -0.515 |
p.adjustANOVA | 0.000189 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Serpinh1 | -8963 |
Hspa1b | -8925 |
Dnajb1 | -8909 |
Hsph1 | -8886 |
Hspa1a | -8857 |
Fkbp4 | -8855 |
Hspb1 | -8786 |
Hsp90aa1 | -8747 |
Ptges3 | -8484 |
Hsp90ab1 | -8390 |
Hspa8 | -8371 |
Dedd2 | -7114 |
Mrpl18 | -6432 |
Hsbp1 | -6298 |
Cryba4 | -5971 |
Dnajb6 | -5640 |
Hsf1 | -5595 |
Ubb | -4777 |
Hspa1l | -2421 |
Tnfrsf21 | -484 |
GeneID | Gene Rank |
---|---|
Serpinh1 | -8963 |
Hspa1b | -8925 |
Dnajb1 | -8909 |
Hsph1 | -8886 |
Hspa1a | -8857 |
Fkbp4 | -8855 |
Hspb1 | -8786 |
Hsp90aa1 | -8747 |
Ptges3 | -8484 |
Hsp90ab1 | -8390 |
Hspa8 | -8371 |
Dedd2 | -7114 |
Mrpl18 | -6432 |
Hsbp1 | -6298 |
Cryba4 | -5971 |
Dnajb6 | -5640 |
Hsf1 | -5595 |
Ubb | -4777 |
Hspa1l | -2421 |
Tnfrsf21 | -484 |
Ep300 | 1462 |
Hspa2 | 2346 |
Rln1 | 4395 |
Crebbp | 6396 |
Col4a6 | 8449 |
EUKARYOTIC TRANSLATION ELONGATION
306 | |
---|---|
set | EUKARYOTIC TRANSLATION ELONGATION |
setSize | 87 |
pANOVA | 2.5e-16 |
s.dist | -0.508 |
p.adjustANOVA | 5.91e-14 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rpl11 | -7708 |
Rps23 | -7621 |
Rpl27 | -7486 |
Rpl31 | -7476 |
Rps8 | -7336 |
Rpl26 | -7286 |
Rpl24 | -7198 |
Rps25 | -7195 |
Rps12 | -7156 |
Rps24 | -6975 |
Rps27a | -6969 |
Rpl22l1 | -6859 |
Rpl39 | -6805 |
Rpl17 | -6723 |
Rpl19 | -6713 |
Rpl13a | -6693 |
Rps19 | -6667 |
Rps11 | -6647 |
Rps3a1 | -6556 |
Fau | -6452 |
GeneID | Gene Rank |
---|---|
Rpl11 | -7708 |
Rps23 | -7621 |
Rpl27 | -7486 |
Rpl31 | -7476 |
Rps8 | -7336 |
Rpl26 | -7286 |
Rpl24 | -7198 |
Rps25 | -7195 |
Rps12 | -7156 |
Rps24 | -6975 |
Rps27a | -6969 |
Rpl22l1 | -6859 |
Rpl39 | -6805 |
Rpl17 | -6723 |
Rpl19 | -6713 |
Rpl13a | -6693 |
Rps19 | -6667 |
Rps11 | -6647 |
Rps3a1 | -6556 |
Fau | -6452 |
Rpl35 | -6281 |
Rpl36a | -6272 |
Rps7 | -6226 |
Rpl23a | -6214 |
Rps15 | -6157 |
Rps3 | -6040 |
Rpl27a | -6018 |
Rpl36al | -6014 |
Rpl9 | -6004 |
Rpl35a | -5975 |
Rpl34 | -5963 |
Rps27 | -5938 |
Rps10 | -5925 |
Rpl13 | -5924 |
Rpl6 | -5898 |
Rps26 | -5809 |
Rps17 | -5738 |
Rpl21 | -5718 |
Rpl37a | -5672 |
Rpl7 | -5582 |
Rpsa | -5493 |
Rps9 | -5458 |
Rps27l | -5441 |
Rpl14 | -5423 |
Rpl4 | -5373 |
Rpl23 | -5330 |
Rps18 | -5277 |
Rps20 | -5257 |
Eef1g | -5256 |
Rpl37 | -5237 |
Rps16 | -5226 |
Rpl10a | -5182 |
Rpl32 | -5161 |
Eef1b2 | -5136 |
Rps21 | -4966 |
Eef1a1 | -4814 |
Rpl3 | -4794 |
Rpl38 | -4676 |
Rps5 | -4675 |
Rps6 | -4661 |
Rpl36 | -4525 |
Rplp0 | -4097 |
Eef1d | -4059 |
Rpl8 | -4033 |
Rps14 | -4004 |
Rplp1 | -3988 |
Rpl18 | -3948 |
Rpl7a | -3883 |
Rps4x | -3874 |
Rpl30 | -3803 |
Rps28 | -3120 |
Rps13 | -2924 |
Eef1a2 | -2828 |
Uba52 | -2734 |
Rps2 | -2210 |
Rplp2 | -1540 |
Rpl12 | -1415 |
Rpl28 | -1401 |
Rpl29 | -1236 |
Rpl18a | -1198 |
Rpl15 | -1189 |
Rps29 | -259 |
Rps15a | 399 |
Rpl22 | 2503 |
Eef2 | 3684 |
Rpl5 | 6278 |
Rpl10 | 8261 |
NEUROTOXICITY OF CLOSTRIDIUM TOXINS
621 | |
---|---|
set | NEUROTOXICITY OF CLOSTRIDIUM TOXINS |
setSize | 10 |
pANOVA | 0.00576 |
s.dist | 0.504 |
p.adjustANOVA | 0.0372 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Sv2c | 8175 |
Vamp1 | 6699 |
Syt1 | 6183 |
Sv2b | 5353 |
Stx1b | 4779 |
Syt2 | 3856 |
Vamp2 | 3219 |
Snap25 | 2565 |
Stx1a | 667 |
Sv2a | 498 |
GeneID | Gene Rank |
---|---|
Sv2c | 8175 |
Vamp1 | 6699 |
Syt1 | 6183 |
Sv2b | 5353 |
Stx1b | 4779 |
Syt2 | 3856 |
Vamp2 | 3219 |
Snap25 | 2565 |
Stx1a | 667 |
Sv2a | 498 |
COMPLEX I BIOGENESIS
172 | |
---|---|
set | COMPLEX I BIOGENESIS |
setSize | 56 |
pANOVA | 8.77e-11 |
s.dist | -0.501 |
p.adjustANOVA | 5.76e-09 |
Top enriched genes
GeneID | Gene Rank |
---|---|
mt-Nd6 | -8802 |
mt-Nd2 | -8617 |
mt-Nd3 | -8399 |
Ndufaf2 | -8280 |
mt-Nd4 | -8047 |
Ndufaf5 | -7997 |
Ndufaf4 | -7906 |
mt-Nd5 | -7797 |
mt-Nd1 | -7586 |
Ndufa6 | -7485 |
Ndufaf6 | -7045 |
Ndufb5 | -6979 |
Tmem186 | -6968 |
Ndufv2 | -6747 |
Ndufc1 | -6577 |
Acad9 | -6205 |
Ndufb2 | -5991 |
Ndufb8 | -5944 |
Tmem126b | -5928 |
Ndufs5 | -5901 |
GeneID | Gene Rank |
---|---|
mt-Nd6 | -8802 |
mt-Nd2 | -8617 |
mt-Nd3 | -8399 |
Ndufaf2 | -8280 |
mt-Nd4 | -8047 |
Ndufaf5 | -7997 |
Ndufaf4 | -7906 |
mt-Nd5 | -7797 |
mt-Nd1 | -7586 |
Ndufa6 | -7485 |
Ndufaf6 | -7045 |
Ndufb5 | -6979 |
Tmem186 | -6968 |
Ndufv2 | -6747 |
Ndufc1 | -6577 |
Acad9 | -6205 |
Ndufb2 | -5991 |
Ndufb8 | -5944 |
Tmem126b | -5928 |
Ndufs5 | -5901 |
Ndufb7 | -5832 |
Ndufaf1 | -5819 |
Ndufb6 | -5617 |
Ndufb1 | -5610 |
Ndufb9 | -5554 |
Ndufb11 | -5506 |
Nubpl | -5459 |
Ndufs4 | -5453 |
Ndufb3 | -5347 |
Ndufa7 | -5328 |
Ndufa11 | -5284 |
Timmdc1 | -5194 |
Ndufa2 | -4952 |
Ndufb4 | -4836 |
Ndufc2 | -4687 |
Ndufa8 | -4285 |
Ndufs6 | -4125 |
Ndufs8 | -3266 |
Ndufb10 | -3215 |
Ndufv3 | -3043 |
Ndufa3 | -2882 |
Ndufa5 | -2863 |
Ndufa9 | -2263 |
Ndufa1 | -1801 |
Ndufa10 | -1508 |
Ndufa12 | -1388 |
Ndufs3 | -1228 |
Ecsit | -1156 |
Ndufs7 | -1125 |
Ndufv1 | -937 |
Ndufaf7 | -936 |
Ndufab1 | -800 |
Ndufa13 | -554 |
Ndufs2 | 484 |
Ndufaf3 | 2156 |
Ndufs1 | 3474 |
NITRIC OXIDE STIMULATES GUANYLATE CYCLASE
630 | |
---|---|
set | NITRIC OXIDE STIMULATES GUANYLATE CYCLASE |
setSize | 21 |
pANOVA | 9.99e-05 |
s.dist | 0.49 |
p.adjustANOVA | 0.00139 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pde1a | 8170 |
Pde2a | 8151 |
Kcnma1 | 7305 |
Irag1 | 6527 |
Nos2 | 6519 |
Itpr1 | 6448 |
Pde9a | 6422 |
Nos1 | 6341 |
Prkg1 | 6273 |
Kcnmb4 | 5894 |
Gucy1a1 | 5825 |
Pde11a | 5655 |
Pde10a | 5262 |
Pde1b | 5227 |
Gucy1b1 | 3822 |
Pde5a | 3744 |
Nos3 | 3283 |
Gucy1a2 | 1831 |
Kcnmb2 | -641 |
Kcnmb1 | -7801 |
GeneID | Gene Rank |
---|---|
Pde1a | 8170 |
Pde2a | 8151 |
Kcnma1 | 7305 |
Irag1 | 6527 |
Nos2 | 6519 |
Itpr1 | 6448 |
Pde9a | 6422 |
Nos1 | 6341 |
Prkg1 | 6273 |
Kcnmb4 | 5894 |
Gucy1a1 | 5825 |
Pde11a | 5655 |
Pde10a | 5262 |
Pde1b | 5227 |
Gucy1b1 | 3822 |
Pde5a | 3744 |
Nos3 | 3283 |
Gucy1a2 | 1831 |
Kcnmb2 | -641 |
Kcnmb1 | -7801 |
Prkg2 | -8674 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING
181 | |
---|---|
set | COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING |
setSize | 26 |
pANOVA | 1.81e-05 |
s.dist | -0.486 |
p.adjustANOVA | 0.00035 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cct6a | -8719 |
Vbp1 | -8711 |
Cct4 | -8600 |
Pfdn4 | -8596 |
Cct3 | -8472 |
Tubb2b | -8362 |
Cct7 | -8082 |
Cct5 | -7980 |
Cct2 | -7639 |
Tcp1 | -6822 |
Tubb4b | -6225 |
Pfdn5 | -6102 |
Tuba1a | -5910 |
Pfdn1 | -5324 |
Tubb2a | -4830 |
Pfdn6 | -4828 |
Cct8 | -4816 |
Pfdn2 | -4239 |
Tuba1b | -3302 |
Tubb3 | -2952 |
GeneID | Gene Rank |
---|---|
Cct6a | -8719 |
Vbp1 | -8711 |
Cct4 | -8600 |
Pfdn4 | -8596 |
Cct3 | -8472 |
Tubb2b | -8362 |
Cct7 | -8082 |
Cct5 | -7980 |
Cct2 | -7639 |
Tcp1 | -6822 |
Tubb4b | -6225 |
Pfdn5 | -6102 |
Tuba1a | -5910 |
Pfdn1 | -5324 |
Tubb2a | -4830 |
Pfdn6 | -4828 |
Cct8 | -4816 |
Pfdn2 | -4239 |
Tuba1b | -3302 |
Tubb3 | -2952 |
Tubb4a | -2063 |
Tuba4a | -520 |
Actb | 188 |
Tubb6 | 373 |
Tuba8 | 8044 |
Tuba1c | 8476 |
ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE
9 | |
---|---|
set | ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE |
setSize | 17 |
pANOVA | 0.000528 |
s.dist | 0.486 |
p.adjustANOVA | 0.00564 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Slc18a3 | 8193 |
Slc5a7 | 7967 |
Chat | 7695 |
Cplx1 | 6715 |
Syt1 | 6183 |
Ppfia4 | 6170 |
Rims1 | 6058 |
Unc13b | 5558 |
Ppfia2 | 3818 |
Vamp2 | 3219 |
Ppfia1 | 2673 |
Snap25 | 2565 |
Stxbp1 | 1550 |
Stx1a | 667 |
Ppfia3 | 569 |
Tspoap1 | -373 |
Rab3a | -655 |
GeneID | Gene Rank |
---|---|
Slc18a3 | 8193 |
Slc5a7 | 7967 |
Chat | 7695 |
Cplx1 | 6715 |
Syt1 | 6183 |
Ppfia4 | 6170 |
Rims1 | 6058 |
Unc13b | 5558 |
Ppfia2 | 3818 |
Vamp2 | 3219 |
Ppfia1 | 2673 |
Snap25 | 2565 |
Stxbp1 | 1550 |
Stx1a | 667 |
Ppfia3 | 569 |
Tspoap1 | -373 |
Rab3a | -655 |
CHOLESTEROL BIOSYNTHESIS
148 | |
---|---|
set | CHOLESTEROL BIOSYNTHESIS |
setSize | 24 |
pANOVA | 3.84e-05 |
s.dist | -0.485 |
p.adjustANOVA | 0.00063 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Idi1 | -8905 |
Msmo1 | -8816 |
Sqle | -8815 |
Cyp51 | -8456 |
Acat3 | -8369 |
Mvd | -8188 |
Sc5d | -8185 |
Hmgcs1 | -7923 |
Fdps | -7793 |
Mvk | -7773 |
Ebp | -6416 |
Hsd17b7 | -6386 |
Fdft1 | -6244 |
Ggps1 | -6129 |
Pmvk | -4568 |
Lbr | -4403 |
Nsdhl | -3436 |
Lss | -2755 |
Dhcr24 | -2128 |
Hmgcr | 1279 |
GeneID | Gene Rank |
---|---|
Idi1 | -8905 |
Msmo1 | -8816 |
Sqle | -8815 |
Cyp51 | -8456 |
Acat3 | -8369 |
Mvd | -8188 |
Sc5d | -8185 |
Hmgcs1 | -7923 |
Fdps | -7793 |
Mvk | -7773 |
Ebp | -6416 |
Hsd17b7 | -6386 |
Fdft1 | -6244 |
Ggps1 | -6129 |
Pmvk | -4568 |
Lbr | -4403 |
Nsdhl | -3436 |
Lss | -2755 |
Dhcr24 | -2128 |
Hmgcr | 1279 |
Arv1 | 2846 |
Dhcr7 | 4058 |
Tm7sf2 | 5062 |
Plpp6 | 5401 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY
841 | |
---|---|
set | RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY |
setSize | 95 |
pANOVA | 4.52e-16 |
s.dist | -0.482 |
p.adjustANOVA | 8.91e-14 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ddit3 | -8873 |
Atf3 | -8436 |
Rpl11 | -7708 |
Rps23 | -7621 |
Rpl27 | -7486 |
Rpl31 | -7476 |
Rps8 | -7336 |
Eif2s1 | -7333 |
Rpl26 | -7286 |
Rpl24 | -7198 |
Rps25 | -7195 |
Rps12 | -7156 |
Rps24 | -6975 |
Rps27a | -6969 |
Rpl22l1 | -6859 |
Rpl39 | -6805 |
Rpl17 | -6723 |
Rpl19 | -6713 |
Rpl13a | -6693 |
Rps19 | -6667 |
GeneID | Gene Rank |
---|---|
Ddit3 | -8873 |
Atf3 | -8436 |
Rpl11 | -7708 |
Rps23 | -7621 |
Rpl27 | -7486 |
Rpl31 | -7476 |
Rps8 | -7336 |
Eif2s1 | -7333 |
Rpl26 | -7286 |
Rpl24 | -7198 |
Rps25 | -7195 |
Rps12 | -7156 |
Rps24 | -6975 |
Rps27a | -6969 |
Rpl22l1 | -6859 |
Rpl39 | -6805 |
Rpl17 | -6723 |
Rpl19 | -6713 |
Rpl13a | -6693 |
Rps19 | -6667 |
Rps11 | -6647 |
Impact | -6590 |
Rps3a1 | -6556 |
Cebpg | -6496 |
Fau | -6452 |
Rpl35 | -6281 |
Rpl36a | -6272 |
Rps7 | -6226 |
Rpl23a | -6214 |
Rps15 | -6157 |
Rps3 | -6040 |
Rpl27a | -6018 |
Rpl36al | -6014 |
Rpl9 | -6004 |
Rpl35a | -5975 |
Rpl34 | -5963 |
Rps27 | -5938 |
Rps10 | -5925 |
Rpl13 | -5924 |
Rpl6 | -5898 |
Rps26 | -5809 |
Rps17 | -5738 |
Rpl21 | -5718 |
Rpl37a | -5672 |
Rpl7 | -5582 |
Atf4 | -5578 |
Rpsa | -5493 |
Rps9 | -5458 |
Rps27l | -5441 |
Rpl14 | -5423 |
Rpl4 | -5373 |
Rpl23 | -5330 |
Rps18 | -5277 |
Rps20 | -5257 |
Rpl37 | -5237 |
Rps16 | -5226 |
Rpl10a | -5182 |
Rpl32 | -5161 |
Rps21 | -4966 |
Eif2s2 | -4953 |
Rpl3 | -4794 |
Rpl38 | -4676 |
Rps5 | -4675 |
Rps6 | -4661 |
Rpl36 | -4525 |
Rplp0 | -4097 |
Rpl8 | -4033 |
Rps14 | -4004 |
Rplp1 | -3988 |
Rpl18 | -3948 |
Rpl7a | -3883 |
Rps4x | -3874 |
Rpl30 | -3803 |
Trib3 | -3166 |
Rps28 | -3120 |
Rps13 | -2924 |
Uba52 | -2734 |
Atf2 | -2467 |
Rps2 | -2210 |
Rplp2 | -1540 |
Rpl12 | -1415 |
Rpl28 | -1401 |
Rpl29 | -1236 |
Rpl18a | -1198 |
Rpl15 | -1189 |
Rps29 | -259 |
Eif2s3x | 18 |
Rps15a | 399 |
Cebpb | 2021 |
Rpl22 | 2503 |
Asns | 4233 |
Rpl5 | 6278 |
Eif2ak4 | 6628 |
Gcn1 | 7143 |
Rpl10 | 8261 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE
1014 | |
---|---|
set | SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE |
setSize | 106 |
pANOVA | 1.9e-17 |
s.dist | -0.478 |
p.adjustANOVA | 7.48e-15 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Sec11a | -7800 |
Rpl11 | -7708 |
Rps23 | -7621 |
Rpl27 | -7486 |
Rpl31 | -7476 |
Rps8 | -7336 |
Rpl26 | -7286 |
Srp14 | -7210 |
Rpl24 | -7198 |
Rps25 | -7195 |
Rps12 | -7156 |
Sec11c | -7082 |
Rps24 | -6975 |
Rps27a | -6969 |
Rpl22l1 | -6859 |
Rpl39 | -6805 |
Rpl17 | -6723 |
Rpl19 | -6713 |
Rpl13a | -6693 |
Rps19 | -6667 |
GeneID | Gene Rank |
---|---|
Sec11a | -7800 |
Rpl11 | -7708 |
Rps23 | -7621 |
Rpl27 | -7486 |
Rpl31 | -7476 |
Rps8 | -7336 |
Rpl26 | -7286 |
Srp14 | -7210 |
Rpl24 | -7198 |
Rps25 | -7195 |
Rps12 | -7156 |
Sec11c | -7082 |
Rps24 | -6975 |
Rps27a | -6969 |
Rpl22l1 | -6859 |
Rpl39 | -6805 |
Rpl17 | -6723 |
Rpl19 | -6713 |
Rpl13a | -6693 |
Rps19 | -6667 |
Rps11 | -6647 |
Rps3a1 | -6556 |
Fau | -6452 |
Spcs2 | -6336 |
Rpl35 | -6281 |
Rpl36a | -6272 |
Rps7 | -6226 |
Rpl23a | -6214 |
Spcs3 | -6189 |
Ssr3 | -6185 |
Rps15 | -6157 |
Rps3 | -6040 |
Rpl27a | -6018 |
Rpl36al | -6014 |
Rpl9 | -6004 |
Rpl35a | -5975 |
Rpl34 | -5963 |
Rps27 | -5938 |
Rps10 | -5925 |
Rpl13 | -5924 |
Rpl6 | -5898 |
Rps26 | -5809 |
Srp19 | -5747 |
Rps17 | -5738 |
Rpl21 | -5718 |
Rpl37a | -5672 |
Rpl7 | -5582 |
Tram1 | -5545 |
Rpsa | -5493 |
Rps9 | -5458 |
Rps27l | -5441 |
Rpl14 | -5423 |
Rpl4 | -5373 |
Rpl23 | -5330 |
Rps18 | -5277 |
Rps20 | -5257 |
Rpl37 | -5237 |
Rps16 | -5226 |
Srp9 | -5217 |
Rpl10a | -5182 |
Rpl32 | -5161 |
Ssr4 | -5160 |
Rps21 | -4966 |
Rpl3 | -4794 |
Spcs1 | -4766 |
Rpn1 | -4732 |
Srprb | -4700 |
Rpl38 | -4676 |
Rps5 | -4675 |
Rps6 | -4661 |
Rpl36 | -4525 |
Rplp0 | -4097 |
Rpl8 | -4033 |
Rps14 | -4004 |
Rplp1 | -3988 |
Sec61b | -3987 |
Rpl18 | -3948 |
Rpl7a | -3883 |
Rps4x | -3874 |
Rpl30 | -3803 |
Ddost | -3644 |
Ssr2 | -3395 |
Sec61g | -3212 |
Rps28 | -3120 |
Rps13 | -2924 |
Uba52 | -2734 |
Rps2 | -2210 |
Sec61a1 | -1917 |
Rplp2 | -1540 |
Rpl12 | -1415 |
Rpl28 | -1401 |
Rpl29 | -1236 |
Rpl18a | -1198 |
Rpl15 | -1189 |
Rps29 | -259 |
Rps15a | 399 |
Rpn2 | 610 |
Srp68 | 1093 |
Ssr1 | 1530 |
Srp54a | 2064 |
Rpl22 | 2503 |
Srpr | 2632 |
Sec61a2 | 2848 |
Srp72 | 4040 |
Rpl5 | 6278 |
Rpl10 | 8261 |
CGMP EFFECTS
144 | |
---|---|
set | CGMP EFFECTS |
setSize | 15 |
pANOVA | 0.00177 |
s.dist | 0.466 |
p.adjustANOVA | 0.0153 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pde1a | 8170 |
Pde2a | 8151 |
Kcnma1 | 7305 |
Irag1 | 6527 |
Itpr1 | 6448 |
Pde9a | 6422 |
Prkg1 | 6273 |
Kcnmb4 | 5894 |
Pde11a | 5655 |
Pde10a | 5262 |
Pde1b | 5227 |
Pde5a | 3744 |
Kcnmb2 | -641 |
Kcnmb1 | -7801 |
Prkg2 | -8674 |
GeneID | Gene Rank |
---|---|
Pde1a | 8170 |
Pde2a | 8151 |
Kcnma1 | 7305 |
Irag1 | 6527 |
Itpr1 | 6448 |
Pde9a | 6422 |
Prkg1 | 6273 |
Kcnmb4 | 5894 |
Pde11a | 5655 |
Pde10a | 5262 |
Pde1b | 5227 |
Pde5a | 3744 |
Kcnmb2 | -641 |
Kcnmb1 | -7801 |
Prkg2 | -8674 |
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC
341 | |
---|---|
set | FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC |
setSize | 19 |
pANOVA | 0.00074 |
s.dist | -0.447 |
p.adjustANOVA | 0.00747 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cct6a | -8719 |
Cct4 | -8600 |
Cct3 | -8472 |
Tubb2b | -8362 |
Cct7 | -8082 |
Cct5 | -7980 |
Cct2 | -7639 |
Tcp1 | -6822 |
Tubb4b | -6225 |
Tuba1a | -5910 |
Tubb2a | -4830 |
Cct8 | -4816 |
Tuba1b | -3302 |
Tubb3 | -2952 |
Tubb4a | -2063 |
Tuba4a | -520 |
Tubb6 | 373 |
Tuba8 | 8044 |
Tuba1c | 8476 |
GeneID | Gene Rank |
---|---|
Cct6a | -8719 |
Cct4 | -8600 |
Cct3 | -8472 |
Tubb2b | -8362 |
Cct7 | -8082 |
Cct5 | -7980 |
Cct2 | -7639 |
Tcp1 | -6822 |
Tubb4b | -6225 |
Tuba1a | -5910 |
Tubb2a | -4830 |
Cct8 | -4816 |
Tuba1b | -3302 |
Tubb3 | -2952 |
Tubb4a | -2063 |
Tuba4a | -520 |
Tubb6 | 373 |
Tuba8 | 8044 |
Tuba1c | 8476 |
REDUCTION OF CYTOSOLIC CA LEVELS
787 | |
---|---|
set | REDUCTION OF CYTOSOLIC CA LEVELS |
setSize | 11 |
pANOVA | 0.0104 |
s.dist | 0.446 |
p.adjustANOVA | 0.0623 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Atp2b1 | 7624 |
Atp2b4 | 7525 |
Atp2a3 | 7380 |
Slc8a2 | 7173 |
Atp2b2 | 6848 |
Slc8a3 | 5990 |
Atp2b3 | 5886 |
Slc8a1 | 1694 |
Atp2a2 | -2163 |
Calm1 | -3498 |
Sri | -3863 |
GeneID | Gene Rank |
---|---|
Atp2b1 | 7624 |
Atp2b4 | 7525 |
Atp2a3 | 7380 |
Slc8a2 | 7173 |
Atp2b2 | 6848 |
Slc8a3 | 5990 |
Atp2b3 | 5886 |
Slc8a1 | 1694 |
Atp2a2 | -2163 |
Calm1 | -3498 |
Sri | -3863 |
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S
28 | |
---|---|
set | ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S |
setSize | 59 |
pANOVA | 3.28e-09 |
s.dist | -0.445 |
p.adjustANOVA | 1.8e-07 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Eif3j2 | -8498 |
Rps23 | -7621 |
Eif3a | -7614 |
Rps8 | -7336 |
Eif2s1 | -7333 |
Rps25 | -7195 |
Rps12 | -7156 |
Rps24 | -6975 |
Rps27a | -6969 |
Eif4a2 | -6837 |
Eif3g | -6727 |
Rps19 | -6667 |
Rps11 | -6647 |
Rps3a1 | -6556 |
Eif3k | -6484 |
Eif4a1 | -6470 |
Fau | -6452 |
Eif3h | -6311 |
Rps7 | -6226 |
Rps15 | -6157 |
GeneID | Gene Rank |
---|---|
Eif3j2 | -8498 |
Rps23 | -7621 |
Eif3a | -7614 |
Rps8 | -7336 |
Eif2s1 | -7333 |
Rps25 | -7195 |
Rps12 | -7156 |
Rps24 | -6975 |
Rps27a | -6969 |
Eif4a2 | -6837 |
Eif3g | -6727 |
Rps19 | -6667 |
Rps11 | -6647 |
Rps3a1 | -6556 |
Eif3k | -6484 |
Eif4a1 | -6470 |
Fau | -6452 |
Eif3h | -6311 |
Rps7 | -6226 |
Rps15 | -6157 |
Rps3 | -6040 |
Rps27 | -5938 |
Rps10 | -5925 |
Rps26 | -5809 |
Rps17 | -5738 |
Eif3i | -5680 |
Eif1ax | -5511 |
Rpsa | -5493 |
Rps9 | -5458 |
Rps27l | -5441 |
Rps18 | -5277 |
Rps20 | -5257 |
Rps16 | -5226 |
Rps21 | -4966 |
Eif2s2 | -4953 |
Rps5 | -4675 |
Rps6 | -4661 |
Pabpc1 | -4581 |
Eif3e | -4358 |
Rps14 | -4004 |
Rps4x | -3874 |
Eif3m | -3404 |
Eif4e | -3136 |
Rps28 | -3120 |
Rps13 | -2924 |
Rps2 | -2210 |
Eif3f | -1564 |
Eif3j1 | -1026 |
Eif4ebp1 | -975 |
Eif3d | -274 |
Rps29 | -259 |
Eif2s3x | 18 |
Rps15a | 399 |
Eif3b | 1266 |
Eif3l | 1306 |
Eif4g1 | 3758 |
Eif4h | 4068 |
Eif3c | 5492 |
Eif4b | 7706 |
ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES
75 | |
---|---|
set | ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES |
setSize | 10 |
pANOVA | 0.0148 |
s.dist | 0.445 |
p.adjustANOVA | 0.0809 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Mbtps1 | 8232 |
Angptl4 | 7492 |
Furin | 7476 |
Creb3l3 | 7315 |
Pcsk5 | 5812 |
Lmf1 | 5802 |
Lpl | 3697 |
Mbtps2 | 1558 |
Pcsk6 | -5185 |
Lmf2 | -5383 |
GeneID | Gene Rank |
---|---|
Mbtps1 | 8232 |
Angptl4 | 7492 |
Furin | 7476 |
Creb3l3 | 7315 |
Pcsk5 | 5812 |
Lmf1 | 5802 |
Lpl | 3697 |
Mbtps2 | 1558 |
Pcsk6 | -5185 |
Lmf2 | -5383 |
LONG TERM POTENTIATION
522 | |
---|---|
set | LONG TERM POTENTIATION |
setSize | 23 |
pANOVA | 0.000245 |
s.dist | 0.442 |
p.adjustANOVA | 0.00289 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Grin2a | 8460 |
Grin2c | 8431 |
Nrgn | 8390 |
Camk2b | 8091 |
Grin2b | 7962 |
Camk2a | 7879 |
Gria1 | 6723 |
Dlg2 | 6327 |
Dlg4 | 5548 |
Actn2 | 5460 |
Erbb4 | 5208 |
Camk2d | 3958 |
Grin1 | 3087 |
Gria2 | 2478 |
Dlg3 | 2466 |
Lrrc7 | 2033 |
Src | 1697 |
Nefl | -170 |
Nrg1 | -429 |
Grin2d | -693 |
GeneID | Gene Rank |
---|---|
Grin2a | 8460 |
Grin2c | 8431 |
Nrgn | 8390 |
Camk2b | 8091 |
Grin2b | 7962 |
Camk2a | 7879 |
Gria1 | 6723 |
Dlg2 | 6327 |
Dlg4 | 5548 |
Actn2 | 5460 |
Erbb4 | 5208 |
Camk2d | 3958 |
Grin1 | 3087 |
Gria2 | 2478 |
Dlg3 | 2466 |
Lrrc7 | 2033 |
Src | 1697 |
Nefl | -170 |
Nrg1 | -429 |
Grin2d | -693 |
Camk2g | -2707 |
Dlg1 | -2759 |
Calm1 | -3498 |
TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS
1111 | |
---|---|
set | TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS |
setSize | 17 |
pANOVA | 0.00166 |
s.dist | 0.44 |
p.adjustANOVA | 0.0148 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Grip1 | 7822 |
Prkcb | 7805 |
Prkca | 7669 |
Gria3 | 7618 |
Ap2b1 | 6804 |
Gria1 | 6723 |
Prkcg | 5625 |
Nsf | 4890 |
Ap2a1 | 4290 |
Grip2 | 4139 |
Gria2 | 2478 |
Pick1 | 1581 |
Tspan7 | 803 |
Ap2m1 | 557 |
Gria4 | -890 |
Ap2a2 | -1871 |
Ap2s1 | -4173 |
GeneID | Gene Rank |
---|---|
Grip1 | 7822 |
Prkcb | 7805 |
Prkca | 7669 |
Gria3 | 7618 |
Ap2b1 | 6804 |
Gria1 | 6723 |
Prkcg | 5625 |
Nsf | 4890 |
Ap2a1 | 4290 |
Grip2 | 4139 |
Gria2 | 2478 |
Pick1 | 1581 |
Tspan7 | 803 |
Ap2m1 | 557 |
Gria4 | -890 |
Ap2a2 | -1871 |
Ap2s1 | -4173 |
SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS
1004 | |
---|---|
set | SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS |
setSize | 11 |
pANOVA | 0.0117 |
s.dist | -0.439 |
p.adjustANOVA | 0.0669 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Snrpf | -7226 |
Snrpd3 | -6649 |
Lsm11 | -6397 |
Slbp | -6299 |
Snrpe | -5664 |
Snrpb | -4087 |
Lsm10 | -2996 |
Ncbp2 | -2209 |
Snrpg | -1906 |
Zfp473 | -1716 |
Ncbp1 | 509 |
GeneID | Gene Rank |
---|---|
Snrpf | -7226 |
Snrpd3 | -6649 |
Lsm11 | -6397 |
Slbp | -6299 |
Snrpe | -5664 |
Snrpb | -4087 |
Lsm10 | -2996 |
Ncbp2 | -2209 |
Snrpg | -1906 |
Zfp473 | -1716 |
Ncbp1 | 509 |
UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION
1161 | |
---|---|
set | UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION |
setSize | 21 |
pANOVA | 0.000524 |
s.dist | 0.437 |
p.adjustANOVA | 0.00564 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Grin2a | 8460 |
Grin2c | 8431 |
Camk2b | 8091 |
Grin2b | 7962 |
Camk2a | 7879 |
Gria3 | 7618 |
Gria1 | 6723 |
Dlg2 | 6327 |
Dlg4 | 5548 |
Actn2 | 5460 |
Camk2d | 3958 |
Grin1 | 3087 |
Gria2 | 2478 |
Dlg3 | 2466 |
Lrrc7 | 2033 |
Nefl | -170 |
Grin2d | -693 |
Gria4 | -890 |
Camk2g | -2707 |
Dlg1 | -2759 |
GeneID | Gene Rank |
---|---|
Grin2a | 8460 |
Grin2c | 8431 |
Camk2b | 8091 |
Grin2b | 7962 |
Camk2a | 7879 |
Gria3 | 7618 |
Gria1 | 6723 |
Dlg2 | 6327 |
Dlg4 | 5548 |
Actn2 | 5460 |
Camk2d | 3958 |
Grin1 | 3087 |
Gria2 | 2478 |
Dlg3 | 2466 |
Lrrc7 | 2033 |
Nefl | -170 |
Grin2d | -693 |
Gria4 | -890 |
Camk2g | -2707 |
Dlg1 | -2759 |
Calm1 | -3498 |
RESPIRATORY ELECTRON TRANSPORT
838 | |
---|---|
set | RESPIRATORY ELECTRON TRANSPORT |
setSize | 102 |
pANOVA | 2.5e-14 |
s.dist | -0.437 |
p.adjustANOVA | 3.28e-12 |
Top enriched genes
GeneID | Gene Rank |
---|---|
mt-Nd6 | -8802 |
mt-Nd2 | -8617 |
mt-Nd3 | -8399 |
Ndufaf2 | -8280 |
mt-Nd4 | -8047 |
Ndufaf5 | -7997 |
Ndufaf4 | -7906 |
mt-Nd5 | -7797 |
mt-Co3 | -7668 |
mt-Co2 | -7592 |
mt-Nd1 | -7586 |
Ndufa6 | -7485 |
Coq10b | -7404 |
mt-Co1 | -7188 |
Ndufaf6 | -7045 |
Ndufb5 | -6979 |
Tmem186 | -6968 |
Cox16 | -6867 |
mt-Cytb | -6802 |
Ndufv2 | -6747 |
GeneID | Gene Rank |
---|---|
mt-Nd6 | -8802 |
mt-Nd2 | -8617 |
mt-Nd3 | -8399 |
Ndufaf2 | -8280 |
mt-Nd4 | -8047 |
Ndufaf5 | -7997 |
Ndufaf4 | -7906 |
mt-Nd5 | -7797 |
mt-Co3 | -7668 |
mt-Co2 | -7592 |
mt-Nd1 | -7586 |
Ndufa6 | -7485 |
Coq10b | -7404 |
mt-Co1 | -7188 |
Ndufaf6 | -7045 |
Ndufb5 | -6979 |
Tmem186 | -6968 |
Cox16 | -6867 |
mt-Cytb | -6802 |
Ndufv2 | -6747 |
Ndufc1 | -6577 |
Cox11 | -6479 |
Uqcr10 | -6314 |
Acad9 | -6205 |
Uqcrh | -6107 |
Ndufa4 | -6059 |
Ndufb2 | -5991 |
Ndufb8 | -5944 |
Tmem126b | -5928 |
Ndufs5 | -5901 |
Ndufb7 | -5832 |
Ndufaf1 | -5819 |
Cox19 | -5623 |
Ndufb6 | -5617 |
Ndufb1 | -5610 |
Ndufb9 | -5554 |
Ndufb11 | -5506 |
Nubpl | -5459 |
Ndufs4 | -5453 |
Cycs | -5431 |
Cox6c | -5366 |
Ndufb3 | -5347 |
Ndufa7 | -5328 |
Ndufa11 | -5284 |
Timmdc1 | -5194 |
Cox7c | -5170 |
Uqcrq | -5122 |
Cox7a2l | -5118 |
Ndufa2 | -4952 |
Cox7b | -4937 |
Sco2 | -4847 |
Ndufb4 | -4836 |
Ndufc2 | -4687 |
Cox5a | -4660 |
Ndufa8 | -4285 |
Uqcrc2 | -4226 |
Ndufs6 | -4125 |
Sdhc | -4031 |
Uqcrb | -3805 |
Cox4i1 | -3773 |
Uqcrc1 | -3688 |
Cox6b1 | -3552 |
Cox18 | -3386 |
Sdhb | -3338 |
Ndufs8 | -3266 |
Ndufb10 | -3215 |
Cox8a | -3134 |
Ndufv3 | -3043 |
Cox5b | -2962 |
Ndufa3 | -2882 |
Ndufa5 | -2863 |
Cyc1 | -2440 |
Etfdh | -2320 |
Ndufa9 | -2263 |
Uqcr11 | -2258 |
Taco1 | -2193 |
Uqcrfs1 | -2059 |
Cox6a1 | -1961 |
Ndufa1 | -1801 |
Sdhd | -1687 |
Etfb | -1615 |
Ndufa10 | -1508 |
Ndufa12 | -1388 |
Ndufs3 | -1228 |
Ecsit | -1156 |
Cox20 | -1148 |
Ndufs7 | -1125 |
Coq10a | -963 |
Ndufv1 | -937 |
Ndufaf7 | -936 |
Etfa | -835 |
Ndufab1 | -800 |
Ndufa13 | -554 |
Surf1 | -326 |
Ndufs2 | 484 |
Cox14 | 759 |
Sdha | 1760 |
Ndufaf3 | 2156 |
Trap1 | 3342 |
Ndufs1 | 3474 |
Lrpprc | 5296 |
Sco1 | 6559 |
COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING
180 | |
---|---|
set | COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING |
setSize | 35 |
pANOVA | 8.65e-06 |
s.dist | -0.434 |
p.adjustANOVA | 0.000189 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cct6a | -8719 |
Cct4 | -8600 |
Gng5 | -8487 |
Cct3 | -8472 |
Cct7 | -8082 |
Cct5 | -7980 |
Gna14 | -7943 |
Gng11 | -7683 |
Cct2 | -7639 |
Gng13 | -7337 |
Gng10 | -6910 |
Gng2 | -6879 |
Tcp1 | -6822 |
Rgs7 | -6598 |
Gngt2 | -6500 |
Csnk2a1 | -6471 |
Gnb4 | -6235 |
Gnaq | -5480 |
Cct8 | -4816 |
Gng3 | -4364 |
GeneID | Gene Rank |
---|---|
Cct6a | -8719 |
Cct4 | -8600 |
Gng5 | -8487 |
Cct3 | -8472 |
Cct7 | -8082 |
Cct5 | -7980 |
Gna14 | -7943 |
Gng11 | -7683 |
Cct2 | -7639 |
Gng13 | -7337 |
Gng10 | -6910 |
Gng2 | -6879 |
Tcp1 | -6822 |
Rgs7 | -6598 |
Gngt2 | -6500 |
Csnk2a1 | -6471 |
Gnb4 | -6235 |
Gnaq | -5480 |
Cct8 | -4816 |
Gng3 | -4364 |
Rgs11 | -3585 |
Gna11 | -3107 |
Gna15 | -2602 |
Gnb5 | -2168 |
Gnb2 | -2000 |
Gnb1 | -1413 |
Rgs6 | -874 |
Pdcl | -395 |
Gng8 | -185 |
Csnk2b | -168 |
Gng4 | 1097 |
Csnk2a2 | 1549 |
Gng12 | 1797 |
Rgs9 | 6688 |
Gng7 | 6965 |
VOLTAGE GATED POTASSIUM CHANNELS
1174 | |
---|---|
set | VOLTAGE GATED POTASSIUM CHANNELS |
setSize | 39 |
pANOVA | 4.31e-06 |
s.dist | 0.425 |
p.adjustANOVA | 0.000121 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Kcnf1 | 8468 |
Kcna5 | 8440 |
Kcnd1 | 8141 |
Kcng1 | 8072 |
Kcnh3 | 8018 |
Kcng2 | 7849 |
Kcnh8 | 7748 |
Kcnab2 | 7592 |
Kcnq5 | 7555 |
Kcns2 | 7490 |
Kcnab3 | 7401 |
Kcnab1 | 7219 |
Kcnv1 | 6837 |
Kcnq3 | 6767 |
Kcnq2 | 6412 |
Kcnh7 | 6320 |
Kcnb1 | 5744 |
Kcnd3 | 5156 |
Kcna1 | 5098 |
Kcnc1 | 4914 |
GeneID | Gene Rank |
---|---|
Kcnf1 | 8468 |
Kcna5 | 8440 |
Kcnd1 | 8141 |
Kcng1 | 8072 |
Kcnh3 | 8018 |
Kcng2 | 7849 |
Kcnh8 | 7748 |
Kcnab2 | 7592 |
Kcnq5 | 7555 |
Kcns2 | 7490 |
Kcnab3 | 7401 |
Kcnab1 | 7219 |
Kcnv1 | 6837 |
Kcnq3 | 6767 |
Kcnq2 | 6412 |
Kcnh7 | 6320 |
Kcnb1 | 5744 |
Kcnd3 | 5156 |
Kcna1 | 5098 |
Kcnc1 | 4914 |
Kcnh1 | 4798 |
Kcnc2 | 4352 |
Kcnh6 | 4244 |
Kcnc4 | 3861 |
Kcna2 | 3842 |
Kcnh4 | 1902 |
Kcnh5 | 1813 |
Kcns1 | 1324 |
Kcnd2 | 820 |
Kcnq4 | 122 |
Kcng4 | -51 |
Kcnc3 | -681 |
Kcnh2 | -2652 |
Kcna3 | -2904 |
Kcnb2 | -3221 |
Kcna4 | -3835 |
Kcna6 | -5517 |
Kcnq1 | -5542 |
Kcns3 | -7345 |
GLYCOGEN STORAGE DISEASES
392 | |
---|---|
set | GLYCOGEN STORAGE DISEASES |
setSize | 12 |
pANOVA | 0.0108 |
s.dist | -0.425 |
p.adjustANOVA | 0.0635 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ppp1r3c | -8232 |
G6pc3 | -8009 |
Gbe1 | -7817 |
Gyg | -7417 |
Rps27a | -6969 |
Ubb | -4777 |
Gaa | -4751 |
Uba52 | -2734 |
Nhlrc1 | -1594 |
Ubc | -1368 |
Gys1 | -859 |
Epm2a | 7324 |
GeneID | Gene Rank |
---|---|
Ppp1r3c | -8232 |
G6pc3 | -8009 |
Gbe1 | -7817 |
Gyg | -7417 |
Rps27a | -6969 |
Ubb | -4777 |
Gaa | -4751 |
Uba52 | -2734 |
Nhlrc1 | -1594 |
Ubc | -1368 |
Gys1 | -859 |
Epm2a | 7324 |
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES
1038 | |
---|---|
set | SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES |
setSize | 29 |
pANOVA | 7.53e-05 |
s.dist | -0.425 |
p.adjustANOVA | 0.00111 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Uchl3 | -8664 |
Ube2g1 | -8540 |
Uba6 | -8424 |
Ube2r2 | -8423 |
Ube2q2 | -8239 |
Ube2a | -7963 |
Ube2e3 | -7698 |
Ube2b | -7423 |
Ube2w | -7079 |
Rps27a | -6969 |
Ube2d1 | -6673 |
Ube2e1 | -5840 |
Ube2k | -5688 |
Ubb | -4777 |
Ube2s | -4597 |
Usp5 | -4082 |
Ube2d2a | -3441 |
Usp7 | -2796 |
Uba52 | -2734 |
Usp9x | -2601 |
GeneID | Gene Rank |
---|---|
Uchl3 | -8664 |
Ube2g1 | -8540 |
Uba6 | -8424 |
Ube2r2 | -8423 |
Ube2q2 | -8239 |
Ube2a | -7963 |
Ube2e3 | -7698 |
Ube2b | -7423 |
Ube2w | -7079 |
Rps27a | -6969 |
Ube2d1 | -6673 |
Ube2e1 | -5840 |
Ube2k | -5688 |
Ubb | -4777 |
Ube2s | -4597 |
Usp5 | -4082 |
Ube2d2a | -3441 |
Usp7 | -2796 |
Uba52 | -2734 |
Usp9x | -2601 |
Ube2l3 | -2221 |
Cdc34 | -1886 |
Ubc | -1368 |
Ube2h | -334 |
Ube2g2 | -207 |
Uba1 | 1239 |
Ube2z | 1521 |
Ube2t | 5970 |
Otulin | 6027 |
EUKARYOTIC TRANSLATION INITIATION
307 | |
---|---|
set | EUKARYOTIC TRANSLATION INITIATION |
setSize | 114 |
pANOVA | 6.04e-15 |
s.dist | -0.423 |
p.adjustANOVA | 8.91e-13 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Eif3j2 | -8498 |
Rpl11 | -7708 |
Rps23 | -7621 |
Eif3a | -7614 |
Rpl27 | -7486 |
Rpl31 | -7476 |
Rps8 | -7336 |
Eif2s1 | -7333 |
Rpl26 | -7286 |
Rpl24 | -7198 |
Rps25 | -7195 |
Rps12 | -7156 |
Rps24 | -6975 |
Rps27a | -6969 |
Rpl22l1 | -6859 |
Eif4a2 | -6837 |
Rpl39 | -6805 |
Eif3g | -6727 |
Rpl17 | -6723 |
Rpl19 | -6713 |
GeneID | Gene Rank |
---|---|
Eif3j2 | -8498 |
Rpl11 | -7708 |
Rps23 | -7621 |
Eif3a | -7614 |
Rpl27 | -7486 |
Rpl31 | -7476 |
Rps8 | -7336 |
Eif2s1 | -7333 |
Rpl26 | -7286 |
Rpl24 | -7198 |
Rps25 | -7195 |
Rps12 | -7156 |
Rps24 | -6975 |
Rps27a | -6969 |
Rpl22l1 | -6859 |
Eif4a2 | -6837 |
Rpl39 | -6805 |
Eif3g | -6727 |
Rpl17 | -6723 |
Rpl19 | -6713 |
Rpl13a | -6693 |
Rps19 | -6667 |
Rps11 | -6647 |
Rps3a1 | -6556 |
Eif3k | -6484 |
Eif4a1 | -6470 |
Fau | -6452 |
Eif3h | -6311 |
Rpl35 | -6281 |
Rpl36a | -6272 |
Rps7 | -6226 |
Rpl23a | -6214 |
Rps15 | -6157 |
Rps3 | -6040 |
Rpl27a | -6018 |
Eif2b2 | -6017 |
Rpl36al | -6014 |
Rpl9 | -6004 |
Rpl35a | -5975 |
Rpl34 | -5963 |
Rps27 | -5938 |
Rps10 | -5925 |
Rpl13 | -5924 |
Rpl6 | -5898 |
Rps26 | -5809 |
Rps17 | -5738 |
Rpl21 | -5718 |
Eif3i | -5680 |
Rpl37a | -5672 |
Rpl7 | -5582 |
Eif1ax | -5511 |
Rpsa | -5493 |
Rps9 | -5458 |
Rps27l | -5441 |
Rpl14 | -5423 |
Rpl4 | -5373 |
Rpl23 | -5330 |
Rps18 | -5277 |
Rps20 | -5257 |
Rpl37 | -5237 |
Rps16 | -5226 |
Rpl10a | -5182 |
Rpl32 | -5161 |
Rps21 | -4966 |
Eif2s2 | -4953 |
Rpl3 | -4794 |
Rpl38 | -4676 |
Rps5 | -4675 |
Rps6 | -4661 |
Pabpc1 | -4581 |
Rpl36 | -4525 |
Eif3e | -4358 |
Rplp0 | -4097 |
Rpl8 | -4033 |
Rps14 | -4004 |
Rplp1 | -3988 |
Rpl18 | -3948 |
Rpl7a | -3883 |
Rps4x | -3874 |
Rpl30 | -3803 |
Eif3m | -3404 |
Eif4e | -3136 |
Rps28 | -3120 |
Rps13 | -2924 |
Uba52 | -2734 |
Rps2 | -2210 |
Eif3f | -1564 |
Rplp2 | -1540 |
Eif5b | -1448 |
Rpl12 | -1415 |
Rpl28 | -1401 |
Rpl29 | -1236 |
Rpl18a | -1198 |
Rpl15 | -1189 |
Eif3j1 | -1026 |
Eif4ebp1 | -975 |
Eif3d | -274 |
Rps29 | -259 |
Eif2s3x | 18 |
Rps15a | 399 |
Eif3b | 1266 |
Eif3l | 1306 |
Eif2b5 | 1397 |
Eif5 | 2012 |
Eif2b3 | 2399 |
Rpl22 | 2503 |
Eif2b1 | 3257 |
Eif4g1 | 3758 |
Eif4h | 4068 |
Eif3c | 5492 |
Rpl5 | 6278 |
Eif4b | 7706 |
Eif2b4 | 7959 |
Rpl10 | 8261 |
AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA
85 | |
---|---|
set | AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA |
setSize | 53 |
pANOVA | 1.1e-07 |
s.dist | -0.422 |
p.adjustANOVA | 4.8e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Hspa1a | -8857 |
Hspb1 | -8786 |
Hspa8 | -8371 |
Psma4 | -8222 |
Psma1 | -8126 |
Psmd5 | -8116 |
Psmd12 | -7812 |
Psmc6 | -7536 |
Psmc2 | -7131 |
Psmd14 | -7122 |
Rps27a | -6969 |
Psmb3 | -6924 |
Psma7 | -6871 |
Psmd1 | -6789 |
Psma3 | -6623 |
Sem1 | -6563 |
Psma6 | -6549 |
Psme2 | -6497 |
Psmb1 | -6399 |
Psmb6 | -6200 |
GeneID | Gene Rank |
---|---|
Hspa1a | -8857 |
Hspb1 | -8786 |
Hspa8 | -8371 |
Psma4 | -8222 |
Psma1 | -8126 |
Psmd5 | -8116 |
Psmd12 | -7812 |
Psmc6 | -7536 |
Psmc2 | -7131 |
Psmd14 | -7122 |
Rps27a | -6969 |
Psmb3 | -6924 |
Psma7 | -6871 |
Psmd1 | -6789 |
Psma3 | -6623 |
Sem1 | -6563 |
Psma6 | -6549 |
Psme2 | -6497 |
Psmb1 | -6399 |
Psmb6 | -6200 |
Psma2 | -6169 |
Psmd10 | -5518 |
Psmd6 | -5516 |
Psme1 | -5290 |
Psmb9 | -4797 |
Ubb | -4777 |
Psmb4 | -4713 |
Pabpc1 | -4581 |
Psmb8 | -4445 |
Psmd11 | -4311 |
Psmb5 | -3923 |
Psmb10 | -3806 |
Psmd4 | -3790 |
Psmc5 | -3637 |
Psmc1 | -3600 |
Psmc3 | -3073 |
Uba52 | -2734 |
Psma5 | -2323 |
Psmc4 | -1980 |
Ubc | -1368 |
Psmb7 | -1285 |
Psmd8 | -1101 |
Psmd9 | -960 |
Psmb2 | -709 |
Psmd13 | -469 |
Psmd3 | 6 |
Psmd7 | 94 |
Psme3 | 2393 |
Psmf1 | 2577 |
Hnrnpd | 2868 |
Eif4g1 | 3758 |
Psmd2 | 6444 |
Psme4 | 6731 |
RHOBTB2 GTPASE CYCLE
863 | |
---|---|
set | RHOBTB2 GTPASE CYCLE |
setSize | 23 |
pANOVA | 0.000491 |
s.dist | -0.42 |
p.adjustANOVA | 0.00537 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Hsp90aa1 | -8747 |
Cct6a | -8719 |
Txnl1 | -8636 |
Tra2b | -8448 |
Hsp90ab1 | -8390 |
Cct7 | -8082 |
Cct2 | -7639 |
Phip | -7120 |
Hnrnpc | -6170 |
Rhobtb2 | -5762 |
Tmod3 | -5346 |
Cul3 | -5038 |
Actn1 | -4466 |
Actg1 | -2753 |
Cdc37 | -2743 |
Twf1 | -1625 |
Ddx39b | -1194 |
Msi2 | -842 |
Stk38 | -318 |
Myo6 | 1081 |
GeneID | Gene Rank |
---|---|
Hsp90aa1 | -8747 |
Cct6a | -8719 |
Txnl1 | -8636 |
Tra2b | -8448 |
Hsp90ab1 | -8390 |
Cct7 | -8082 |
Cct2 | -7639 |
Phip | -7120 |
Hnrnpc | -6170 |
Rhobtb2 | -5762 |
Tmod3 | -5346 |
Cul3 | -5038 |
Actn1 | -4466 |
Actg1 | -2753 |
Cdc37 | -2743 |
Twf1 | -1625 |
Ddx39b | -1194 |
Msi2 | -842 |
Stk38 | -318 |
Myo6 | 1081 |
Srrm1 | 1991 |
Dbn1 | 2458 |
Rbmx | 7118 |
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX
147 | |
---|---|
set | CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX |
setSize | 10 |
pANOVA | 0.0223 |
s.dist | -0.417 |
p.adjustANOVA | 0.11 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ywhaq | -7442 |
Chek2 | -6324 |
Chek1 | -6321 |
Ywhab | -6041 |
Ywhah | -4995 |
Ywhae | -4529 |
Wee1 | -3670 |
Sfn | -451 |
Ywhaz | 364 |
Ywhag | 735 |
GeneID | Gene Rank |
---|---|
Ywhaq | -7442 |
Chek2 | -6324 |
Chek1 | -6321 |
Ywhab | -6041 |
Ywhah | -4995 |
Ywhae | -4529 |
Wee1 | -3670 |
Sfn | -451 |
Ywhaz | 364 |
Ywhag | 735 |
EFFECTS OF PIP2 HYDROLYSIS
277 | |
---|---|
set | EFFECTS OF PIP2 HYDROLYSIS |
setSize | 27 |
pANOVA | 0.000177 |
s.dist | 0.417 |
p.adjustANOVA | 0.0022 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rasgrp1 | 8463 |
Daglb | 8136 |
Trpc3 | 7237 |
Dgkz | 7169 |
Dgke | 6963 |
Prkce | 6907 |
Itpr1 | 6448 |
Dgkg | 6136 |
Dgkh | 6101 |
Dagla | 5723 |
Rasgrp2 | 5523 |
Itpr3 | 5255 |
Dgkd | 4810 |
Dgka | 4614 |
Prkcq | 4210 |
Dgkb | 3652 |
Prkcd | 3422 |
Mgll | 3420 |
Dgki | 2434 |
Dgkq | 2366 |
GeneID | Gene Rank |
---|---|
Rasgrp1 | 8463 |
Daglb | 8136 |
Trpc3 | 7237 |
Dgkz | 7169 |
Dgke | 6963 |
Prkce | 6907 |
Itpr1 | 6448 |
Dgkg | 6136 |
Dgkh | 6101 |
Dagla | 5723 |
Rasgrp2 | 5523 |
Itpr3 | 5255 |
Dgkd | 4810 |
Dgka | 4614 |
Prkcq | 4210 |
Dgkb | 3652 |
Prkcd | 3422 |
Mgll | 3420 |
Dgki | 2434 |
Dgkq | 2366 |
Dgkk | 1818 |
Prkch | -1728 |
Itpr2 | -2124 |
Abhd12 | -3156 |
Trpc7 | -3402 |
Trpc6 | -3864 |
Abhd6 | -3891 |
REGULATION OF EXPRESSION OF SLITS AND ROBOS
794 | |
---|---|
set | REGULATION OF EXPRESSION OF SLITS AND ROBOS |
setSize | 161 |
pANOVA | 1.06e-19 |
s.dist | -0.415 |
p.adjustANOVA | 6.27e-17 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Magohb | -8868 |
Rbm8a | -8725 |
Psma4 | -8222 |
Psma1 | -8126 |
Psmd5 | -8116 |
Psmd12 | -7812 |
Isl1 | -7810 |
Rpl11 | -7708 |
Rps23 | -7621 |
Psmc6 | -7536 |
Rpl27 | -7486 |
Rpl31 | -7476 |
Rps8 | -7336 |
Magoh | -7335 |
Rpl26 | -7286 |
Cul2 | -7279 |
Eloc | -7250 |
Rpl24 | -7198 |
Rps25 | -7195 |
Lhx3 | -7168 |
GeneID | Gene Rank |
---|---|
Magohb | -8868 |
Rbm8a | -8725 |
Psma4 | -8222 |
Psma1 | -8126 |
Psmd5 | -8116 |
Psmd12 | -7812 |
Isl1 | -7810 |
Rpl11 | -7708 |
Rps23 | -7621 |
Psmc6 | -7536 |
Rpl27 | -7486 |
Rpl31 | -7476 |
Rps8 | -7336 |
Magoh | -7335 |
Rpl26 | -7286 |
Cul2 | -7279 |
Eloc | -7250 |
Rpl24 | -7198 |
Rps25 | -7195 |
Lhx3 | -7168 |
Rps12 | -7156 |
Psmc2 | -7131 |
Psmd14 | -7122 |
Rps24 | -6975 |
Rps27a | -6969 |
Psmb3 | -6924 |
Psma7 | -6871 |
Rpl22l1 | -6859 |
Rpl39 | -6805 |
Psmd1 | -6789 |
Rpl17 | -6723 |
Rpl19 | -6713 |
Rpl13a | -6693 |
Rps19 | -6667 |
Rps11 | -6647 |
Psma3 | -6623 |
Usp33 | -6601 |
Sem1 | -6563 |
Rps3a1 | -6556 |
Psma6 | -6549 |
Psme2 | -6497 |
Fau | -6452 |
Psmb1 | -6399 |
Rpl35 | -6281 |
Rpl36a | -6272 |
Rps7 | -6226 |
Rpl23a | -6214 |
Psmb6 | -6200 |
Psma2 | -6169 |
Rps15 | -6157 |
Rps3 | -6040 |
Rpl27a | -6018 |
Rpl36al | -6014 |
Rpl9 | -6004 |
Rpl35a | -5975 |
Rpl34 | -5963 |
Rps27 | -5938 |
Rps10 | -5925 |
Rpl13 | -5924 |
Rpl6 | -5898 |
Rps26 | -5809 |
Rps17 | -5738 |
Rpl21 | -5718 |
Rpl37a | -5672 |
Gspt2 | -5653 |
Upf3b | -5630 |
Rpl7 | -5582 |
Psmd10 | -5518 |
Psmd6 | -5516 |
Rpsa | -5493 |
Rps9 | -5458 |
Rps27l | -5441 |
Rpl14 | -5423 |
Rpl4 | -5373 |
Rpl23 | -5330 |
Psme1 | -5290 |
Rps18 | -5277 |
Rps20 | -5257 |
Rpl37 | -5237 |
Rps16 | -5226 |
Rpl10a | -5182 |
Rpl32 | -5161 |
Elob | -5042 |
Rps21 | -4966 |
Etf1 | -4927 |
Psmb9 | -4797 |
Rpl3 | -4794 |
Ubb | -4777 |
Psmb4 | -4713 |
Rpl38 | -4676 |
Rps5 | -4675 |
Rps6 | -4661 |
Pabpc1 | -4581 |
Rpl36 | -4525 |
Slit2 | -4481 |
Psmb8 | -4445 |
Psmd11 | -4311 |
Rplp0 | -4097 |
Rpl8 | -4033 |
Rps14 | -4004 |
Rplp1 | -3988 |
Rpl18 | -3948 |
Psmb5 | -3923 |
Rpl7a | -3883 |
Rps4x | -3874 |
Psmb10 | -3806 |
Rpl30 | -3803 |
Psmd4 | -3790 |
Upf2 | -3777 |
Psmc5 | -3637 |
Psmc1 | -3600 |
Col4a5 | -3522 |
Rps28 | -3120 |
Psmc3 | -3073 |
Robo1 | -2972 |
Rps13 | -2924 |
Uba52 | -2734 |
Rnps1 | -2644 |
Psma5 | -2323 |
Rps2 | -2210 |
Ncbp2 | -2209 |
Psmc4 | -1980 |
Rplp2 | -1540 |
Rpl12 | -1415 |
Rpl28 | -1401 |
Ubc | -1368 |
Psmb7 | -1285 |
Rpl29 | -1236 |
Rpl18a | -1198 |
Rpl15 | -1189 |
Psmd8 | -1101 |
Psmd9 | -960 |
Dag1 | -957 |
Msi1 | -814 |
Psmb2 | -709 |
Psmd13 | -469 |
Rps29 | -259 |
Psmd3 | 6 |
Psmd7 | 94 |
Rbx1 | 254 |
Rps15a | 399 |
Ncbp1 | 509 |
Ldb1 | 1371 |
Eif4a3 | 1717 |
Lhx9 | 1718 |
Gspt1 | 1743 |
Zswim8 | 2125 |
Psme3 | 2393 |
Rpl22 | 2503 |
Psmf1 | 2577 |
Eif4g1 | 3758 |
Slit1 | 4222 |
Casc3 | 5442 |
Rpl5 | 6278 |
Psmd2 | 6444 |
Psme4 | 6731 |
Robo3 | 6841 |
Upf3a | 6897 |
Robo2 | 7529 |
Rpl10 | 8261 |
Lhx2 | 8445 |
TRAFFICKING OF AMPA RECEPTORS
1110 | |
---|---|
set | TRAFFICKING OF AMPA RECEPTORS |
setSize | 31 |
pANOVA | 7.78e-05 |
s.dist | 0.41 |
p.adjustANOVA | 0.00113 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Camk2b | 8091 |
Camk2a | 7879 |
Grip1 | 7822 |
Prkcb | 7805 |
Prkca | 7669 |
Gria3 | 7618 |
Cacng8 | 7544 |
Ap2b1 | 6804 |
Gria1 | 6723 |
Akap5 | 6720 |
Epb41l1 | 6521 |
Cacng3 | 5787 |
Prkcg | 5625 |
Dlg4 | 5548 |
Mdm2 | 4949 |
Nsf | 4890 |
Ap2a1 | 4290 |
Grip2 | 4139 |
Camk2d | 3958 |
Gria2 | 2478 |
GeneID | Gene Rank |
---|---|
Camk2b | 8091 |
Camk2a | 7879 |
Grip1 | 7822 |
Prkcb | 7805 |
Prkca | 7669 |
Gria3 | 7618 |
Cacng8 | 7544 |
Ap2b1 | 6804 |
Gria1 | 6723 |
Akap5 | 6720 |
Epb41l1 | 6521 |
Cacng3 | 5787 |
Prkcg | 5625 |
Dlg4 | 5548 |
Mdm2 | 4949 |
Nsf | 4890 |
Ap2a1 | 4290 |
Grip2 | 4139 |
Camk2d | 3958 |
Gria2 | 2478 |
Pick1 | 1581 |
Myo6 | 1081 |
Tspan7 | 803 |
Ap2m1 | 557 |
Gria4 | -890 |
Ap2a2 | -1871 |
Camk2g | -2707 |
Dlg1 | -2759 |
Ap2s1 | -4173 |
Cacng2 | -4848 |
Cacng4 | -5166 |
SCF SKP2 MEDIATED DEGRADATION OF P27 P21
912 | |
---|---|
set | SCF SKP2 MEDIATED DEGRADATION OF P27 P21 |
setSize | 60 |
pANOVA | 5.02e-08 |
s.dist | -0.407 |
p.adjustANOVA | 2.47e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ccnd1 | -8489 |
Psma4 | -8222 |
Psma1 | -8126 |
Psmd5 | -8116 |
Ccne2 | -8004 |
Psmd12 | -7812 |
Skp1 | -7696 |
Ccna1 | -7547 |
Psmc6 | -7536 |
Cks1b | -7205 |
Psmc2 | -7131 |
Psmd14 | -7122 |
Rps27a | -6969 |
Psmb3 | -6924 |
Psma7 | -6871 |
Psmd1 | -6789 |
Psma3 | -6623 |
Sem1 | -6563 |
Psma6 | -6549 |
Psme2 | -6497 |
GeneID | Gene Rank |
---|---|
Ccnd1 | -8489 |
Psma4 | -8222 |
Psma1 | -8126 |
Psmd5 | -8116 |
Ccne2 | -8004 |
Psmd12 | -7812 |
Skp1 | -7696 |
Ccna1 | -7547 |
Psmc6 | -7536 |
Cks1b | -7205 |
Psmc2 | -7131 |
Psmd14 | -7122 |
Rps27a | -6969 |
Psmb3 | -6924 |
Psma7 | -6871 |
Psmd1 | -6789 |
Psma3 | -6623 |
Sem1 | -6563 |
Psma6 | -6549 |
Psme2 | -6497 |
Cdkn1b | -6455 |
Psmb1 | -6399 |
Psmb6 | -6200 |
Psma2 | -6169 |
Psmd10 | -5518 |
Psmd6 | -5516 |
Psme1 | -5290 |
Psmb9 | -4797 |
Cdk2 | -4790 |
Ubb | -4777 |
Psmb4 | -4713 |
Psmb8 | -4445 |
Psmd11 | -4311 |
Cdk4 | -3955 |
Psmb5 | -3923 |
Psmb10 | -3806 |
Psmd4 | -3790 |
Psmc5 | -3637 |
Psmc1 | -3600 |
Psmc3 | -3073 |
Uba52 | -2734 |
Psma5 | -2323 |
Ccna2 | -2156 |
Psmc4 | -1980 |
Ubc | -1368 |
Psmb7 | -1285 |
Psmd8 | -1101 |
Psmd9 | -960 |
Psmb2 | -709 |
Psmd13 | -469 |
Psmd3 | 6 |
Psmd7 | 94 |
Ptk6 | 357 |
Skp2 | 1496 |
Psme3 | 2393 |
Psmf1 | 2577 |
Ccne1 | 4569 |
Cul1 | 5941 |
Psmd2 | 6444 |
Cdkn1a | 7257 |
SELENOAMINO ACID METABOLISM
915 | |
---|---|
set | SELENOAMINO ACID METABOLISM |
setSize | 110 |
pANOVA | 3.4e-13 |
s.dist | -0.402 |
p.adjustANOVA | 3.34e-11 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Dars | -8650 |
Gsr | -8534 |
Hnmt | -8159 |
Rpl11 | -7708 |
Rps23 | -7621 |
Rpl27 | -7486 |
Rpl31 | -7476 |
Rps8 | -7336 |
Rpl26 | -7286 |
Rpl24 | -7198 |
Rps25 | -7195 |
Rps12 | -7156 |
Aimp2 | -7104 |
Txnrd1 | -7012 |
Rps24 | -6975 |
Rps27a | -6969 |
Rpl22l1 | -6859 |
Rpl39 | -6805 |
Rpl17 | -6723 |
Rpl19 | -6713 |
GeneID | Gene Rank |
---|---|
Dars | -8650 |
Gsr | -8534 |
Hnmt | -8159 |
Rpl11 | -7708 |
Rps23 | -7621 |
Rpl27 | -7486 |
Rpl31 | -7476 |
Rps8 | -7336 |
Rpl26 | -7286 |
Rpl24 | -7198 |
Rps25 | -7195 |
Rps12 | -7156 |
Aimp2 | -7104 |
Txnrd1 | -7012 |
Rps24 | -6975 |
Rps27a | -6969 |
Rpl22l1 | -6859 |
Rpl39 | -6805 |
Rpl17 | -6723 |
Rpl19 | -6713 |
Rpl13a | -6693 |
Rps19 | -6667 |
Rps11 | -6647 |
Rps3a1 | -6556 |
Fau | -6452 |
Rpl35 | -6281 |
Rpl36a | -6272 |
Rps7 | -6226 |
Rpl23a | -6214 |
Rps15 | -6157 |
Rps3 | -6040 |
Rpl27a | -6018 |
Rpl36al | -6014 |
Rpl9 | -6004 |
Rpl35a | -5975 |
Rpl34 | -5963 |
Rps27 | -5938 |
Rps10 | -5925 |
Rpl13 | -5924 |
Rpl6 | -5898 |
Rps26 | -5809 |
Rps17 | -5738 |
Rpl21 | -5718 |
Rpl37a | -5672 |
Sephs2 | -5621 |
Rpl7 | -5582 |
Rpsa | -5493 |
Rps9 | -5458 |
Rps27l | -5441 |
Rpl14 | -5423 |
Rpl4 | -5373 |
Papss2 | -5334 |
Rpl23 | -5330 |
Rps18 | -5277 |
Rps20 | -5257 |
Rpl37 | -5237 |
Rps16 | -5226 |
Rpl10a | -5182 |
Rpl32 | -5161 |
Rps21 | -4966 |
Rpl3 | -4794 |
Rpl38 | -4676 |
Rps5 | -4675 |
Rps6 | -4661 |
Rpl36 | -4525 |
Eef1e1 | -4455 |
Kars | -4270 |
Rplp0 | -4097 |
Rpl8 | -4033 |
Rps14 | -4004 |
Rplp1 | -3988 |
Rpl18 | -3948 |
Rpl7a | -3883 |
Rps4x | -3874 |
Rpl30 | -3803 |
Secisbp2 | -3220 |
Rps28 | -3120 |
Aimp1 | -3085 |
Rps13 | -2924 |
Uba52 | -2734 |
Rps2 | -2210 |
Rars | -1631 |
Rplp2 | -1540 |
Cth | -1423 |
Rpl12 | -1415 |
Rpl28 | -1401 |
Ahcy | -1310 |
Qars | -1292 |
Rpl29 | -1236 |
Rpl18a | -1198 |
Rpl15 | -1189 |
Pstk | -1081 |
Sars | -588 |
Rps29 | -259 |
Papss1 | 169 |
Rps15a | 399 |
Inmt | 482 |
Mars1 | 1183 |
Nnmt | 2106 |
Rpl22 | 2503 |
Gnmt | 3157 |
Scly | 3531 |
Iars | 3800 |
Eefsec | 4448 |
Rpl5 | 6278 |
Sepsecs | 7338 |
Lars | 7807 |
Cbs | 7892 |
Eprs | 8243 |
Rpl10 | 8261 |
STAT5 ACTIVATION DOWNSTREAM OF FLT3 ITD MUTANTS
1016 | |
---|---|
set | STAT5 ACTIVATION DOWNSTREAM OF FLT3 ITD MUTANTS |
setSize | 10 |
pANOVA | 0.028 |
s.dist | 0.401 |
p.adjustANOVA | 0.132 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Bcl2l1 | 7588 |
Stat5a | 7340 |
Cdkn1a | 7257 |
Ptpn11 | 7155 |
Pim1 | 3119 |
Flt3 | 2865 |
Nox4 | 1526 |
Stat5b | 335 |
Grb2 | -921 |
Gab2 | -3280 |
GeneID | Gene Rank |
---|---|
Bcl2l1 | 7588 |
Stat5a | 7340 |
Cdkn1a | 7257 |
Ptpn11 | 7155 |
Pim1 | 3119 |
Flt3 | 2865 |
Nox4 | 1526 |
Stat5b | 335 |
Grb2 | -921 |
Gab2 | -3280 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12
40 | |
---|---|
set | ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 |
setSize | 19 |
pANOVA | 0.00248 |
s.dist | -0.401 |
p.adjustANOVA | 0.0196 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Gng5 | -8487 |
Gnai1 | -8311 |
Gng11 | -7683 |
Gng13 | -7337 |
Gng10 | -6910 |
Gng2 | -6879 |
Gngt2 | -6500 |
Gnb4 | -6235 |
Gnai2 | -5305 |
Gng3 | -4364 |
P2ry12 | -4332 |
Gnai3 | -2476 |
Gnb5 | -2168 |
Gnb2 | -2000 |
Gnb1 | -1413 |
Gng8 | -185 |
Gng4 | 1097 |
Gng12 | 1797 |
Gng7 | 6965 |
GeneID | Gene Rank |
---|---|
Gng5 | -8487 |
Gnai1 | -8311 |
Gng11 | -7683 |
Gng13 | -7337 |
Gng10 | -6910 |
Gng2 | -6879 |
Gngt2 | -6500 |
Gnb4 | -6235 |
Gnai2 | -5305 |
Gng3 | -4364 |
P2ry12 | -4332 |
Gnai3 | -2476 |
Gnb5 | -2168 |
Gnb2 | -2000 |
Gnb1 | -1413 |
Gng8 | -185 |
Gng4 | 1097 |
Gng12 | 1797 |
Gng7 | 6965 |
GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION
369 | |
---|---|
set | GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION |
setSize | 19 |
pANOVA | 0.00249 |
s.dist | 0.401 |
p.adjustANOVA | 0.0196 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Slc6a1 | 7904 |
Cplx1 | 6715 |
Slc32a1 | 6480 |
Slc6a13 | 6375 |
Gad1 | 6214 |
Syt1 | 6183 |
Slc6a12 | 6157 |
Rims1 | 6058 |
Gad2 | 4846 |
Dnajc5 | 3788 |
Abat | 3356 |
Vamp2 | 3219 |
Aldh5a1 | 3218 |
Snap25 | 2565 |
Stxbp1 | 1550 |
Stx1a | 667 |
Rab3a | -655 |
Slc6a11 | -3724 |
Hspa8 | -8371 |
GeneID | Gene Rank |
---|---|
Slc6a1 | 7904 |
Cplx1 | 6715 |
Slc32a1 | 6480 |
Slc6a13 | 6375 |
Gad1 | 6214 |
Syt1 | 6183 |
Slc6a12 | 6157 |
Rims1 | 6058 |
Gad2 | 4846 |
Dnajc5 | 3788 |
Abat | 3356 |
Vamp2 | 3219 |
Aldh5a1 | 3218 |
Snap25 | 2565 |
Stxbp1 | 1550 |
Stx1a | 667 |
Rab3a | -655 |
Slc6a11 | -3724 |
Hspa8 | -8371 |
SIGNALING BY HIPPO
966 | |
---|---|
set | SIGNALING BY HIPPO |
setSize | 20 |
pANOVA | 0.002 |
s.dist | -0.399 |
p.adjustANOVA | 0.0166 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Amotl2 | -8930 |
Wwtr1 | -8746 |
Wwc1 | -8592 |
Tjp2 | -8464 |
Yap1 | -7838 |
Casp3 | -7787 |
Amot | -7034 |
Stk3 | -6995 |
Amotl1 | -6394 |
Ywhab | -6041 |
Tjp1 | -5599 |
Ywhae | -4529 |
Sav1 | -3646 |
Stk4 | -3450 |
Lats1 | 86 |
Mob1b | 592 |
Dvl2 | 2182 |
Lats2 | 2834 |
Mob1a | 5891 |
Nphp4 | 8319 |
GeneID | Gene Rank |
---|---|
Amotl2 | -8930 |
Wwtr1 | -8746 |
Wwc1 | -8592 |
Tjp2 | -8464 |
Yap1 | -7838 |
Casp3 | -7787 |
Amot | -7034 |
Stk3 | -6995 |
Amotl1 | -6394 |
Ywhab | -6041 |
Tjp1 | -5599 |
Ywhae | -4529 |
Sav1 | -3646 |
Stk4 | -3450 |
Lats1 | 86 |
Mob1b | 592 |
Dvl2 | 2182 |
Lats2 | 2834 |
Mob1a | 5891 |
Nphp4 | 8319 |
G PROTEIN ACTIVATION
358 | |
---|---|
set | G PROTEIN ACTIVATION |
setSize | 22 |
pANOVA | 0.00125 |
s.dist | -0.397 |
p.adjustANOVA | 0.0118 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Gng5 | -8487 |
Gna14 | -7943 |
Gng11 | -7683 |
Gng13 | -7337 |
Gng10 | -6910 |
Gng2 | -6879 |
Gngt2 | -6500 |
Gnb4 | -6235 |
Pomc | -6154 |
Gnaq | -5480 |
Gng3 | -4364 |
Pdyn | -4151 |
Gna11 | -3107 |
Gna15 | -2602 |
Gnb5 | -2168 |
Gnb2 | -2000 |
Oprm1 | -1470 |
Gnb1 | -1413 |
Gng8 | -185 |
Gng4 | 1097 |
GeneID | Gene Rank |
---|---|
Gng5 | -8487 |
Gna14 | -7943 |
Gng11 | -7683 |
Gng13 | -7337 |
Gng10 | -6910 |
Gng2 | -6879 |
Gngt2 | -6500 |
Gnb4 | -6235 |
Pomc | -6154 |
Gnaq | -5480 |
Gng3 | -4364 |
Pdyn | -4151 |
Gna11 | -3107 |
Gna15 | -2602 |
Gnb5 | -2168 |
Gnb2 | -2000 |
Oprm1 | -1470 |
Gnb1 | -1413 |
Gng8 | -185 |
Gng4 | 1097 |
Gng12 | 1797 |
Gng7 | 6965 |
HEDGEHOG LIGAND BIOGENESIS
416 | |
---|---|
set | HEDGEHOG LIGAND BIOGENESIS |
setSize | 61 |
pANOVA | 7.95e-08 |
s.dist | -0.397 |
p.adjustANOVA | 3.76e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Notum | -8940 |
Psma4 | -8222 |
Psma1 | -8126 |
Psmd5 | -8116 |
Gpc5 | -8079 |
Psmd12 | -7812 |
Derl2 | -7715 |
Psmc6 | -7536 |
Psmc2 | -7131 |
Psmd14 | -7122 |
Rps27a | -6969 |
Psmb3 | -6924 |
Psma7 | -6871 |
Psmd1 | -6789 |
Psma3 | -6623 |
Adam17 | -6621 |
Sem1 | -6563 |
Psma6 | -6549 |
Shh | -6509 |
Psme2 | -6497 |
GeneID | Gene Rank |
---|---|
Notum | -8940 |
Psma4 | -8222 |
Psma1 | -8126 |
Psmd5 | -8116 |
Gpc5 | -8079 |
Psmd12 | -7812 |
Derl2 | -7715 |
Psmc6 | -7536 |
Psmc2 | -7131 |
Psmd14 | -7122 |
Rps27a | -6969 |
Psmb3 | -6924 |
Psma7 | -6871 |
Psmd1 | -6789 |
Psma3 | -6623 |
Adam17 | -6621 |
Sem1 | -6563 |
Psma6 | -6549 |
Shh | -6509 |
Psme2 | -6497 |
Psmb1 | -6399 |
Psmb6 | -6200 |
Psma2 | -6169 |
Os9 | -5535 |
Psmd10 | -5518 |
Psmd6 | -5516 |
Psme1 | -5290 |
P4hb | -5239 |
Syvn1 | -4895 |
Psmb9 | -4797 |
Ubb | -4777 |
Psmb4 | -4713 |
Psmb8 | -4445 |
Psmd11 | -4311 |
Psmb5 | -3923 |
Psmb10 | -3806 |
Psmd4 | -3790 |
Psmc5 | -3637 |
Psmc1 | -3600 |
Psmc3 | -3073 |
Uba52 | -2734 |
Erlec1 | -2501 |
Psma5 | -2323 |
Psmc4 | -1980 |
Vcp | -1938 |
Ubc | -1368 |
Psmb7 | -1285 |
Psmd8 | -1101 |
Psmd9 | -960 |
Psmb2 | -709 |
Sel1l | -632 |
Psmd13 | -469 |
Psmd3 | 6 |
Psmd7 | 94 |
Psme3 | 2393 |
Psmf1 | 2577 |
Disp2 | 2722 |
Hhat | 5464 |
Psmd2 | 6444 |
Psme4 | 6731 |
Scube2 | 8271 |
MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS
570 | |
---|---|
set | MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS |
setSize | 13 |
pANOVA | 0.0133 |
s.dist | -0.397 |
p.adjustANOVA | 0.0745 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fdx1 | -8842 |
Slc25a28 | -8219 |
Fxn | -7931 |
Lyrm4 | -7646 |
Fdxr | -5019 |
Iscu | -4427 |
Glrx5 | -3504 |
Isca2 | -1713 |
Hscb | -1351 |
Nfs1 | -773 |
Fdx2 | -485 |
Slc25a37 | 268 |
Isca1 | 1738 |
GeneID | Gene Rank |
---|---|
Fdx1 | -8842 |
Slc25a28 | -8219 |
Fxn | -7931 |
Lyrm4 | -7646 |
Fdxr | -5019 |
Iscu | -4427 |
Glrx5 | -3504 |
Isca2 | -1713 |
Hscb | -1351 |
Nfs1 | -773 |
Fdx2 | -485 |
Slc25a37 | 268 |
Isca1 | 1738 |
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING
738 | |
---|---|
set | PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING |
setSize | 11 |
pANOVA | 0.0233 |
s.dist | 0.395 |
p.adjustANOVA | 0.114 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cacnb3 | 6899 |
Cacna1e | 6774 |
Cacna2d3 | 6369 |
Cacna1b | 5457 |
Cacnb2 | 5250 |
Cacna2d2 | 4713 |
Cacnb4 | 4421 |
Cacna1a | 4144 |
Cacnb1 | 1649 |
Cacng2 | -4848 |
Cacng4 | -5166 |
GeneID | Gene Rank |
---|---|
Cacnb3 | 6899 |
Cacna1e | 6774 |
Cacna2d3 | 6369 |
Cacna1b | 5457 |
Cacnb2 | 5250 |
Cacna2d2 | 4713 |
Cacnb4 | 4421 |
Cacna1a | 4144 |
Cacnb1 | 1649 |
Cacng2 | -4848 |
Cacng4 | -5166 |
PD 1 SIGNALING
685 | |
---|---|
set | PD 1 SIGNALING |
setSize | 10 |
pANOVA | 0.0316 |
s.dist | 0.393 |
p.adjustANOVA | 0.145 |
Top enriched genes
GeneID | Gene Rank |
---|---|
H2-Eb1 | 8451 |
H2-Ab1 | 8374 |
H2-Aa | 8315 |
Cd4 | 7561 |
Ptpn11 | 7155 |
Cd247 | 6302 |
Cd274 | 6041 |
Lck | -2803 |
Csk | -8465 |
Ptpn6 | -8713 |
GeneID | Gene Rank |
---|---|
H2-Eb1 | 8451 |
H2-Ab1 | 8374 |
H2-Aa | 8315 |
Cd4 | 7561 |
Ptpn11 | 7155 |
Cd247 | 6302 |
Cd274 | 6041 |
Lck | -2803 |
Csk | -8465 |
Ptpn6 | -8713 |
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY
821 | |
---|---|
set | REGULATION OF RUNX3 EXPRESSION AND ACTIVITY |
setSize | 53 |
pANOVA | 9.22e-07 |
s.dist | -0.39 |
p.adjustANOVA | 3.11e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cbfb | -8474 |
Psma4 | -8222 |
Psma1 | -8126 |
Psmd5 | -8116 |
Psmd12 | -7812 |
Psmc6 | -7536 |
Tgfb1 | -7445 |
Psmc2 | -7131 |
Psmd14 | -7122 |
Rps27a | -6969 |
Psmb3 | -6924 |
Psma7 | -6871 |
Psmd1 | -6789 |
Psma3 | -6623 |
Sem1 | -6563 |
Psma6 | -6549 |
Psme2 | -6497 |
Psmb1 | -6399 |
Psmb6 | -6200 |
Psma2 | -6169 |
GeneID | Gene Rank |
---|---|
Cbfb | -8474 |
Psma4 | -8222 |
Psma1 | -8126 |
Psmd5 | -8116 |
Psmd12 | -7812 |
Psmc6 | -7536 |
Tgfb1 | -7445 |
Psmc2 | -7131 |
Psmd14 | -7122 |
Rps27a | -6969 |
Psmb3 | -6924 |
Psma7 | -6871 |
Psmd1 | -6789 |
Psma3 | -6623 |
Sem1 | -6563 |
Psma6 | -6549 |
Psme2 | -6497 |
Psmb1 | -6399 |
Psmb6 | -6200 |
Psma2 | -6169 |
Psmd10 | -5518 |
Psmd6 | -5516 |
Psme1 | -5290 |
Psmb9 | -4797 |
Ubb | -4777 |
Psmb4 | -4713 |
Psmb8 | -4445 |
Psmd11 | -4311 |
Psmb5 | -3923 |
Psmb10 | -3806 |
Psmd4 | -3790 |
Psmc5 | -3637 |
Psmc1 | -3600 |
Psmc3 | -3073 |
Uba52 | -2734 |
Psma5 | -2323 |
Psmc4 | -1980 |
Smurf2 | -1709 |
Ubc | -1368 |
Psmb7 | -1285 |
Psmd8 | -1101 |
Psmd9 | -960 |
Psmb2 | -709 |
Psmd13 | -469 |
Psmd3 | 6 |
Psmd7 | 94 |
Ep300 | 1462 |
Src | 1697 |
Psme3 | 2393 |
Psmf1 | 2577 |
Mdm2 | 4949 |
Psmd2 | 6444 |
Smurf1 | 7044 |
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS
839 | |
---|---|
set | RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS |
setSize | 125 |
pANOVA | 8.49e-14 |
s.dist | -0.386 |
p.adjustANOVA | 1e-11 |
Top enriched genes
GeneID | Gene Rank |
---|---|
mt-Nd6 | -8802 |
mt-Nd2 | -8617 |
mt-Nd3 | -8399 |
Ndufaf2 | -8280 |
mt-Nd4 | -8047 |
Ndufaf5 | -7997 |
Ndufaf4 | -7906 |
mt-Nd5 | -7797 |
mt-Co3 | -7668 |
mt-Co2 | -7592 |
mt-Nd1 | -7586 |
Ndufa6 | -7485 |
Coq10b | -7404 |
mt-Co1 | -7188 |
Ndufaf6 | -7045 |
Ndufb5 | -6979 |
Tmem186 | -6968 |
Atp5h | -6957 |
Atp5pb | -6909 |
Cox16 | -6867 |
GeneID | Gene Rank |
---|---|
mt-Nd6 | -8802 |
mt-Nd2 | -8617 |
mt-Nd3 | -8399 |
Ndufaf2 | -8280 |
mt-Nd4 | -8047 |
Ndufaf5 | -7997 |
Ndufaf4 | -7906 |
mt-Nd5 | -7797 |
mt-Co3 | -7668 |
mt-Co2 | -7592 |
mt-Nd1 | -7586 |
Ndufa6 | -7485 |
Coq10b | -7404 |
mt-Co1 | -7188 |
Ndufaf6 | -7045 |
Ndufb5 | -6979 |
Tmem186 | -6968 |
Atp5h | -6957 |
Atp5pb | -6909 |
Cox16 | -6867 |
mt-Cytb | -6802 |
Ndufv2 | -6747 |
Ndufc1 | -6577 |
Cox11 | -6479 |
mt-Atp6 | -6402 |
Uqcr10 | -6314 |
Acad9 | -6205 |
Uqcrh | -6107 |
Ndufa4 | -6059 |
Ndufb2 | -5991 |
Ndufb8 | -5944 |
Tmem126b | -5928 |
Ndufs5 | -5901 |
Ndufb7 | -5832 |
Ndufaf1 | -5819 |
Cox19 | -5623 |
Ndufb6 | -5617 |
Ndufb1 | -5610 |
Ndufb9 | -5554 |
Atp5l | -5513 |
Ndufb11 | -5506 |
Nubpl | -5459 |
Ndufs4 | -5453 |
Cycs | -5431 |
Cox6c | -5366 |
Ndufb3 | -5347 |
Ndufa7 | -5328 |
Ndufa11 | -5284 |
Timmdc1 | -5194 |
Cox7c | -5170 |
Atp5j2 | -5123 |
Uqcrq | -5122 |
Cox7a2l | -5118 |
Atp5g1 | -5117 |
Atp5o | -5087 |
Slc25a14 | -4971 |
Ndufa2 | -4952 |
Atp5c1 | -4943 |
Cox7b | -4937 |
Sco2 | -4847 |
Ndufb4 | -4836 |
Ndufc2 | -4687 |
Cox5a | -4660 |
Ndufa8 | -4285 |
Uqcrc2 | -4226 |
Atp5j | -4220 |
Ndufs6 | -4125 |
Sdhc | -4031 |
Uqcrb | -3805 |
Atp5e | -3789 |
Cox4i1 | -3773 |
Uqcrc1 | -3688 |
Cox6b1 | -3552 |
Cox18 | -3386 |
Sdhb | -3338 |
Ndufs8 | -3266 |
Ndufb10 | -3215 |
Cox8a | -3134 |
Ndufv3 | -3043 |
Cox5b | -2962 |
Ndufa3 | -2882 |
Ndufa5 | -2863 |
Cyc1 | -2440 |
Etfdh | -2320 |
Ndufa9 | -2263 |
Uqcr11 | -2258 |
Taco1 | -2193 |
Uqcrfs1 | -2059 |
Cox6a1 | -1961 |
Ndufa1 | -1801 |
Sdhd | -1687 |
Etfb | -1615 |
Atp5k | -1551 |
Ndufa10 | -1508 |
Ndufa12 | -1388 |
Ndufs3 | -1228 |
Ecsit | -1156 |
Cox20 | -1148 |
Ndufs7 | -1125 |
mt-Atp8 | -995 |
Coq10a | -963 |
Atp5g3 | -955 |
Ndufv1 | -937 |
Ndufaf7 | -936 |
Etfa | -835 |
Ndufab1 | -800 |
Ndufa13 | -554 |
Pm20d1 | -515 |
Surf1 | -326 |
Atp5b | -255 |
Atp5g2 | 29 |
Atp5a1 | 91 |
Ndufs2 | 484 |
Cox14 | 759 |
Sdha | 1760 |
Ndufaf3 | 2156 |
Atp5d | 2427 |
Slc25a27 | 3270 |
Trap1 | 3342 |
Ndufs1 | 3474 |
Dmac2l | 3489 |
Lrpprc | 5296 |
Sco1 | 6559 |
Ucp2 | 8275 |
Ucp3 | 8522 |
DEGRADATION OF DVL
225 | |
---|---|
set | DEGRADATION OF DVL |
setSize | 55 |
pANOVA | 8.1e-07 |
s.dist | -0.385 |
p.adjustANOVA | 2.97e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Psma4 | -8222 |
Psma1 | -8126 |
Psmd5 | -8116 |
Psmd12 | -7812 |
Hecw1 | -7743 |
Psmc6 | -7536 |
Psmc2 | -7131 |
Psmd14 | -7122 |
Rps27a | -6969 |
Psmb3 | -6924 |
Psma7 | -6871 |
Psmd1 | -6789 |
Psma3 | -6623 |
Sem1 | -6563 |
Psma6 | -6549 |
Psme2 | -6497 |
Psmb1 | -6399 |
Psmb6 | -6200 |
Psma2 | -6169 |
Psmd10 | -5518 |
GeneID | Gene Rank |
---|---|
Psma4 | -8222 |
Psma1 | -8126 |
Psmd5 | -8116 |
Psmd12 | -7812 |
Hecw1 | -7743 |
Psmc6 | -7536 |
Psmc2 | -7131 |
Psmd14 | -7122 |
Rps27a | -6969 |
Psmb3 | -6924 |
Psma7 | -6871 |
Psmd1 | -6789 |
Psma3 | -6623 |
Sem1 | -6563 |
Psma6 | -6549 |
Psme2 | -6497 |
Psmb1 | -6399 |
Psmb6 | -6200 |
Psma2 | -6169 |
Psmd10 | -5518 |
Psmd6 | -5516 |
Dact1 | -5349 |
Psme1 | -5290 |
Cul3 | -5038 |
Psmb9 | -4797 |
Ubb | -4777 |
Psmb4 | -4713 |
Psmb8 | -4445 |
Psmd11 | -4311 |
Psmb5 | -3923 |
Psmb10 | -3806 |
Psmd4 | -3790 |
Psmc5 | -3637 |
Psmc1 | -3600 |
Psmc3 | -3073 |
Dvl1 | -3071 |
Uba52 | -2734 |
Psma5 | -2323 |
Psmc4 | -1980 |
Ubc | -1368 |
Psmb7 | -1285 |
Psmd8 | -1101 |
Psmd9 | -960 |
Psmb2 | -709 |
Psmd13 | -469 |
Psmd3 | 6 |
Psmd7 | 94 |
Rbx1 | 254 |
Klhl12 | 2142 |
Dvl2 | 2182 |
Psme3 | 2393 |
Psmf1 | 2577 |
Dvl3 | 2680 |
Psmd2 | 6444 |
Psme4 | 6731 |
NONSENSE MEDIATED DECAY NMD
634 | |
---|---|
set | NONSENSE MEDIATED DECAY NMD |
setSize | 109 |
pANOVA | 5.77e-12 |
s.dist | -0.382 |
p.adjustANOVA | 4.26e-10 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Magohb | -8868 |
Rbm8a | -8725 |
Rpl11 | -7708 |
Pnrc2 | -7691 |
Rps23 | -7621 |
Rpl27 | -7486 |
Rpl31 | -7476 |
Rps8 | -7336 |
Magoh | -7335 |
Rpl26 | -7286 |
Rpl24 | -7198 |
Rps25 | -7195 |
Rps12 | -7156 |
Rps24 | -6975 |
Rps27a | -6969 |
Rpl22l1 | -6859 |
Rpl39 | -6805 |
Rpl17 | -6723 |
Rpl19 | -6713 |
Rpl13a | -6693 |
GeneID | Gene Rank |
---|---|
Magohb | -8868 |
Rbm8a | -8725 |
Rpl11 | -7708 |
Pnrc2 | -7691 |
Rps23 | -7621 |
Rpl27 | -7486 |
Rpl31 | -7476 |
Rps8 | -7336 |
Magoh | -7335 |
Rpl26 | -7286 |
Rpl24 | -7198 |
Rps25 | -7195 |
Rps12 | -7156 |
Rps24 | -6975 |
Rps27a | -6969 |
Rpl22l1 | -6859 |
Rpl39 | -6805 |
Rpl17 | -6723 |
Rpl19 | -6713 |
Rpl13a | -6693 |
Rps19 | -6667 |
Rps11 | -6647 |
Rps3a1 | -6556 |
Fau | -6452 |
Rpl35 | -6281 |
Rpl36a | -6272 |
Rps7 | -6226 |
Rpl23a | -6214 |
Rps15 | -6157 |
Rps3 | -6040 |
Rpl27a | -6018 |
Rpl36al | -6014 |
Rpl9 | -6004 |
Rpl35a | -5975 |
Rpl34 | -5963 |
Rps27 | -5938 |
Rps10 | -5925 |
Rpl13 | -5924 |
Rpl6 | -5898 |
Rps26 | -5809 |
Rps17 | -5738 |
Rpl21 | -5718 |
Rpl37a | -5672 |
Gspt2 | -5653 |
Upf3b | -5630 |
Rpl7 | -5582 |
Rpsa | -5493 |
Rps9 | -5458 |
Rps27l | -5441 |
Rpl14 | -5423 |
Rpl4 | -5373 |
Rpl23 | -5330 |
Rps18 | -5277 |
Rps20 | -5257 |
Rpl37 | -5237 |
Rps16 | -5226 |
Rpl10a | -5182 |
Rpl32 | -5161 |
Rps21 | -4966 |
Etf1 | -4927 |
Rpl3 | -4794 |
Rpl38 | -4676 |
Rps5 | -4675 |
Rps6 | -4661 |
Pabpc1 | -4581 |
Rpl36 | -4525 |
Rplp0 | -4097 |
Rpl8 | -4033 |
Rps14 | -4004 |
Ppp2r2a | -4000 |
Rplp1 | -3988 |
Rpl18 | -3948 |
Rpl7a | -3883 |
Rps4x | -3874 |
Rpl30 | -3803 |
Upf2 | -3777 |
Rps28 | -3120 |
Rps13 | -2924 |
Uba52 | -2734 |
Rnps1 | -2644 |
Rps2 | -2210 |
Ncbp2 | -2209 |
Ppp2ca | -1882 |
Rplp2 | -1540 |
Rpl12 | -1415 |
Rpl28 | -1401 |
Rpl29 | -1236 |
Rpl18a | -1198 |
Rpl15 | -1189 |
Rps29 | -259 |
Rps15a | 399 |
Ncbp1 | 509 |
Eif4a3 | 1717 |
Gspt1 | 1743 |
Rpl22 | 2503 |
Ppp2r1a | 2658 |
Smg7 | 2856 |
Eif4g1 | 3758 |
Upf1 | 4027 |
Smg1 | 4271 |
Smg8 | 5067 |
Casc3 | 5442 |
Rpl5 | 6278 |
Smg9 | 6307 |
Upf3a | 6897 |
Dcp1a | 7048 |
Smg6 | 7408 |
Smg5 | 8166 |
Rpl10 | 8261 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.2.1 (2022-06-23)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.1 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3
## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] stats4 stats graphics grDevices utils datasets methods
## [8] base
##
## other attached packages:
## [1] pkgload_1.3.0 GGally_2.1.2
## [3] gtools_3.9.3 echarts4r_0.4.4
## [5] beeswarm_0.4.0 vioplot_0.3.7
## [7] sm_2.2-5.7.1 kableExtra_1.3.4
## [9] topconfects_1.12.0 limma_3.52.4
## [11] eulerr_6.1.1 mitch_1.8.0
## [13] MASS_7.3-58.1 fgsea_1.22.0
## [15] gplots_3.1.3 DESeq2_1.36.0
## [17] SummarizedExperiment_1.26.1 Biobase_2.56.0
## [19] MatrixGenerics_1.8.1 matrixStats_0.62.0
## [21] GenomicRanges_1.48.0 GenomeInfoDb_1.32.4
## [23] IRanges_2.30.1 S4Vectors_0.34.0
## [25] BiocGenerics_0.42.0 reshape2_1.4.4
## [27] forcats_0.5.2 stringr_1.4.1
## [29] dplyr_1.0.10 purrr_0.3.5
## [31] readr_2.1.3 tidyr_1.2.1
## [33] tibble_3.1.8 ggplot2_3.3.6
## [35] tidyverse_1.3.2 zoo_1.8-11
##
## loaded via a namespace (and not attached):
## [1] googledrive_2.0.0 colorspace_2.0-3 ellipsis_0.3.2
## [4] XVector_0.36.0 fs_1.5.2 rstudioapi_0.14
## [7] bit64_4.0.5 AnnotationDbi_1.58.0 fansi_1.0.3
## [10] lubridate_1.8.0 xml2_1.3.3 codetools_0.2-18
## [13] splines_4.2.1 cachem_1.0.6 knitr_1.40
## [16] geneplotter_1.74.0 jsonlite_1.8.2 broom_1.0.1
## [19] annotate_1.74.0 dbplyr_2.2.1 png_0.1-7
## [22] shiny_1.7.2 compiler_4.2.1 httr_1.4.4
## [25] backports_1.4.1 assertthat_0.2.1 Matrix_1.5-1
## [28] fastmap_1.1.0 gargle_1.2.1 cli_3.4.1
## [31] later_1.3.0 htmltools_0.5.3 tools_4.2.1
## [34] gtable_0.3.1 glue_1.6.2 GenomeInfoDbData_1.2.8
## [37] fastmatch_1.1-3 Rcpp_1.0.9 jquerylib_0.1.4
## [40] cellranger_1.1.0 vctrs_0.4.2 Biostrings_2.64.1
## [43] svglite_2.1.0 xfun_0.33 rvest_1.0.3
## [46] mime_0.12 lifecycle_1.0.3 XML_3.99-0.11
## [49] googlesheets4_1.0.1 zlibbioc_1.42.0 scales_1.2.1
## [52] hms_1.1.2 promises_1.2.0.1 parallel_4.2.1
## [55] RColorBrewer_1.1-3 yaml_2.3.5 memoise_2.0.1
## [58] gridExtra_2.3 sass_0.4.2 reshape_0.8.9
## [61] stringi_1.7.8 RSQLite_2.2.18 highr_0.9
## [64] genefilter_1.78.0 caTools_1.18.2 BiocParallel_1.30.3
## [67] systemfonts_1.0.4 rlang_1.0.6 pkgconfig_2.0.3
## [70] bitops_1.0-7 evaluate_0.17 lattice_0.20-45
## [73] htmlwidgets_1.5.4 bit_4.0.4 tidyselect_1.2.0
## [76] plyr_1.8.7 magrittr_2.0.3 R6_2.5.1
## [79] generics_0.1.3 DelayedArray_0.22.0 DBI_1.1.3
## [82] pillar_1.8.1 haven_2.5.1 withr_2.5.0
## [85] survival_3.4-0 KEGGREST_1.36.3 RCurl_1.98-1.9
## [88] modelr_0.1.9 crayon_1.5.2 KernSmooth_2.23-20
## [91] utf8_1.2.2 rmarkdown_2.17 tzdb_0.3.0
## [94] locfit_1.5-9.6 grid_4.2.1 readxl_1.4.1
## [97] data.table_1.14.2 blob_1.2.3 webshot_0.5.4
## [100] reprex_2.0.2 digest_0.6.29 xtable_1.8-4
## [103] httpuv_1.6.6 munsell_0.5.0 viridisLite_0.4.1
## [106] bslib_0.4.0
END of report